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ABSTRACT 
 
Ciliopathy disorders are associated with either abnormal formation or function 
of cilia. Mutations have been described in over 60 ciliary genes to date. With 
the identification of over 1,000 ciliary polypeptides, other disorders exhibiting 
ciliopathy features could result from mutations in other ciliary genes. A new 
ciliopathy disease gene, CENPF, has been identified in a kindred exhibiting 
midgestation lethality with congenital malformations suggestive of a novel 
ciliopathy phenotype. Where conventional approaches such as genome-wide 
linkage analysis and homozygosity mapping had failed, whole exome capture 
coupled with massive parallel deep sequencing was successful in elucidating the 
genetic cause in a single affected case. Identification of compound heterozygous 
mutations in the causative gene was facilitated through analysis of an unfiltered 
approach for depth of coverage. Utilising a combinatorial approach of 
comparative genomics and proteomics, a novel ciliogenic role for the causative 
gene was identified and proposed by modelling cenpf loss of function in D. 
rerio and supported by interactions found with Ift88 and Kif3b, key regulators 
of ciliogenesis. These data support emerging evidence for the existence of a 
cytoplasmic dynein 1– dependent multiprotein complex which has dual roles in 
mitosis and ciliogenesis. 
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CHAPTER 1. INTRODUCTION 
1.1 OVERVIEW OF CILIA BIOLOGY 
1.1.1 The structure of the primary cilium  
Projecting from the cell surface, cilia are microtubule based hair-
like cytoplasmic extensions with motile and sensory functions, which are 
critical for developmental and physiological functions (Afzelius, 1976; 
Barrett, 1947; Nonaka et al., 1998). Expressed on almost all eukaryotic 
cells, cilia show remarkable conservation from protozoa to humans, 
whereby as many as 1000 different polypeptides have been identified 
through combined genomics and proteomics studies, thereby highlighting 
their structural complexity (Blacque et al., 2004; Gherman et al., 2006). 
Comprising the microtubular backbone, the ciliary axoneme develops 
from and is anchored to a specialized centriole called the basal body, 
which acts as a microtubule organising centre for its ciliary counterpart 
(Figure 1.1). The ciliary axoneme consists of nine doublet microtubules 
that originate at the triplet microtubules of the basal body centriole and 
extend the length of the cilium. The ciliary gate lies proximal to the basal 
body and is composed of two structurally distinct sub-regions known as 
the transition fibres and the transition zone (TZ) (Omran et al, 2010). 
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Figure 1.1: Structure of non-motile and motile cilia. Cilia are 
cytoplasmic extensions projecting from the cell surface and are composed 
of a microtubular based ciliary axoneme. Representative cross-section 
transmission electron micrographs (TEM) from non-motile and motile 
cilia are shown on the left and right respectively. Motile cilia are 
characterized by the presence of nine peripheral doublet microtubules and 
a central doublet pair connected to the peripheral microtubule doublets by 
radial spoke proteins (orange). The outer dynein arms connect the 
peripheral microtubule doublets to the ciliary membrane (blue) while the 
inner dynein arms connect the outer doublet microtubules to the radial 
spoke proteins. Non-motile cilia are characterized by the absence of the 
central doublet pair. The basal body region is built from triplet 
microtubules, labelled A, B and C. The transition zone is where the 
microtubules are reorganized into pairs and anchor the pairs to the 
membrane. Transitional fibers and Y-links are shown by arrowheads in 
the TEM micrographs.Transitional fibers, which emanate from the distal 
end of the basal body and contact the ciliary membrane, are shown 
schematically and above these are the Y-linkers which link the 
microtubules to the ciliary membrane necklace. Within this region, these 
two membrane-contacting structures form a ciliary (flagellar) pore 
complex that restricts vesicle and perhaps protein entry into the organelle. 
(Adapted from Silverman et al, 2009). 
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Ciliary gate formation occurs during early ciliogenesis and precedes 
intraflagellar transport (IFT). The basal body terminates proximal to to 
the ciliary gate with the end of the C-tubule and the beginning of the 
transition fibres. While the basic structural components of the TZ appear 
to be conserved, the complexity of the TZ varies between species and 
cell-type (Fisch et al., 2011). The transition fibres arise from the B-
tubules of the basal body triplet and form a ‘pinwheel-like’ structure on 
TEM cross-sections. The microtubules are anchored to the plasma 
membrane by the tips of the transition fibres, which are observed on the 
mature mother centriole. Two proteins which have been implicated in this 
process include CEP164 and ODF2 (outer dense fibre 2/cenexin) (Graser 
et al, 2007; Ishikawa et al, 2005). IFT52 has also been observed on 
transition fibres in Chlamydomonas, suggesting that transition fibres play 
a role in docking IFT and motor proteins required for ciliogenesis (Deane 
et al, 2001). While the exact protein composition of the transition fibres is 
largely unknown, they are thought to form a pore complex similar to the 
nuclear pore complex and are required for transporting proteins in and out 
of cilia (Rosenbaum et al, 2002). 
Y-shaped linkers constitute another component of the TZ and are 
located on the distal side of the ciliary gate. They play a role in 
	   27	  
connecting the outer doublets of microtubules to the plasma membrane 
and the ciliary necklace (O’Toole et al, 2007). Encircling the ciliary 
membrane, the ciliary necklace is formed by strands of fibres which space 
from the membrane to the basal plate. In photoreceptor cells, CEP290 has 
been localized to the TZ of the connecting cilia (Craige et al, 2010). 
Similar to the transition fibres, the TZ has been proposed to regulate 
intracellular trafficking to and from the cilium. 
Depending on the cell type, ciliary morphology can diversify from 
the characteristic slender rod shape. An example of this diversification is 
exemplified by the connecting cilium of the rod and cone photoreceptor 
cells. Vertebrate photoreceptor cells are ciliated sensory cells specialized 
for single photon detection. The outer segment corresponds to the 
prototypical cilium. Within this compartment, membranous disks are 
enveloped by plasma membrane and constitute the highly modified 
ciliary membrane along which a centrin G-protein coupled receptor 
transduction pathway regulates the light driven translocation of the visual 
G-protein transducin through the connecting cilium. This light sensitive 
outer segment is linked to the inner segment by the connecting cilium 
which constitutes the TZ of the photoreceptor cell. The function and 
maintenance of photoreceptor cells is regulated by the import and export 
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of molecules into and out of the outer segment. Mediating this transport, 
are proteins implicated in intraflagellar transport as well as multiprotein 
complexes consisting of retinitis pigmentosa GTPase regulator (RPGR) 
and nephrocystin proteins. Photoreceptor cell death can occur if any of 
these proteins are defective as a result of mutations in the encoding genes 
and give rise to retinal degeneration underlying syndromic and non-
syndromic blindness (Roepman et al., 2007). 
Cilia fall into two broad functional categories: motile and non-
motile cilia. Motile cilia are distinguished from primary cilia by their 
ability to beat rhythmically, an activity which is powered by adenosine 
triphosphate (ATP), hydrolysed by dynein proteins which are anchored to 
the inner and outer aspects of peripheral doublet microtubules (Woolley, 
2000). Motile cilia are utilised in both unicellular and multicellular 
organisms for locomotion. In addition, beating cilia are located on the 
surfaces of cells of many tissues where they are utilised for creating 
localised fluid flow. For example, multiple motile cilia extending from 
cells lining the respiratory tract produce a continuous flow of mucus that 
is essential for pulmonary clearance (Stannard and O'Callaghan, 2006). 
Typically, motile cilia consist of a set of nine doublet microtubules, 
which surround a central pair of singlet microtubules (“9+2” 
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arrangement) to which they are connected by the radial spoke proteins 
(Figure 1.1). Non-motile cilia are characterised by the absence of the 
central pair of singlet microtubules (“9+0” arrangement) (Figure 1.1) 
(Satir et al., 2007).  
In motile cilia, the radial spoke complex consists of 23 proteins 
(RSPs) that work as a mechanochemical transducer between the central 
pair apparatus and the peripheral microtubule doublets (Pigino et al, 
2012). Characterised by a T-shaped structure, a radial spoke is composed 
of an elongated stalk that is anchored on the A-microtubule of the 
peripheral microtubule doublet while the orthogonal head has transient 
contacts with the inner sheath and central pair. Radial spokes mediate 
signal transduction between the central pair and the dynein motors (Smith 
et al., 2004). Sequences found within RSPs 2 and 23 suggest a role for 
signal transduction via cyclic nucleotides due to the presence of a cyclic 
GMP‐binding domain, an adenylyl cyclase domain and a nucleotide 
diphosphate kinase domain. Phosphorylation is thought to play an 
essential role in RSP function whereby the sliding velocity of axonemes 
has been shown to be dependent on the activity of phosphate kinases such 
as protein kinase A (PKA) and casein kinase 1 (CK1) (Howard et al., 
1994; Yang et al., 2000).  
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During early embryogenesis, nodal cilia generate a leftward flow 
of fluid that is critical in initiating asymmetric cues during organogenesis 
(Nonaka et al., 1998). In addition to locomotion, sensory perception is 
another key process mediated by cilia (Ginger et al., 2008). For example, 
immotile cholangiocyte cilia express TRPV4, a calcium channel that is 
regulated by tonicity of the biliary duct (Gradilone et al., 2007).  
1.1.2 Intraflagellar Transport 
Cilia are assembled and maintained by a process called 
intraflagellar transport (IFT) which utilises microtubule-associated motor 
proteins called kinesins to mobilise ciliary cargo such as structural 
axonemal components and membrane receptors in an anterograde fashion 
along the ciliary axoneme (Kozminski et al., 1995; Pazour et al., 1999; 
Qin et al., 2004). Studies from Chlamydomonas and Caenorhabditis 
elegans show that two dynein subunit motors transport and recycle 
proteins in a retrograde direction down along the axoneme toward the 
basal body (Kozminski et al., 1993; Pazour et al., 1999; Pedersen and 
Rosenbaum, 2008; Porter et al., 1999; Signor et al., 1999) (Figure 1.2). 
One encodes LC8, which is a light chain of several dynein isoforms 
(King et al., 1996) (Pazour et al., 1998) while the other encodes DHC1b, 
which is a cytoplasmic dynein heavy chain (DHC) isoform (Mikami et 
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al., 2002; Pazour et al., 1999; Porter et al., 1999; Signor et al., 1999). The 
mammalian orthologue, DHC2, is associated with mammalian cilia 
(Mikami et al., 2002) and was also reported to play a role in the 
organisation and/or function of the Golgi apparatus (Vaisberg et al., 
1996). IFT particles contain 16 different polypetides with masses ranging 
from 20kDa to 172kDa, which are organised into two complexes, A and 
B (Cole, 2003; Cole et al., 1998; Vaisberg et al., 1996). Disruption of 
either of the IFT motors or the basal body proteins essential for their 
function leads to impaired cilia assembly (Brazelton et al., 2001; Pazour 
et al., 2000). 
 
Figure 1.2: Intraflagellar transport. Elongation of the axoneme at the 
distal tip relies on intraflagellar transport (IFT). Anterograde IFT is 
mediated by kinesin-II motors along with axonemal precursors while 
retrograde IFT is mediated by a dynein motor. IFT Type A complexes are 
linked to retrograde transport and IFT type B complexes are linked to 
anterograde transport. 
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Microtubule organisation and polarised membrane trafficking 
regulates early ciliary assembly and several lines of evidence support a 
role for vesicular transport. During ciliogenesis, the Golgi apparatus lies 
in close proximity to the basal body and formation of the new ciliary 
sheath is associated with flattening of a vesicular sheath near the distal 
end of the centriole destined to become the new basal body as revealed by 
sequential electron micrographs (Sorokin, 1968). Vesicle tethering to the 
plasma membrane is mediated by the exocyst, an octameric protein 
complex, composed of Sec3, Sec5, Sec6, Sec8, Sec10, Sec15, Exo70 and 
Exo84 (Amlan et al., 2011). Extracytoplasmic extension of the plasma 
membrane and intracellular vesicular trafficking is modulated by 
proteins, which are members of the Arf and Rab family (Nachury et al., 
2007). The Rab family of small GTPases are master regulators in 
exocytosis. In their GTP-bound form, Rab proteins interact with 
downstream effectors, thereby controlling various steps of exocytosis. 
Components of the exocyst are localized at the base of the cilia (Park et 
al, 2008). Disruption of Rabin8, a GTP nucleotide exchange factor 
specific for Rab8, leads to loss of BBS4 from centriolar satellites and 
impaired cilia formation. Furthermore, Rabin8 interacts with BBS1, a 
component of the BBSome, a multi-protein complex (consisting of BBS 
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1, 2, 4, 5, 7, 8 and 9), involved in cargo transport to primary cilia (Figure 
1.3) (Nachury et al., 2007). Rabin8 is a direct downstream effector of 
Rab11 (Knödler A et al., 2010), which mediates vesicle transport from 
the trans-Golgi network (TGN) and recycling endosomes (Ullrich et al., 
1996) to vesicle docking and fusion at the plasma membrane.  
Other players in the exocytic pathway include Arf4, Rab11, FIP3, 
and the Arf GTPase-activating protein ASAP1 which have been shown to 
be important for the transport of rhodopsins to the retina outer segments 
(Mazelova et al.,2009). The Arf4-based protein complex has been 
postulated to be involved in the selection and packaging of specific 
cargos, including GPCRs, for their delivery to the cilia. Once 
incorporated into the plasma membrane, ciliary cargos are collected by 
the BBSome, which acts as a planar coat that transports proteins to the 
cilia. How vesicle fusion is connected to subsequent cargo entry to cilia 
requires further investigation as does the underlying molecular 
mechanisms governing how the BBSome is coupled to IFT proteins 
(IFTs) for cargo movement within the cilia. IFT proteins share sequence 
homology to coat-protein-I (COP-1) and clarithrin-coated vesicle 
components, thereby suggesting a role for IFT proteins in vesicle 
transport (Jekely and Arendt, 2006).  
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1.1.3 Centriole and basal body biogenesis  
Centrioles and basal bodies (CBB) are assembled in a variety of 
cellular contexts that are cell cycle dependent and include cell division, 
cell motility, cell adhesion and cell polarity (Beisson and Wright, 2003) 
(Bettencourt-Dias and Glover, 2007; Delattre and Gonczy, 2004). 
 
Figure 1.3: The BBSome and vesicular trafficking to the primary 
cilium. The BBSome is a stable protein complex that functions in 
primary ciliogenesis. It is composed of seven highly conserved BBS 
proteins (BBS1, BBS2, BBS4, BBS5, BBS7, BBS8 and BBS9) and 
BBIP10. The BBSome binds to Rabin8, the GTP/GDP exchange factor 
for the small GTPase Rab8, which localises to the primary cilium. In the 
connecting cilium of photoreceptors, Rab8 is required for ciliogenesis and 
mediates the docking and fusion of rhodopsin carrier vesicles. 
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 Centrosomes also act as signalling platforms in cell cycle 
transitions and checkpoints (Doxsey et al., 2005; Sluder, 2005). 
Furthermore, during mitosis, organisation of the spindle poles is a key 
process regulated by the centrosome. The centrosome is the major 
microtubule (MT) organising centre (MTOC) of mammalian cells and 
plays a crucial role in the formation of the mitotic spindle and thereby 
ensures correct chromosome segregation. Centrosome structure is 
dynamically regulated throughout the cell cycle and in G1, is 
characterised by the presence of two MT-based structures called 
centrioles surrounded by an electron dense pericentriolar matrix (PCM) 
(Figure 1.4). Centrioles consist of nine MT triplets and measure 0.5µm 
long and 0.2µm in diameter. The mother centriole has subdistal and distal 
appendages, which dock the cytoplasmic MTs and nucleate cilia and 
flagella by tethering the MTs to the cell membrane as basal bodies (BB) 
which provide the template of the ciliary axoneme which consists of nine 
MT doublets (Figure 1.4). Centrioles and basal bodies (CBB) have been 
found in all eukaryotic groups which suggests that there is a highly 
conserved common molecular assembly pathway (Carvalho-Santos et al., 
2010). Through electron micrographic studies, four stages of centriole 
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biogenesis have been identified: (1) centriole disengagement, (2) 
nucleation of daughter centrioles, (3) elongation of daughter centrioles 
and (4) chromosome separation (Bettencourt-Dias and Glover, 2007; 
Nigg, 2007) (Figure 1.5). 
 
 
Figure 1.4: The centrosome. The centrosome consists of two 
microtubule-based structures, the mother and daughter centrioles, 
arranged in nine microtubule triplets. The mother centriole has distal and 
subdistal appendages, which dock cytoplasmic microtubules and anchor 
centrioles to the cell membrane to serve as basal bodies. 
 
During mitotic exit, centriole disengagement is coordinated with 
chromatid segregation and is required for duplication in the next cell 
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cycle. In G1, the centrioles are disengaged from one another. As the cells 
enter S-phase, new centrioles (daughter centrioles) are built orthogonally 
to existing centrioles (mother centrioles) in a process called procentriole 
formation, which occurs once per cell cycle and is coordinated with DNA 
synthesis. In most organisms, procentrioles consist of short MT triplets 
and a structure called the cartwheel, which is made up of a central 
cylinder with a core and nine spokes radiating from the hub to the MT 
triplets (Bettencourt-Dias and Glover, 2007) (Figure 1.6). Cartwheel 
formation occurs at a very early stage of centriole assembly, followed by 
formation of the peripheral MTs (Anderson et al., 1971). Thus, the 
cartwheel might serve as a scaffold that determines centriole diameter and 
symmetry through the radial arrangement of its nine spokes. Recent work 
has highlighted a crucial role for SAS-6 in the synthesis of cartwheel 
hubs and assembly (van Bruegel et al., 2011).  
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Figure 1.5: Stages of centriole biogenesis. Centrioles are disengaged 
from each other in G1. On entry into S-phase, new centrioles arise 
orthogonally from the mother centriole. In G2, daughter centrioles 
elongate and on entry into mitosis, separation of duplicated centrosomes 
occurs. Centrosomes are held together by a proteinaceous linker that 
connects the proximal ends on the two older centrioles during interphase. 
Loss of known cartwheel component, CEP135, results in aberrant 
centrioles with nine shortened cartwheel spokes and a decreased diameter 
that can accommodate only eight triplet MTs (Hiraki et al, 2007). 
 
Figure 1.6: Cartwheel structure. Wild-type centriole scheme with 
peripheral MT triplets and central cartwheel structure (Cw.) with hub and 
spokes. 
Aberrant number of triplet MTs occurs in SAS-6 deficient 
Chlamydomonas, Drosophila and Paramecium suggesting that self-
assembly of SAS-6 might lead to the formation of the cartwheel hub and 
thereby dictate centriole symmetry (Strnad et al., 2008). Tubule formation 
consists of an initiation and a growth phase. Initiation begins with the 
formation of the A tubule as it lies juxtaposed to a cartwheel spoke within 
the wall material of the annulus. Following initiation of all nine A 
tubules, formation of B and C tubules then occurs. Sequential initiation of 
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all three tubules occurs around the procentriole. Simultaneous with tubule 
initiation is a nonsequential growth of each tubule. The tubules lengthen 
and the procentriole is complete when it is about 200µm long. The 
procentriole increases in length and diameter during its maturation into a 
basal body. The addition of a basal foot, nine alar sheets, and a rootlet 
completes the maturation process. 
During interphase, the centrosomes are held together by a 
proteinaceous linker that extends between the proximal ends of the two 
older centrioles (Fry et al., 1998; Yang et al., 2006). Centriole elongation 
occurs in G2 phase of the cell cycle and on mitotic entry, the duplicated 
centrosomes separate and nucleate the microtubules of the mitotic 
spindle. This process is called centrosome dysjunction whereby 
dissembly of the proteinaceous linker occurs (Faragher and Fry, 2003). 
Molecular components of the centriole assembly pathway 
Polo-like kinase 4 (PLK4/SAK) is critical for centriole biogenesis 
in human cells and Drosophila melanogaster (Bettencourt-Dias et al., 
2005), (Habedanck et al., 2005), (Kleylein-Sohn et al., 2007), (Rodrigues-
Martins et al., 2007). PLK4 is recruited to the centrosome by centrosomal 
protein 152kDa (CEP152), which also binds centrosomal P4.1-associated 
protein (CPAP, also called SAS4 in Caenorhabditis elegans) (Figure 1.7) 
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(Dzhindzhev et al., 2010). CEP152 acts as a scaffold protein to recruit 
PLK4, a trigger of centriole biogenesis and CPAP, a regulator of 
centriole-microtubule recruitment and elongation. Procentriole formation 
begins in S-phase with recruitment of spindle assembly abnormal protein 
6 (SAS6), CEP135 and SCL-interrupting locus protein (STIL also known 
as SAS5) which are required for the cartwheel structure that defines the 
ninefold symmetry of the centriole. 
 
Figure 1.7: Molecular regulation of centriolar biogenesis. Centriolar 
biogenesis is triggered by polo-like kinase-4 (PLK-4) and is recruited to 
the centrosome by CEP152 which also binds CPAP. Other proteins 
implicated in procentriole formation include SAS6, CEP135 and STIL 
which form the cartwheel and confer the centriole ninefold symmetry. 
CPAP also plays a role in centriole elongation. In G2, several molecules 
are needed for entry into microtubule (MT) nucleation, stability and 
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focusing the pericentriolar material (PCM), including pericentrin 
(PCTN), CEP192, CDK5RAP2 and ASPM. NEK2 regulates separation of 
the two centrosomes and on mitotic exit, the centrioles disengage, a 
process regulated by PLK1 and separase. Adapted from (Bettencourt-
Dias et al., 2011). 
CPAP and CEP152 also have a role in centrosome maturation 
where CPAP plays a role in centriole elongation (Bettencourt-Dias and 
Glover, 2007; Nigg and Raff, 2009). CDK2 accelerates procentriole 
formation and elongation and is coordinated with DNA replication. In 
G2, the daughter centriole reaches full elongation and maturation with the 
recruitment of several molecules that are needed for MT nucleation, 
stability and focusing of the PCM, which include pericentrin (PCTN), 
CEP192 (also called SPD2 in C elegans), CDK5 regulatory subunit 
associated protein 2 (CDK5RAP2, also called CNN in Drosophila) and 
abnormal spindle associated microcephaly protein (ASPM). CDK5RAP2 
plays an important role in tethering the centrosome and spindle pole 
during mitosis (Barrera et al., 2010) (Barr et al., 2010), (Lee, 2010). 
Without CDK5RAP2, centrioles detach from the PCM and form the 
mitotic spindle (Gonzalez et al., 1990). Centrosome separation is 
mediated by the kinase, never in mitosis gene a-related kinase 2, (Nek2). 
On mitotic exit, the centrioles within the centrosomes disengage through 
the action of PLK4 and separase. Centriole reduplication is prevented by 
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molecules that prevent DNA re-replication such as Origin recognition 
complex (ORC) 1.  
1.1.4 Transcriptional regulation of ciliogenesis 
1.1.4.1 RFX and FOXJ-1 transcription factors 
Over 1000 proteins have been identified within the ciliary proteome and 
as a result of the complexity of ciliary biogenesis, coordinated control of 
a great number of proteins is required (Thomas et al., 2010). A highly 
conserved role for both the forkhead box J1 (FOXJ1) and the regulatory 
transcription factor X (RFX) family of transcription factors has been 
shown in both vertebrates and invertebrates (Dubruille et al., 2002; Liu et 
al., 2007; Swoboda et al., 2000), (Bonnafe et al., 2004; Brody et al., 2000; 
Chen et al., 1998), (Chung et al., 2012; Ma and Jiang, 2007), (Bisgrove et 
al., 2012). Characterised by a winged-type DNA binding domain, RFX 
proteins are comprised of seven mammalian members (RFX1-7) which 
have been shown to regulate target gene expression by binding to a cis-
acting transcriptional regulatory element called an X-box within the 
promoter of target genes (Emery et al., 1996). In Drosophila and C 
elegans, a single X-box transcription factor (dRFX and daf-19, 
respectively) regulates ciliogenesis in sensory neurons via transcriptional 
regulation of intraflagellar transport (IFT) proteins (Blacque et al., 2005; 
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Dubruille et al., 2002; Efimenko et al., 2005; Swoboda et al., 2000). Rfx3-
/- mutant mice display left-right asymmetry and stunted nodal cilia 
(Bonnafe et al., 2004; Brody et al., 2000; Chen et al., 1998). Additional 
features include hydrocephalus resulting from ciliary defects on the 
specialised ependymal cells in addition to diabetes from abnormal 
differentiation of the pancreatic β cells (Ait-Lounis et al., 2007; Ait-
Lounis et al.; Baas et al., 2006). Ependymal cells are multiciliated 
epithelial cells that line the cerebrospinal fluid-filled ventricles in the 
brain and the central canal of the spinal cord. Ependymal cell cilia have a 
9+2 structure and project from the cell’s apical surface into the ventricle. 
Planar-polarised ciliary beating generates directional fluid flow (Tissir et 
al., 2010) and is believed to be involved in the circulation of CSF from 
the choroid plexuses, where it is produced, to the subarachnoid spaces, 
where it is absorbed. Hydrocephalus has been reported in animal models 
of ependymal ciliary dysfunction as well as human syndromes associated 
with defective ciliary gene function (Olbrich et al., 2012). Therefore, the 
directional beating of planar-polarised ependymal cilia is important for 
maintaining proper brain function. 
Regarding other RFX genes, an N-ethyl-N-nitrosourea, (ENU) 
screen identified a Rfx4 (L298P) mouse mutant which displayed defects 
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in cilia formation with distinct dorsoventral patterning defects in the 
ventral spinal cord and telencephalon due to aberrant Sonic hedgehog 
(Shh) signaling and Gli3 activity (Ashique et al., 2009). More recently, 
RFX4 has been shown to mediate the coordinated expressions of 
TMEM138 and TMEM216, transmembrane proteins that regulate 
ciliogenesis (Lee et al., 2012). A hierarchial transcriptional network in 
motile ciliogenesis programmes has recently been highlighted whereby 
rfx2 expression in ciliated tissues is regulated by foxj1 transcription 
factors (Yu et al., 2008). Mice deficient for Foxj1, develop hydrocephalus 
and heterotaxia and their respiratory epithelia are devoid of cilia (Brody 
et al., 2000; Chen et al., 1998). As Foxj1-/- deficient mice lack motile cilia 
only, it has been suggested that Foxj1 specifically regulates motile 
ciliogenesis. Studies in Xenopus and Danio rerio have confirmed that 
foxj1 morphant embryos fail to form cilia in the zebrafish embryonic 
node known as Kupffer’s vesicle (KV), in addition to cilia of the floor 
plate and pronephric duct (Yu et al., 2008). 
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Table 1.1: Molecular components of the centriole-assembly pathway 
(Bettencourt-Dias and Glover, 2009) 
PCM Recruitment and Duplication Protein Resultant Phenotype 
 SPD2 (Ce, Dm) 
CEP192 (Hs) 
No centriole duplication (Ce) 
<PCM recruited (Ce, Dm and Hs); no 
basal body duplication (Dm) 
 Asterless (Dm)/ 
CEP152 (Hs) 
Aberrant PCM recruitment (Dm) and 
centriole elongation 
 γ-tubulin (Dm, Hs, Tt, Pt)/TBG (Ce) Aberrant centriole duplication (Ce, Hs, 
Tt) 
centriole structure & separation (Pt, 
Dm) 
Overexpression: de novo formation; 
amplification of basal bodies 
Triggers of Biogenesis SAK/PLK4 (Dm, Hs) No duplication (Dm, Hs); no 
reduplication (Hs); no formation of 
basal bodies (Dm) 
Overexpression: amplification (Dm; 
Hs); de novo formation (Dm) 
 ZYG1 (Ce) No duplication 
Essential Molecules for Centriole 
Biogenesis 
SAS6 (Ce, Hs)/DSAS6 (Dm)/Bld12 (Cr) No duplication (Hs, Dm, Ce); no 
reduplication (Hs) 
Overexpression: amplification (Dm, Hs) 
 SAS4 (Ce/DSAS4 (Dm/CPAP (Hs) No duplication (Hs, Ce, Dm, Cr); No 
reduplication (Hs) 
 SAS5 (Ce) No duplication 
 CP110 (Hs)/DCP110 (Dm) No reduplication or amplification (Hs) 
 Centrin (Hs)/Cdc31 (Sc, Sp)/VLF2 
(Cr)/CEN2/3 (Pt)/CEN1 (Tt) 
No duplication (Sp, Sc, Tt); differing 
duplication results (Hs); aberrant 
centriole segregation (Cr), aberrant 
duplication geometry (Pt) 
 SFL1 (Sc) No SPB duplication 
 δ-tubulin (Hs); δ-PT1 (Pt); UNI3 (Cr) Centrioles with fewer tubules (Cr, Pt) 
 ε-tubulin (XI, Hs, Pt); Bld2 (Cr) Centriole stability disrupted, singlets 
(Cr); no duplication (XI, Pt); aberrant 
PCM organization (XI) 
 Ana1, Ana 2, Ana 3 (Dm) No duplication 
 Centrobin (Hs) No duplication 
 Cep135 (Hs)/BLD10 (Cr)/DBld10 (Dm) No amplification upon SAK/PLK4 
overexpression (Hs); no duplication 
(Dm); disorganized microtubules (Hs); 
no basal body duplication (Cr) 
Overexpression: accumulation of 
particles (Hs) 
Cell Cycle Regulators CDK2 (Hs, XI, Gg) No reduplication, normal duplication, 
needed for duplication in absence of 
CDK1 
 Separase (XI) No centriole disengagement, impaired 
duplication 
 Spliced Sgo 1 (Mm) Precocious centriole disengagement 
 p53 (Mm, Hs) Amplification 
 CHK1 (Gg, Hs) No centrosome amplification upon DNA 
damage 
 PLK1, PLK2 (Hs) No reduplication in S phase-arrested 
cells 
 MPS1 (Hs, Mm, Sc) No reduplication (Hs, Mm); normal 
duplication (Dm); no spindle pole body 
duplication 
 BRCA1 (Hs, Mm) Premature centriole separation and 
reduplication in S-G2 boundary 9Hs); 
amplification (Mm) 
 Cdc14B (Hs) Amplification 
 PP2 (Dm) Centrosome amplification 
Overexpression: prevents reduplication 
 Nucleophosmin/B23 (Mm, Hs) Amplification 
 CAMKII (XI) Blocks early steps in duplication 
 CDK1 (Dm, Sc) Amplification 
 Skp1, Skp2, Cul1, Slimb (SCF complex) 
(Dm, Hs, Mm, XI) 
Blocks separation of M-D pairs and 
reduplication (XI); increased 
centrosome number (Dm, Mm) 
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Loss of expression of the ciliary genes, dnah9 (dynein axonemal heavy 
chain, 9) and centrin 2 was noted in foxj1 morphant fish while ectopic 
expression of foxj1 led to ectopic expression of dnah9 and centrin 2 
thereby further suggesting a hierarchial regulatory role for foxj1 in 
ciliogenesis. Furthermore, supernumerary long motile cilia were observed 
throughout the dorsoventral extent of the neural tube of zebrafish when 
foxj1 was misexpressed by hyperactivating the Hh pathway using 
dominant negative protein kinase A (Yu et al, 2008). Chromatin 
immunoprecipitation assays (ChIP) confirmed that foxj1 directly binds to 
the promoters of the ciliary genes, dynein and wdr78 (Yu et al., 2008). 
ChIP assays are a type of immunoprecipitation experimental technique 
used to investigate the interaction between proteins and DNA in the cell. 
The objective is to determine whether specific proteins are associated 
with specific genomic regions, such as transcription factors on promoters 
or other DNA binding sites. When undertaking a ChIP assay, protein and 
associated chromatin in a cell lysate are temporarily bonded, the DNA-
protein complexes (chromatin-protein) are then sheared and DNA 
fragments associated with the protein(s) of interest are selectively 
immunoprecipitated, and the associated DNA fragments are purified and 
their sequence is determined. These DNA sequences are supposed to be 
associated with the protein of interest in vivo. 
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During early embryogenesis, the homeodomain transcription factor, Noto 
has been shown to be important for nodal ciliogenesis and therefore 
establishment of left-right asymmetry in the developing embryo (Beckers 
et al., 2007). Nodal cilia in Noto-/- deficient mice are present but in less 
numbers and are stunted with incomplete microtubular structures evident 
on electron microscopy (Beckers et al., 2007). In situ hybridisation 
analysis for the transcription factors, Foxj1 and Rfx3 revealed reduced 
expression in the embryonic node in Noto-/- mice (Beckers et al., 2007), 
suggesting that both Foxj1 and Rfx3 gene expression are regulated by 
Noto. 
1.1.4.2. FGF signalling and ciliogenesis 
Very little is known about the signalling pathways which regulate 
the activation of ciliogenic programmes. Fibroblast growth factor 
signalling through fibroblast growth factor receptor 1, FGFR1, has 
recently been shown to regulate ciliogenesis in the zebrafish KV 
(Neugebauer et al., 2009). Both fgfr1 morphant fish and embryos treated 
with a pharmacological inhibitor of FGF, display abnormal ciliogenesis in 
the pronephric ducts and otic vesicle. Expression of both rfx2 and foxj1 
were downregulated in fgfr1 morphant fish as was their ciliary target 
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gene, polaris (Neugebauer et al., 2009), thereby supporting a role for FGF 
signalling in the regulation of ciliogenesis. 
1.1.4.3 Notch signalling and ciliogenesis 
Genetic and pharmacological studies in zebrafish and Xenopus 
have implicated Notch signalling in the specification of multiciliated cell 
(MCC) fate in the zebrafish pronephros, Xenopus epidermis and in 
murine respiratory epithelia (Deblandre et al., 1999; Liu et al., 2007) (Ma 
and Jiang, 2007), (Morimoto et al., 2010). Binding of the Notch ligand 
(jagged 2a) on prospective MCCs to its receptor (notch3) on adjacent 
cells results in cell autonomous repression of rfx2 following nuclear 
translocation of the cleaved intracellular domain of notch3 (NICD) 
(Figure 1.8). Zebrafish mutant for jagged 2a, notch3, mindbomb (required 
for Notch ligand signalling) and her9, results in MCC hyperplasia with 
expansion of rfx2 expression. Jagged2a knockdown and pharmacological 
inhibition of Notch is sufficient to rescue the pronephric cystic phenotype 
of the ciliopathy mutant, double bubble (Liu et al., 2007). Recent 
mammalian studies have shown that an expansion of ciliated respiratory 
epithelial cells occurs at the expense of Clara cell fate in murine embryos 
deficient for the canonical Notch effector, RBP-J kappa (Morimoto et al.; 
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Tsao et al., 2009). The downstream targets of RBP-J kappa in the 
inhibition of ciliogenic programmes requires further investigation. 
 
 
Figure 1.8: A model of Notch regulation of multiciliated cell fate 
versus monociliated cell fate in the developing zebrafish pronephros. 
Activation of notch 3 on ligand binding by jagged 2 represses ciliation 
programmes in the transporting cell (Adapted from Liu et al, 2007). 
1.1.4.4 PCP signalling and ciliogenesis 
Cells orient themselves relative to an axis along the plane of a tissue in a 
process called planar cell polarity (PCP) and is mediated by noncanonical 
Wnt signalling (Wallingford and Mitchell, 2011). Planar polarity is 
determined by the accumulation of core PCP components to distinct 
regions of the cell. Core PCP components include the transmembrane 
proteins, Frizzled, Vangl and Celsr, respectively in addition to the 
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cytoplasmic proteins, Prickle and Dishevelled (McNeill, 2010). A highly 
conserved role for the core PCP effector proteins, Inturned and Fuzzy in 
cilia assembly has been suggested by studies in Xenopus and mice (Dai et 
al., 2011; Gray et al., 2009; Heydeck et al., 2009; Park et al., 2006; Zeng 
et al., 2010). Mice mutant for core PCP effectors, Fuzzy and Inturned 
have neural tube defects, skeletal dysmorphologies and Hedgehog 
signalling defects stemming from disrupted ciliogenesis (Gray et al., 
2009). Knockdown of Inturned in Xenopus revealed a role for Inturned in 
actin assembly, Rho localisation and docking of basal bodies at the apical 
surface in multiciliated cells (Park et al., 2008). Fuzzy appears to be 
important for axoneme elongation whereby it acts together with a Rab-
similar GTPase to regulate from the cytoplasm to the basal bodies and 
from the basal bodies to the tips of cilia (Gray et al., 2009). In addition to 
a role for core PCP ‘effector’ proteins in ciliogenesis, a role for core PCP 
components in cilia formation has also been suggested. As for Inturned, 
Dvl was also shown to mediate apical actin assembly, Rho activity and 
basal body docking (Park et al., 2008). Basal body docking requires the 
association of membrane-bound vesicles and the vesicle tethering exocyst 
complex (Sorokin, 1968; Zuo et al., 2009). In Dvl morphants, basal 
bodies failed to associate with either vesicles or the exocyst (Park et al., 
2008). Defective ciliogenesis has also been described in Celsr mutant 
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mice whereby a failure of basal body docking at the apical membrane of 
ependymal cells has been described (Tissir and Goffinet, 2010). 
Therefore, both core PCP effector proteins in addition to core 
components of PCP play a role in ciliogenesis. 
1. 2. THE PRIMARY CILIUM IN SIGNAL TRANSDUCTION 
1.2.1 Regulation of Hedgehog signalling 
Previous studies have implicated IFT machinery in vertebrate-specific 
Hedgehog signal transduction (Huangfu et al., 2003) (Figure 1.9). 
Mutations in genes encoding Ift172 and Ift88 were identified in two 
mouse mutants which showed characteristic defects in Sonic hedgehog 
signalling (Shh) following an ENU mutagenesis screen undertaken for 
embryonic patterning mutations. Genetic studies showed that IFT 
proteins act at the heart of the Shh pathway, downstream of the 
transmembrane Shh receptor, Patched 1 (Ptch1) and its downstream 
effector, Smoothened (Smo) and upstream of the Gli transcription factors 
that implement the pathway (Huangfu and Anderson, 2005; Huangfu et 
al., 2003). Furthermore, Ptch1 and Smo are dynamically expressed in cilia 
during Shh signalling (Corbit et al., 2005; Rohatgi et al., 2007) and 
activated Smo increases the accumulation of Gli2, the major 
transcriptional activator of Hedgehog signalling, at the ciliary tip. In the 
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absence of ligand, Patched 1 (Ptch1) localizes to cilia and prevents 
translocation of Smoothened (Smo) into cilia (Rohatgi et al., 2007). Kif7 
localizes to the ciliary base, where it forms a complex with Gli proteins, 
the serine-threonine kinase, Fused (FU), Suppressor of Fused (SU(FU)) 
and in other kinases including Protein kinase A (PKA), Casein kinase I 
(CKI) and Glycogen synthase kinase 3β (GSK3β), that promote the 
processing of Gli protein into its repressor form (GliR) which repress Hh 
target genes in the absence of Shh. (Lefers et al., 2001). After activation 
of the pathway, Smo moves to the ciliary membrane and Kif7 translocates 
into the cilium, thereby promoting Gli2 accumulation at the cilium tip. 
The regulatory subunits of vertebrate PKA have recently been localized 
to the ciliary base proximal to the basal body. Gli2 accumulates at the tips 
of primary cilia in Pka-null cells and supports a model whereby the 
accessibility of Gli proteins to PKA at the ciliary base controls the fate of 
Shh signalling (Tuson et al., 2011). Studies in murine embryonic 
epidermis have recently shown that Sufu restricts the activity of Gli2 
through cytoplasmic sequestration (Li et al., 2012). Furthermore, Kif7 can 
promote Hh pathway activity through the dissociation of Sufu-Gli2 
complex and it can also contribute to the repression of Hh target genes in 
the absence of Sufu (Li et al., 2012). 
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Figure 1.9: The primary cilium in Hedgehog signal transduction. In 
vertebrates, Shh signal transduction is dependent on cilia. Shh ligand 
binding to Ptch results in Smo moving to the ciliary membrane and Kif7 
translocates into the cilium thereby promoting Gli2 accummulation at the 
cilium tip. Activated Gli is transported out of the cilium by dynein and 
IFT particles. (Adapted from Goetz et al, 2011). 
1.2.2 Regulation of Wnt signalling 
Several studies have implicated ciliary and basal body proteins in the 
regulation of Wnt signalling (Corbit et al., 2008; Gerdes et al., 2007; Ross 
et al., 2005). Wnt proteins are a family of 19 secreted glycoproteins that 
regulate a variety of biological processes implicated in development and 
disease. In canonical Wnt signalling, a Wnt ligand binds to a complex of 
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the Frizzled (Fz) receptor and low-density lipoprotein receptors (LRP5/6) 
coreceptor, which then binds to Axin and Dishevelled (Dvl), leading to 
stabilisation of β-catenin in the cytoplasm. β-catenin migrates into the 
nucleus, replaces TLE, and activates transcription of β-
catenin/TCF/LEF1-responsive genes. In noncanonical signalling, 
activated Dvl is targeted to the membrane and activates downstream 
targets. Disruption of ciliary or basal body components leads to loss of 
noncanonical Wnt signalling and stabilisation of both Dvl and β-catenin 
in the cytoplasm and nucleus, resulting in activation of canonical Wnt 
signalling. Spatial mechanisms involving compartmentalisation of 
signalling components mediated by primary cilia dampen canonical Wnt 
signalling (Lancaster et al., 2011). Jouberin (Jbn), a ciliopathy protein and 
context-specific Wnt pathway regulator, which is regulated by IFT, is 
diverted away from the nucleus and limits β-catenin nuclear entry. This 
repressive regulation maintains a discrete range of Wnt responsiveness; 
cells without cilia have potentiated Wnt responses, whereas cells with 
multiple cilia have inhibited responses.  
Inversin, the gene mutated in nephronophthisis, has been shown to 
interact with Dvl and localizes to cilia (Otto et al., 2003; Simons et al., 
2005; Watanabe et al., 2003). Supporting a role for the cilium in the 
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regulation of Wnt signalling has been the finding of a hyperactive Wnt 
response in cultured cells in which BBS1, BBS4 and MKKS have been 
knocked down (Gerdes et al., 2007). Further in vivo support comes from 
murine studies of Kif3a, Ift88 and Ofd1-deleted mice which reveal a 
marked increase in cellular responses to canonical Wnt pathway 
activation (Corbit et al., 2008). Finally, chibby, a basal body associated 
protein is able to bind β-catenin, prevent its nuclear entry and thereby 
negatively regulate Wnt (Voronina et al., 2009). Therefore, cilia-related 
proteins appear to play a role in the regulation of canonical Wnt 
signalling, the molecular details of which appear to involve spatial 
compartmentalisation of context-specific Wnt pathway regulators. 
1.2.3 Regulation of Notch signalling 
Notch signal transduction has also been proposed to be regulated 
by the primary cilium (Ezratty et al., 2011). Conditional ablation of Ift88 
and Kif3a in mice in addition to knockdown of several IFT genes have 
shown epidermal differentiation defects reminiscent of defective Notch 
signalling whereby enhanced proliferation and expansion of basal cells 
were observed (Ezratty et al., 2011). Keratinocytes transduced with Ift 
shRNA lentiviral vectors containing a Notch reporter construct showed 
reduced Notch reporter activity. Secondly, basal to spinous cell defects 
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could be partially rescued by transgenic expression of NICD. Ciliary 
localisation of the Notch 3 receptor and Presenilin-2, the catalytic subunit 
of γ-secretase, which mediates cleavage of the Notch receptor 
transmembrane domain during signal transduction has been demonstrated 
both in vitro and in vivo on mammalian epidermal cells (Figure 1.10) 
(Mumm et al., 2000).  
 
Figure 1.10: The Notch signalling pathway. Notch ligand (red) binding 
to the extracellular domain (purple) of the Notch receptor on reciprocal 
cells results in γ-secretase (blue) mediated cleavage of the Notch receptor 
transmembrane domain. Following release of the Notch intracellular 
domain (ICD) (turquoise), nuclear entry occurs followed by interaction 
with DNA-binding RBPJ-κ complex and co-repressors are released. 
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1.3. DISEASES ASSOCIATED WITH CILIA DYSFUNCTION 
1.3.1 Overview of clinical features of ciliopathies 
Systemic involvement characterised by the constellation of 
overlapping phenotypes that include retinal degeneration, polydactyly, 
situs inversus, mental retardation, encephalocele and cysts in the kidney, 
liver, and pancreas are caused by mutations in proteins localised to cilia 
and ciliary basal bodies. As a result, these phenotypically similar and rare 
recessive disorders have been classified as “ciliopathies” (Table 1.2 & 
1.3). It has been predicted that over 100 known conditions fall into this 
category with only a handful studied to date. 
1.3.2 Renal disease in ciliopathy disorders 
A spectrum of renal diseases has been described as a feature of 
several ciliopathy syndromes and includes renal dysplasia, polycystic 
kidney disease (PKD) and nephronophthisis (NPHP) (Table 1.4). Renal 
dysplasia occurs as a result of defective differentiation of the renal 
parenchyma during renal morphogenesis (Woolf et al., 2004). PKD is a 
group of monogenic disorders that result in renal cyst development 
(Harris, 2009). Polycystic kidneys are more commonly inherited in an 
autosomal dominant or recessive fashion but may also be a feature of a 
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rare group of recessively inherited pleiotropic cystic disorders including 
cystic dysplasia. Over the past decade more than 20 genes have been 
identified as causing these disorders (1994) (Hughes et al., 1995) (1995; 
Mochizuki et al., 1996) (Onuchic et al., 2002) (Ward et al., 2002) 
(Consugar et al., 2008). PKD proteins have been shown to localise to the 
cilium and/or its basal body (Pazour et al., 2002; Yoder et al., 2002). 
Evidence that cilia are important in cystic kidney disease comes from the 
initial observation of renal cysts in the Oak Ridge polycystic kidney 
(orpk) mouse that mimics autosomal recessive polycystic kidney disease 
(ARPKD). Orpk mice are hypomorphic for Tg737, which encodes the 
mouse orthologue of Chlamydomonas ift88. Cilia in renal epithelia of 
hypomorphic Tg737orpk mice are structurally shorter than their wild-type 
littermate controls while complete Tg737 null-mice lack cilia and exhibit 
neural tube defects, left-right asymmetry and growth arrest during 
embryogenesis (Moyer et al., 1994) (Yoder et al., 1995) (Murcia et al., 
2000) (Pazour et al., 2000). Several other mouse models linking cilia to 
cystic kidney disease exist (Hou et al., 2002). Genetic inactivation of 
Kif3a in mice leads to renal cyst formation and renal epithelia are 
deficient for cilia (Lin et al., 2003). Almost all of the proteins mutated in 
nephronophthisis (NPHP), have also been localised to the primary cilium  
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Table 1.2. Phenotypic overlap in the ciliopathies  
 
 Ciliopathy LCA SLS NPHP MKS BBS JBS 
Phenotype Cerebellar  
hypoplasia 
  √  √ √ 
 Encephalocele    √   
 Hepatic 
disease 
 √ √ √ √ √ 
 Renal disease  √ √ √ √ √ 
 Intellectual 
disability 
√  √  √ √ 
 Obesity     √ √ 
 Polydactyly    √ √ √ 
 Retinopathy √ √ √  √ √ 
 Situs Inversus  √  √ √ √ 
LCA, Leber congenital amaurosis; SLS, Senior Loken Syndrome; NPHP, 
nephronophthisis; MKS, Meckel Gruber Syndrome; BBS, Bardet Biedl 
Syndrome; JBS, Joubert Syndrome 
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Table 1.3. Genotypic overlap in the ciliopathies 
 
Gene  SLS NPHP MKS BBS JBTS 	   CEP290 √ √ √ √ √ 	   NPHP1 √ √   √ 	   INVS √ √    	   NPHP3 √ √ √   	   NPHP4 √ √    	   NPHP5 √ √    	   GLIS2  √    	   NEK8  √    	   AHI1     √ 	   TMEM67 
TMEM138 
TMEM216 
CEP41 
  √ 
 
√ 
√ √ 
√ 
√ 
√ 	   RPGRIPL1  √ √  √ 	   INPP5E     √ 	   CXORF5     √ 	   TTC21B     √ 	   TCTN1     √ 	   TMEM237     √ 	   TCTN2   √   	   TCTN3     √ 	   SDCCAG8 √ √  √  	   ARL13B 
Bd91 
   
√ 
  	   BBS1    √  	   BBS2    √  	   BBS3    √  	   BBS4    √  	   BBS5    √  	   BBS6    √  	   BBS7    √  	   BBS8    √  	   BBS9    √  	   BBS10    √  	   BBS11    √  	   BBS12    √  	   MGC1203    √  	   MKS1   √ √  	   CC2D2A  √ √ √ √ 	   FRITZ      	   LZTFL1    √  
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LCA, Leber congenital amaurosis; SLS, Senior Loken Syndrome; NPHP, 
nephronophthisis; MKS, Meckel Gruber Syndrome; BBS, Bardet Biedl 
Syndrome; JBS, Joubert Syndrome 
(Hildebrandt et al., 1997; Saunier et al., 1997) (Otto et al., 2002) (Mollet 
et al., 2002) (Yoder et al., 2002) (Pazour et al., 2002) (Lin et al., 2003) 
(Hildebrandt and Otto, 2005) (Sayer et al., 2006) (Ferland et al., 2004) 
(Dixon-Salazar et al., 2004) (Attanasio et al., 2007; Delous et al., 2007) 
(Watnick and Germino, 2003) (Germino, 2005) (Arts et al., 2007) 
(Valente et al., 2006) (Wolf et al., 2007) (Otto et al., 2008) (Hoefele et 
al., 2007) (Otto et al., 2009) (O'Toole et al.) and therefore suggest a role 
for cilia proteins in renal cystogenesis. Several molecular mechanisms 
underly the development of renal cystogenesis. Initiating events described 
in the pathogenesis of cystogenesis include hyperproliferation of 
incompletely differentiated epithelial cells (Nadasky et al., 1995) 
followed by cyst growth and expansion which are caused by 
abnormalities in the extracellular matrix and transepithelial fluid 
secretion. Cellular proliferation and fluid secretion can be accelerated by 
growth factors such as epidermal growth factor (EGF) (Du et al., 1995). 
EGF has been shown to hyperstimulate proliferation in autosomal 
dominant polycystic kidney disease (ADPKD) and ARPKD cystic 
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epithelia. EGF and EGF-reactive peptide species are secreted into the 
apical medium of cultured ADPKD epithelia, and high, potentially 
mitogenic concentrations have been measured in cyst fluids collected 
from ADPKD patients. Ligand-induced activation of EGFR receptors can 
stimulate a variety of intracellular pathways including PKC/AKT, PLCγ, 
MEK/Erk or c-Src. c-Src binds to and phosphorylates EGFR at Y845 and 
is required for EGFR family-mediated signalling and proliferation in 
normal cells as well as in cystic renal epithelia (Richards et al, 1998; 
Biscardi et al, 1999). Overexpression, constitutive activation, and 
abnormal location of EGFR and ErbB2 receptors on the apical (luminal) 
surface of cyst lining epithelia, together with secretion of soluble ligands 
by PKD cyst lining epithelia, creates a sustained cycle of autocrine–
paracrine stimulation of proliferation in cysts (Zheleznova et al., 2011). 
cAMP stimulated fluid secretion occurs early in embryonic renal 
tubule development in wild-type and PKD kidneys at the time when renal 
cysts first appear in ADPKD, suggesting that a cAMP-driven mechanism 
may be involved in the initial stages of cyst formation in ADPKD 
(Magenheimer et al., 2006). The cystic fibrosis transmembrane 
conductance regulator Cl-channel (CFTR) exists in apical membranes of 
human ADPKD cells and cAMP has been shown to stimulate solute and 
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fluid secretion through activation of CFTR (Hanaoka et al, 1996). cAMP 
stimulates the proliferation of PKD cystic epithelial cells, but not normal 
renal cells, through activation of the ERK mitogen-activated protein 
kinase pathway. Aberrant intracellular calcium signaling and/or reduced 
steady-state calcium levels in PKD cells determine the mitogenic 
response to cAMP. Several approaches to reduce renal cAMP and inhibit 
cAMP-dependent cell proliferation and fluid secretion are being 
considered for the treatment of PKD. CFTR inhibitors partially inhibited 
cyst growth and preserved renal function in a mouse model of ADPKD 
(Yang et al, 2008). Apicobasal polarity of some transporters and receptors 
is abnormal in ADPKD. EGF and its related growth factors have a 
biphasic effect on ENaC-mediated sodium absorption. ENaC-mediated 
sodium absorption might be involved in the development of PKD. 
Composition and regulation of adherens, focal adhesion and polarity 
complexes determine polarity. Cystic proteins form multi-molecular 
complexes with adhesive polarity complexes. Mutations in adhesive 
polarity complexes and trafficking proteins have also been shown to 
cause renal cystogenesis. 
Primary cilia dysfunction alters renal tubular cell proliferation and 
differentiation and associates with accelerated cyst formation in PKD. 
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Conditional knockout of the Ift88 gene leads to delayed, adult-onset renal 
cystic disease. Recent studies have demonstrated a significant two-fold 
increase in the number of proliferating BrdU-positive cells in 
contralateral kidneys of Ift88 conditional knockout mice following 
unilateral nephrectomy (Bell et al., 2011). Enhanced mammalian target of 
rapamycin complex (mTORC) signalling was also observed in 
association with increased cell proliferation in the contralateral kidneys of 
Ift88 conditional knockout mice following unilateral nephrectomy (Bell et 
al., 2011). Tuberous sclerosis complex (TSC) is a multiorgan 
hamartomatous disease caused by loss of function mutations of either the 
TSC1 or TSC2 genes (Kwiatkowski et al, 2003). Conditional inactivation 
of Tsc1 in murine distal convoluted tubules (DCT) leads to renal 
cystogenesis and is also associated with increased mTORC1 but 
decreased mTORC2 signalling (Armour et al, 2012). mTOR inhibition 
ameliorates cyst formation in murine cystic kidney disease (Novalic et al, 
2012). Interestingly, von Hippel-Lindau (VHL) disease also results in 
renal cystogenesis with similar features to ADPKD. Recent work has 
shown polycystin-1 (PC1) and pVHL proteins may participate in the 
same key signalling pathways (Foy et al, 2012). pVHL has been shown to 
stabilize Jade-1, a pro-apoptotic and growth suppressive ubiquitin ligase 
for beta-catenin and transcriptional coactivator associated with histone 
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acetyltransferase activity. Elegant studies have highlighted a role for PC-
1 in the regulation of Jade-1 activity whereby PC-1 can bind and inhibit 
Jade-1 ubiquitination. ADPKD-associated PC1 mutants fail to regulate 
Jade-1, indicating a potential disease link between VHL disease and 
ADPKD (Foy et al., 2012). Defects in the establishment and maintenance 
of nephron diameter have been shown by several investigators to be 
implicated in the pathogenesis of cyst formation. Aberrant activation of 
signal transduction pathways have also been implicated. For example, 
constitutive expression of β-catenin in transgenic mice leads to renal 
cysts supporting a role for canonical Wnt activation in renal cystogenesis 
(Saadi-Kheddouci et al., 2001). Furthermore, mutations in NPHP7 
(GLIS2), a component of the SHH pathway, also point towards a role for 
defective SHH signalling in renal cystogenesis (Attanasio et al., 2007). 
As these key pathways are implicated in cell proliferation and 
differentiation, several other pathways regulating these processes in renal 
epithelia have been implicated in renal cystogenesis (Torres and Harris, 
2009). Studies in mice suggest that severity of cyst formation is 
temporally related to renal tubule morphogenesis. Murine conditional 
inactivation of Pkd1, the gene mutated in 85% of cases of PKD before 
postnatal (PN) day 13 results in rapid progressive cystic enlargement 
whereas later inactivation results in a much milder course.  
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Table 1.4. The renal ciliopathies 
 
 
Renal Phenotype 
 
 
Histopathology 
 
Gene (protein) 
 
Subcellular 
localisation 
 
Extrarenal  
Signs 
Polycystic kidneys 
 
1. ADPKD 
 
 
 
 
 
 
 
2. ARPKD 
 
 
 
 
3. Syndromic 
 
 
1. Focal cysts at 
all levels of the 
nephron 
 
 
 
 
 
2. Radial pattern 
of fusiform cysts 
in the dilated 
collecting ducts 
 
1. Focal cysts at 
all levels of the 
nephron 
 
 
 
1. PKD1 (PC-1) 
2. PKD2 (PC-2) 
 
 
 
 
 
 
1. PKHD1 
(Fibrocystin)  
 
 
 
1. BBS1-15 
 
 
 
2. MKS1-4 
 
 
 
 
Cilia/basal 
bodies 
Cell-cell 
junctions 
Cell-matrix 
Interactions 
 
 
Cilia/basal 
bodies 
Interacts with 
polycystins 
 
Cilia/basal 
bodies 
 
 
Cilia/basal 
bodies 
 
 
 
Hepatic & 
pancreatic 
cysts, 
intracranial 
aneurysms 
 
 
 
Liver 
cysts/fibrosis 
 
 
Obesity, 
diabetes, RP, 
Polydactyly 
 
Encephalocele, 
polydactyly, 
dysplasia of 
multiple 
organs 
 
 
Nephronophthisis 
 
Cortico-
medullary cysts, 
tubular basement 
membrane 
disruption and 
tubulointerstitial 
nephropathy 
 
NPHP1-11 
NPHP1L 
SDCCAG8 
ZNF423 
CEP164 
Primary cilia, 
basal bodies 
& 
centrosomes 
RP 
Liver 
cysts/fibrosis 
JS 
MKS 
Skeletal 
dysplasia 
 
Renal Dysplasia 
 
Incompletely 
branched 
collecting duct 
precursors 
surrounded by 
undifferentiated 
mesenchymal 
stroma. 
 
 
BBS 
NPHP3 
MKS1-4 
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1.3.2.1 Defective oriented cell division and renal cystogenesis 
During renal morphogenesis, tubule diameter is established during 
early morphogenetic stages by convergent extension processes and 
maintained by polarized cell divisions whereby > 95% of renal epithelial 
cells divide at an angle < 340 relative to the longitudinal axis of the 
developing tubule (Karner et al., 2009). Defective oriented cell division 
(OCD) has been described in at least five distinct models of PKD (Fischer 
et al., 2006; Jonassen et al., 2008; Patel et al., 2008), (Saburi et al, 2008) 
(Figure 1.11). Hypomorphic Wnt9b mutant mice exhibit defects in 
polarised cell orientation during kidney tubule morphogenesis and by day 
30 of postnatal life, exhibit severely dilated and cystic tubules (Karner et 
al, 2009). Further evidence that defective PCP signalling plays a role in 
renal cystogenesis comes from murine studies demonstrating renal cyst 
formation at embryonic day 16.5 in mice deficient for the core PCP 
effector, Fat4 (Saburi et al., 2008). Inversin, the gene mutated in 
nephronophthisis (NPHP2) is localized to the primary cilium and is 
involved with the activation of PCP signalling (Simons et al, 2005). 
During urine flow, increased levels of inversin target Dvl for 
ubiquitinylation, which allows reassembly, and activation of the β-catenin 
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destruction complex and thereby mediating a switch from canonical to 
noncanonical Wnt signalling (Simons et al., 2005).  
Defective OCD has also been observed in Notch-deficient 
proximal tubular epithelia prior to the development of renal cysts 
(Surendran et al., 2010). Furthermore, in MDCK cells treated with 
DAPT, a γ-secretase inhibitor, the fraction of cells dividing parallel to the 
basement membrane was less than 58% and the mitotic angle between the 
plane of the spindle poles and the plate surface was > 25o compared to 
controls where the mitotic angle was <10o in >94% of cells. 
 
Figure 1.11: Malfunction of cystoprotein leads to disruption of 
planar cell polarity and renal cystogenesis. Alignment of mitotic 
spindle perpendicular to the tubular lumen in polycystic kidney disease 
leads to tubular dilation and cyst formation (Adapted from (Happe et al., 
2011), (Hildebrandt et al., 2009). 
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The occurrence of mitotic spindle planes perpendicular to the basement 
membrane before cyst formation in Notch-deficient proximal tubular 
epithelia indicates that Notch 1 and Notch 2 are components of a 
molecular programme that restrict mitotic spindles to a plane parallel to 
the basement membrane (Surendran et al.). Future investigation will be 
necessary to determine the molecular components of this programme. 
1.3.2.2 Role of cilia proteins in mitotic spindle orientation 
During mitosis, centrosomes (spindle poles) participate in the 
organisation and orientation of the mitotic spindle (Luders and Stearns, 
2007; O'Connell and Wang, 2000). Mitotic spindle orientation is 
facilitated by the interaction of astral microtubules with the cell cortex 
(O'Connell and Wang, 2000). Several proteins involved in cilia function 
have been localised to the spindle poles including IFT88, polycystins, 
Nde1 and CEP290. Intriguingly, IFT88 protein depletion has been 
reported to cause mitotic delay associated with spindle pole disruption, 
chromosome misalignment and spindle misorientation where IFT88-
depleted cells result in a spindle angle greater than 10o relative to the cell-
substrate adhesion plane (Delaval et al., 2011) (Figure 1.11). 
Cystogenesis has been previously associated with structural cilia 
abnormalities and misoriented cell division (Fischer et al, 2006). While 
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cilia appear to regulate planar cell polarity, which has been implicated 
mechanistically in cystogenesis, the mechanism leading to misoriented 
cell division remains unclear (Saburi et al, 2008). Therefore the 
mechanisms underlying cystogenesis in diseases associated with 
mutations in cilia genes, could actually be the result of cilia proteins 
playing a role in spindle orientation rather than cilia formation. 
1.3.3 Predicting new ciliopathy disorders  
 
Mutations in over 60 genes to date, have been implicated in human 
ciliopathy disorders. Depending on the cell type, the ciliary proteome has 
been found to contain between 500 and 1800 ciliary proteins. Therefore, 
it has been estimated that potentially many more cilia-related diseases 
exist (Baker and Beales, 2009). Recent work has shown that Mainzer 
Saldino and Sensenbrenner syndromes, disorders characterised by 
skeletal dysplasia, renal disease and retinal degeneration are also 
ciliopathy disorders. Mutations in IFT122, WDR35, WDR19, IFT43 and 
IFT140 have been found in to be mutated in Sensenbrenner and Mainzer 
Saldino syndromes respectively (Arts et al., 2011; Bredrup et al., 2011; 
Gilissen et al., 2010; Walczak-Sztulpa et al., 2010)(Isabelle et al, 2012). 
Through accurate phenotyping approaches together with a greater 
awareness of the range of ciliopathy morphological features, coupled with 
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next generation sequencing technologies, it is highly anticipated that the 
genetic aetiology of several new ciliopathy disorders will be uncovered. 
Summary 
Ciliopathies are disorders associated with genetic mutations 
resulting in dysfunctioning cilia. As cilia are a component of almost all 
vertebrate cells, cilia dysfunction can manifest as a constellation of 
features that include characteristically, situs inversus, retinal 
degeneration, cystic renal disease, obesity, diabetes, cerebral 
malformations and skeletal disorders. With over 1,000 polypeptides 
currently identified within the ciliary proteome, several other disorders 
associated with this constellation of clinical features will likely be 
ascribed to mutations in other ciliary genes. The mechanisms underlying 
many of the disease phenotypes associated with ciliary dysfunction have 
yet to be fully elucidated. Recent work has shown that cilia proteins such 
as IFT components can play a role in mitotic spindle orientation, a 
mechanism, which when defective, could help explain certain ciliopathy 
phenotypes such as cystic kidney disease. The focus of the current work 
was to identify a new ciliopathy disease gene and elucidate a novel 
ciliogenic function for its encoded protein, whose function had been 
previously well characterised in mitosis. 
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CHAPTER 2. MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 General laboratory reagents and materials 
All the reagents that were used were obtained from Sigma Aldrich or 
BDH laboratory supplies, except where indicated. Glassware was 
obtained from Fisher Scientific (UK), Pyrex ® (USA) and schott Duran 
(Germany). Plastic ware was from Becton Dickson Labware or Bibby 
Sterilin Ltd. 0.2ml PCR tube strips were obtained from ThermoScientific 
Ltd. Glassware, solutions and media were autoclaved at 15pst, 121 oC for 
20 minutes as required. Water was purified using MiliRo Water 
Purification System (Milipore SA) and further purified where necessary 
using a Mili-Q reagent Grade Water Ultrafiltration System (Milipore SA) 
and sterilized by autoclaving. 
2.1.2 Other reagents and materials 
Electrophoresis molecular biology grade agarose was obtained from 
Invitrogen Life Technologies. Bacto-agar, bactotryptone, bactopeptone, 
agar and yeast extract were from Fisher. Absolute alcohol, methanol and 
isopropanolol were obtained from Fisher VWR International. NBT/BCIP 
were purchased from Roche. Sterile loops were obtained from Greiner 
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BioOne. Super Premium microscope slides were purchased from VWR 
International. Vectashield mounting medium kit for fluorescence with 
DAPI was purchased from Vector Laboratories Inc. 
2.1.3 General laboratory stock solutions and buffers 
A buffer is an aqueous solution consisting of a mixture of a weak acid 
and its conjugate base or a weak base and its conjugate acid. Buffer 
solutions are used as a means of keeping pH at a nearly constant value. 
1x PBS  137mM NaCl, 3mM KCl, 10mM Na2HPO4, 
1.8mM KH2PO4, pH 7.2 
1x PBT  1x PBS + 0.1% Tween-20 
1x TE buffer            10mM Tris-HCl, 1mM EDTA, pH 8.0 
1x TAE    40mM Tris-acetate, 1mM EDTA, pH 8.0 
RIPA lysis buffer   50 mM Tris–HCl [pH 7.5], 150 mM NaCl,  
0.5% Triton X-100, 0.5% sodium deoxycholate, 
0.1% sodium dodecyl sulphate 
10x Running Buffer        30 g Tris base, 144g glycine,  10 g SDS,  
1L H2O, [pH 8.3] 
5x Transfer Buffer  14.5 g Tris, 72g glycine, 1L H2O  
5% Milk    2.5g Skimmed milk powder, 50mls 1xPBS 
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2.2 METHODS 
2.2.1 Exome capture 
2.2.1.1 Research subjects 
In addition to the index family, we obtained blood samples following 
informed consent from families with Bardet Biedl syndrome. Approval 
for human subjects research was obtained from the Institute of Child 
Health Research Ethics Board, University College London and the other 
institutions involved. 
2.2.1.2 Linkage analysis 
Genetic studies were approved by the Institute of Child Health–Great 
Ormond Street Hospital Research Ethics Committee, and the parents 
provided written informed consent. For genome-wide single-nucleotide 
polymorphism (SNP) mapping the GeneChip® Human Mapping 500k 
Array from Affymetrix was used. Genotypes were examined with the use 
of a multipoint parametric linkage analysis and haplotype reconstruction 
performed with GENEHUNTER 2.1 (Kruglyak et al, 1996, Strauch et al, 
2000) through stepwise use of a sliding window with sets of 110 SNPs 
and the program ALLEGRO (Gudbjartsson et al, 2000) for an autosomal 
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recessive model with complete penetrance and a disease allele frequency 
of 0.0001 and Caucasian marker allele frequencies.  
2.2.1.3           Target selection and sequencing 
Targeted capture was performed on genomic DNA from 1 affected and 1 
unaffected sibling.  
2.2.1.4 Oligonucleotides and adaptors 
All oligonucleotides were synthesised by Roche Nimblegen. SeqCap EZ 
Human Exome Library v1.0 design utilized genomic content from 
RefSeq, CCDS and miRBase databases which encompassed 25, 000 
coding genes and 180, 000 exons. Oligonucleotides were resuspended in 
nuclease-free water to a stock concentration of 100 μM. Double-stranded 
library adaptors SP1 and SP2 were prepared to a final concentration of 50 
μM by incubating equimolar amounts of SP1_HI and SP1_LO together 
and SP2_HI and SP2_LO together at 95°C for 3 mins and then leaving 
the adaptors to cool to room temperature in the heat block. 
2.2.1.5 Sample library construction 
Sample libraries were generated from 3µγ of genomic DNA (gDNA) 
using the Illumina Paired-End Genomic DNA Sample Prep Kit protocol. 
For each sample, gDNA in 100µl 1× Tris-EDTA was first sonicated for 
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30 min using a Covaris Sonolab set at high, then end-repaired for 55 mins 
in a 100µl reaction volume using 1× End-It Buffer, 10µl dNTP mix and 
10µl ATP as supplied in the Paired-End Genomic DNA Sample Prep Kit 
(Illumina). The End-It™ DNA End-Repair Kit converts DNA containing 
damaged or incompatible 5´- and/or 3´-protruding ends to 5´-
phosphorylated, blunt-ended DNA. The fragments were then A-tailed for 
55 mins at 70°C in a 100µl reaction volume with 1× PCR buffer (Applied 
Biosystems), 1.5mM MgCl2, 1mM dATP and 5U AmpliTaq DNA 
polymerase (Applied Biosystems). Next, library adaptors SP1 and SP2 
were ligated to the A-tailed sample in a 90µl reaction volume with 1× 
Quick Ligation Buffer (New England Biolabs) with 5µl Quick T4 DNA 
Ligase (New England Biolabs) and each adaptor in 10× molar excess of 
sample. Samples were purified on MinElute columns (Qiagen) after each 
of these four steps and DNA concentration determined on an Agilent 
DNA 1000 chip when necessary. MinElute Kits contain a silica 
membrane assembly for binding of DNA in high-salt buffer and elution 
with low-salt buffer or water. The purification procedure removes 
primers, nucleotides, enzymes, mineral oil, salts, agarose, ethidium 
bromide, and other impurities from DNA samples. Silica-membrane 
technology eliminates the problems and inconvenience associated with 
loose resins and slurries. Specialized binding buffers are optimized for 
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specific applications and promote selective adsorption of DNA molecules 
within particular size ranges. 
Each sample was subsequently size selected for fragments of size 
200–400bp using gel electrophoresis on a 6% TBE-polyacrylamide gel 
(Invitrogen). A gel slice containing the fragments of interest was then 
excised and transferred to a siliconized 0.5ml microfuge tube (Ambion) 
with a 20G needle-punched hole in the bottom. This tube was placed in a 
1.5ml siliconised microfuge tube (Ambion), and centrifuged at 13.2 xg 
for 5mins to create a gel slurry that was then resuspended in 200 μl 1× 
Tris-EDTA and incubated at 65°C for 2hrs, with periodic vortexing. This 
allowed for passive elution of DNA, and the aqueous phase was then 
separated from gel fragments by centrifugation through 0.2 μm NanoSep 
columns (Pall Life Sciences) and the DNA recovered using a standard 
ethanol precipitation. 
Recovered DNA was resuspended in EB buffer (10mM Tris-Cl, 
pH8.5, Qiagen) and 4µl was used in a 200 µl bulk PCR reaction volume 
and thereafter divided into 4 reaction volumes with 2 x Phusion High-
Fidelity PCR Master Mix and 2 uM each of primers PE-PRE 1 and PE-
PRE 2 in the following conditions – 98°C for 30s; 98°C for 10s; 65°C for 
30s and 72°C for 30s; 11 cycles of 98°C for 10s; 65°C for 30s and 72°C 
for 30s; and finally 72°C for 5 min. Combined 4 PCR products were 
! 78!
purified across 1 QIAquick columns (Qiagen) and eluted with PCR grade 
water. DNA concentration determined on a Nanodrop spectrophotometer 
and then run on an Agilent DNA 1000 chip when necessary with 
fragments between 200-400bp. 
2.2.1.6 Hybridization to exome libraries 
100 µl of 1mg/ml Cot DNA and 1µg of amplified sample library was 
added to a 1.5 ml microfuge tube. 1 µl of each 1000 µM PE-HE1 and PE-
HE2 oligos to the amplified sample library plus Cot DNA. A hole was 
then made in the closed lid of the tube with a 20G needle. The amplified 
sample library/Cot-1 DNA/PE-HE Oligos were then dried in a SpeedVac 
at 60°C for at least 30 minutes. Cot-1 DNA is genomic DNA that is 
highly enriched for repetitive elements, such as SINES (short interspersed 
repetitive elements, or Alu repeats) and LINES (long interspersed 
repetitive elements, or L1 elements). Cot-1 DNA is used as an unlabelled 
blocking agent in hybridization experiments to prevent non-specific 
hybridization by hybridizing to repetitive elements in the genome. 
Following drying, 7.5 µl of 2x SC Hybridization buffer was added with 3 
µl of SC Hybridization component A. The hole in the lid of the microfuge 
was then covered with a sticker and the amplified library/Cot DNA/PE-
HE Oligos plus Hybridization Cocktail was vortexed for 10 seconds and 
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centrifuged at maximum speed for 10 seconds. The amplified sample 
library/Cot DNA/PE-HE/Hybridization Cocktail was centrifuged at 
maximum speed for 10 seconds at 25oC. The amplified sample 
library/Cot/DNA/PE-HE Oligos/Hybridization Cocktail was transferred 
to the 4.5 µl aliquot of EZ Exome Library (Roche Nimblegen) which was 
vortexed for 3 seconds and then centrifuged at maximum speed for 10 
seconds. The amplified sample library/Cot/DNA/PE-HE 
Oligos/Hybridization Cocktail with the EZ Exome Library was then 
incubated in a thermocycler at 47°C for 64-72 hours. 
2.2.1.7 Recovery of captured DNA 
10X SC Wash Buffers (I, II and III) and 2X Stringent Wash Buffer was 
diluted to 1X working concentrations. 1X Stringent Wash Buffer and 1X 
SC Wash Buffers I was heated to 47°C in a water bath. The streptavidin 
dynabeads were warmed to room temperature for 30 minutes prior to use. 
The beads were then mixed thoroughly by vortexing for 1 minute. For 
each capture, 100 µl of beads were aliquoted into a single 1.5 ml tube, 
which was then placed in a Dyna-Mag2 device. The liquid was then 
removed and the beads left behind were washed with 200 µl of wash 
buffer. After removal of the tube from the Dyna-Mag2 device, the tube 
was vortexed for a further 10 seconds and the tube was replaced again in 
the Dyna-Mag2 device and washed with wash buffer for another 2 
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washes. Following the second wash, the beads were resuspended by 
vortexing in 1x the original volume using the Streptavidin bead binding 
and wash buffer. 100 µl of beads were aliquoted into 2 new tubes and the 
beads were again bound using the Dyna-Mag2 device. The hybridization 
samples were then transferred to the streptavidin dynabeads and mixed by 
pipetting. The solution with the hydridization samples and streptavidin 
dynabeads were then incubated in a thermocycler at 47°C for 45 minutes. 
The sample was vortexed every minute for 3 seconds to maintain the 
beads in suspension. The dynabeads with bound DNA was then placed in 
the Dyna-Mag2 device, the liquid was first removed and thereafter the 
tube, from the Dyna-Mag2 device. The beads and bound DNA was then 
washed with 200µl of Stringent wash buffer heated to 47°C for a total of 
2 washes. Subsequently the beads and bound DNA were then washed in 
SC Wash Buffer I, II and III following placement in the Dyna-Mag2 
device with removal of liquid after each wash. 50 µl of PCR grade water 
was then added to the bead-bound captured DNA sample. 
2.2.1.8 Amplification of captured DNA 
The bead-bound captured DNA sample was vortexed to achieve a 
homogenous mixture of beads. 4µl of bead-bound captured DNA was 
aliquoted into 10 reaction tubes each containing 46µl of LM-PCR Post 
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Capture Master Mix (2X Phusion High Fidelity PCR Master Mix, 2µM 
PE-POST Oligo 1, 2µM PE-POST Oligo 2 and PCR grade water) , in the 
following conditions – 98°C for 30s; 98°C for 10s; 60°C for 30s and 
72°C for 30s; 19 cycles of 98°C for 10s; 65°C for 30s and 72°C for 30s; 
and finally 72°C for 5 min. Combined 10 PCR products were purified 
across 2 QIAquick columns (Qiagen) and eluted into EB buffer. DNA 
concentration from the combined eluates was then determined on a 
Nanodrop spectrophotometer and then run on an Agilent DNA 1000 chip 
when necessary with fragments between 200-400bp. The LM-PCR yield 
> 1 µg. 
2.2.1.9 Measurement of enrichment using qPCR 
A standardised set of qPCR SYBR Green assays were employed as 
internal quality controls to estimate the relative abundance of control 
targets in amplified sample library and amplified captured DNA. For each 
PCR reaction, 1µl of 5ng/ µl template (amplified sample library, 
amplified captured library DNA, positive control genomic DNA or 
negative control PCR grade water) was added to 5.9µl PCR grade water, 
0.3µl NSC assay forward primer (2µM) and reverse primer (2µM) and 
7.5 µl SYBR Green Master Mix (2X). Primers used were NSC-0237, 
NSC-0247, NSC-0268, NSC-0272 (Nimblegen). The PCR conditions 
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were as follows: 95°C for 10 minutes, 40 cycles of 95°C for 10 seconds 
with 60°C for 1 minute, 95°C for 10 seconds, 65°C for 1 minute, 95°C 
for 5 acquisitions per degree, 40°C for 10 seconds. The relative mRNA 
abundance of target enrichment of amplified captured DNA from 
amplified sample library was calculated using the second derivative 
maximum method. The cut-off values for successful fold enrichment 
were as follows: NSC-237, 250; NSC-247, 50; NSC-268, 300 and NSC-
272, 300.  
2.2.1.10    Massive parallel deep sequencing 
Following amplification of captured DNA, single-stranded DNA 
fragments were annealed to a flow cell surface in a cluster station, 
automated flow cell processor, (Illumina) and 46 cycles of bridge 
amplification were applied on a single lane of a Solexa/Illumina Genome 
Analyzer II platform. "Bridged" amplification occurs on the surface of 
the flow cell which is a water-tight microscope slide. The flow cell 
surface is coated with single stranded oligonucleotides that correspond to 
the sequences of the adapters ligated during the sample preparation stage. 
Single-stranded, adapter-ligated fragments are bound to the surface of the 
flow cell exposed to reagents for polyermase-based extension. Priming 
occurs as the free/distal end of a ligated fragment "bridges" to a 
complementary oligo on the surface. Repeated denaturation and extension 
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results in localized amplification of single molecules in millions of 
unique locations across the flow cell surface. ‘Sequencing by synthesis’ is 
a process whereby automated cycles of extension and imaging are 
undertaken in a flow cell containing millions of unique clusters following 
loading into the 1G sequencer. The first cycle of sequencing consists the 
incorporation of a single fluorescent nucleotide, followed by high 
resolution imaging of the entire flow cell. These images represent the data 
collected for the first base. Any signal above background identifies the 
physical location of a cluster (or polony), and the fluorescent emission 
identifies which of the four bases was incorporated at that position. This 
cycle is repeated, one base at a time, generating a series of images each 
representing a single base extension at a specific cluster. Base calls are 
derived with an algorithm that identifies the emission color over time. 
Image analysis and base calling was generated by the Genome Analyzer 
Pipeline 1.5 with default parameters. Illumina specific FASTQ file 
containing sequence information and quality scores for each base call 
were exported for further analysis.  
2.2.1.11         Quality control 
After the sequencing reactions were complete, the Illumina analysis 
pipeline was used to process the raw sequencing data (Bustard and 
Gerald) and produce FASTQ format files (Justyna Porwisz, UCL 
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Genomics Facility). The quality of the sequencing runs were assessed by 
evaluating the percentage of clusters passing the filter, and by running the 
FastQC software and evaluating read length and base quality profiles, GC 
content, average GC content per base, average base content per read 
position, and checking for any indication of over-represented sequences.  
 
Sample 
 
Clusters 
(raw) 
 
Clusters 
(PF) 
 
% PF 
 
PCR 
Duplicates 
removed 
(mln) 
 
Affected 
 
252567 +/- 
5886 
 
 
180734 +/- 
7104 
 
 
71.55 +/- 
2.32 
 
6.85 
 
Unaffected 
 
234697 +/- 
4834 
 
 
180749 +/- 
3459 
 
 
77.02 +/- 
1.15 
 
11.69 
 
2.2.1.11        Alignment (undertaken by Francesco Lescai) 
Once the raw sequence data was assessed for quality, the reads were 
aligned to a human reference genome (GRC37 release, downloaded from 
the ENSEMBL database). Three different software programmes were 
used: Maq, BWA and Novoalign. Maq performed an ungapped 
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alignment, with limited gapped alignment on non-paired reads. BWA and 
Novoalign perform gapped alignments. Maq and BWA were used with 
their default parameters. Novoalign was launched with the additional hard 
clipping option based on read base quality (-H) and the default adaptor 
removal option (-a). The alignment summary was reported by using in-
house perl scripts that count the bitwise flags for the sam files produced 
during the alignments steps. The coverage along the genome was 
calculated using BEDtools (GenomeCoverageBed function), without 
omitting zero values. Alignments were visualized in UCSC Genome 
Browser using the BED files and in Integrated Genome Browser using 
the BAM files. 
2.2.1.13       SNP and InDel calling (undertaken by Francesco Lescai) 
2.2.1.13.1    SNP calling with Maq and Samtools 
On Maq alignments, its internal function was used in order to remove 
PCR duplicates (maq rmdup). Although Maq performs mostly an 
ungapped alignment, two internal functions exist to call consistent indels 
from paired end reads (maq indelpe) and to call potential homozygous 
indels and break points by detecting the abnormal alignment pattern 
around indels and break points (maq indelsoa). These two functions were 
used to generate potential indels locations and to mask these loci during 
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the SNP calling. SNP calling with Samtools version 0.1.7-6 was also 
employed. The internal function (rmdup) was used in order to remove 
potential PCR duplicates. The new bam was then used as an input to 
extract a pileup with a Maq-like consensus sequence (paramenters “-vc”). 
A preliminary pileup output was used to filter the variant calls (function 
samtools.pl varFilter) with parameters (set by Francesco Lescai). The 
final output was then converted to variant call format (VCF) format. 
2.2.2 Tissue Culture 
Human Embryonic Kidney (HEK) 293T, National Institute of Health 3T3 
fibroblasts and retinal pigment epithelial (RPE) cells were grown and 
serially passaged in order to produce Cenp-F proteins. For passaging, 
cells were incubated in 2ml 0.05% trypsin solution (Gibco) at 37oC until 
all cells had detached from the flask (between 3 to 5 minutes): after 
addition of an equal volume of growth medium, the number of cells was 
determined using a haemocytometer; the cells were then pelleted, 
resuspended in growth medium and replated according to the determined 
total number of cells. Cells were grown in a humidified incubator at 37oC 
with 5% CO2 on tissue culture grade plastic dishes purchased from 
Invitrogen (Corning MA).  
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2.2.2.1 Transfection 
Human embryonic kidney cells (HEKT293), mouse embryonic fibroblast 
cells (NIH 3T3) and RPE cells were cultured in DMEM media (Gibco 
containing 10% foetal bovine serum (Gibco) and 1% 
penicillin/streptomycin (Gibco). Cells were transfected using the 
Effectene ® transfection reagent (Qiagen). Following condensation of 
DNA, the Effectene® reagent coats the condensed DNA molecules with 
cationic lipids to the plasmid DNA resulting in micelle formation. The 
complexes are mixed with growth medium and are added directly to the 
cells which are then incubated and harvested at optimal time-points to 
analyze gene expression. 
Preparation of the transfection solution in 24-well plates: 
Cells were plated on the day before transfection at 2-8 x 105 cells per 
60mm dish in 5mls of DMEM with 10% FBS and 1% 
penicillin/streptomicin. Cells were incubated at 37oC and 5% CO2 and 
were between 40-80% confluent on the day of transfection. On the day of 
transfection, 1µg of plasmid DNA was diluted in 150 µl of the DNA-
condensation buffer, Buffer EC. 8 µl of Enhancer was added to the 
solution, which was then vortexed for 1 second. The solution was then 
incubated for 2 to 5 minutes at room temperature and then spun down for 
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a few minutes to remove drops from the top of the tube. Next 25 µl of 
Effectene transfection reagent (Qiagen) was then added to the DNA-
Enhancer mixture and gently mixed by vortexing for 10 seconds. Samples 
were then incubated for 5-10 minutes at room temperature to allow 
transfection-complex formation. While complex formation was taking 
place, growth medium was gently aspirated from the plate and cells were 
washed once with 4mls of 1xPBS. 4 mls of fresh DMEM with 10% FBS 
and 1% penicillin/streptomycin was added to the cells. After incubation, 1 
ml of DMEM containing 10% FBS and penicillin with streptomycin was 
added to the tube containing the transfection complexes. The solution was 
gently mixed by pipetting up and down twice and the transfection 
complexes were then added drop-wise onto the cells in the 60mm dishes. 
The dish was gently swirled to ensure uniform distribution of the 
transfection complexes.  
2.2.2 Bacterial culture 
2.2.3.1 Bacterial strains 
The bacterial strain used was Escherichia coli JM109 (Promega) for 
plasmid DNA propagation. 
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2.2.3.2         Bacterial growth media 
L-Broth   10g/l Bacto-tryptone, 5g/l yeast extract, 5g/l NaCl 
LB agar   L-Broth + 15g/l agar added prior to autoclaving 
NZY+ Broth  5g/l NaCl, 10g/l casein hydrolysate,  
5g/l yeast extract, 12.5mls 1M MgSO4,  
12.5mls 1M MgCl2, 10mls 2M glucose 
2.2.3.3       Selection antibiotics for bacteria  
Ampicillin (stock 50mg/ml in sterile water, stored at -20oC) was added to 
L-Broth, LB agar to a final concentration of 100 µg/ml. 
2.2.3.4       Bacterial transformation 
Preparation of transformation-competent bacteria:  
A single colony of JM109 bacteria was cultured overnight without 
shaking in 10 ml L-broth medium at 37oC. 100 ml of L-broth medium 
were inoculated with the entire overnight culture and grown in a 37oC 
bacterial shaker until the O.D 600 reached 0.4 (approximately 4 hours). 
The bacteria were pelleted by centrifugation at 6000 rpm for 10 minutes 
at 4oC, washed once in ice cold 10mM NaCl, resuspended in 100ml ice 
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cold 50 mM CaCl2 and incubated on ice for 15 minutes. Bacteria were 
pelleted again by centrifugation at 6000 rpm for 10 minutes at 4oC, 
resuspended in 10 ml ice cold 50 mM CaCl2 containing 16% glycerol 
(w/v) and aliquoted into 1.5 ml tubes which were pre-cooled in a dry 
ice/ethanol bath. Aliquots were stored at -70oC. Competence was tested 
by transformation with the plasmid pBluescript II KS (+/-). Typically, 
100 µl of competent bacteria were able to produce approximately 106 
colonies per µg DNA. 
Transformation of bacteria:  
50 µl of competent bacteria were thawed on ice and then gently mixed 
with 25ng of plasmid DNA. The cells were then chilled on ice for 10 
minutes and then transferred to a water bath at 42oC and electroporated 
by heating for 50 seconds. The cells were then transferred back to ice for 
another 2 minutes before adding 450 µl of cold L-broth and the cell 
suspension was gently mixed and incubated with shaking for 1 hour at 
37oC. 225 µl culture was spread onto LB agar containing a suitable 
antibiotic and incubated overnight at 37oC. Next, single colonies were 
picked with a sterile loop to inoculate 2.5 mls LB medium containing the 
appropriate antibiotic and incubated overnight in an orbital shaker at 
37oC. 1ml was then inoculated into 50 mls of LB containing the 
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appropriate antibiotic in a sterile conical flask and incubated at 37oC in an 
orbital shaker overnight. For glycerol stocks, 140 µl of the overnight 
culture was added to 40 µl of 80% glycerol and stored at -80oC. Colonies 
were tested to determine if bacterial transformation was effective by 
restriction enzyme digestion of mini- and midi- prepared DNA. 
2.2.4 DNA techniques 
2.2.4.1       Purification of plasmid DNA from bacteria 
For purification of plasmid DNA from bacteria, QIAquick mini and 
midiprep kits (Qiagen Ltd.) were used. The procedure for plasmid DNA 
purification from bacteria is a modified version of alkaline lysis method 
of Birnboim and Doly (Birnboim and Doly, 1979). Briefly, bacteria are 
lysed under alkaline conditions, leading to release of the cell contents and 
subsequent denaturation of proteins, chromosomal and plasmid DNA. 
The lysate is subsequently neutralized and adjusted to high-salt binding 
conditions, causing denatured proteins, chromosomal DNA and cellular 
debris to precipitate, while the smaller plasmid DNA renatures and stays 
in solution ready to be purified. Depending on the size of the plasmid 
DNA scale preparation, DNA can be purified by isopropranolol 
precipitation (small scale) or through a Qiagen anion-exchange resin 
under appropriate high-salt and pH conditions (medium scale). 
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For small scale preparation of plasmid DNA (”miniprep”), eg to 
screen colonies after transformation, 3mls LB-media containing a suitable 
antibiotic was inoculated with a single bacterial colony and grown 
overnight in a 37oC orbital shaker. Plasmid DNA was isolated from the 
pelleted bacteria by resuspension in 500 µl ice cold solution P1 
(containing RNase A), followed by addition of 500 µl solution P2 
(NaOH/SDS-containing lysis solution) and mixing, then 500 µl ice cold 
solution P3 (high-salt neutralizing solution) and mixing, centrifugation at 
14000 rpm in a microfuge for 5 minutes, and finally precipitation with 0.7 
volumes of isopropranolol. DNA was dissolved in 1x TE containing 100 
µg/ml RNAse A. 
For medium scale preparations (“midiprep”), 3 mls LB-media 
containing a suitable antibiotic was inoculated with a single bacterial 
colony and grown overnight in a 37oC orbital shaker. Next day, 50 ml 
LB-media containing a suitable antibiotic was inoculated with 1.5 ml of 
the overnight culture and grown overnight in a 37oC orbital shaker. On 
the following day, the 50ml culture was harvested by centrifugation at 
6000 rpm for 15 minutes at 4oC. The pellet was resuspended in 6 ml of 
Buffer P1. 6ml of Buffer P2 was added, mixed thoroughly by vigorously 
inverting the tube 4-6 times and then incubated at room temperature (15-
25oC) for 5 minutes. Then, 6ml of chilled Buffer P3 was added, mixed 
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vigorously by inverting the solution 4-6 times. The lysate was then 
poured into the barrel of the QIAFilter cartridge and incubated at room 
temperature for 10 minutes. A HiSpeed MIDI was equilibrated by 
applying 4 mls of QBT and the column was allowed to empty by gravity 
flow. The nozzle was removed from the QIAFilter cartridge and the 
plunger was inserted into the QIAFilter midi cartridge and the cell lysate 
was filtered into the previously equilibrated HiSpeed tip. The cleared 
lysate was allowed to enter the resin by gravity flow. The HiSpeed Midi 
was washed with 20mls of Buffer QC. The DNA was eluted by adding 
3.5mls of room temperature isopropanolol to the eluted DNA. The sample 
was then mixed and incubated at room temperature for 5 minutes. During 
the incubation procedure, the plunger was removed from the 20ml 
syringe and attached to the QIAprecipitator Midi Module onto the outlet 
nozzle. The eluate/isopropanolol mixture was transferred into the 20mls 
syringe and the plunger was inserted under constant pressure. The 
QIAprecipitator was re-attached and 2mls of 70% ethanol was added to 
the syringe. The DNA was washed by inserting the plunger and pressing 
the ethanol through the QIAprecipitator. The QIAprecipitator was 
removed from the 20ml syringe and pulled out and inserted again while 
the membrane was dried by pressing air through the QIApercipitator 
forcefully and quickly. A 5 ml syringe was then attached to the 
QIAprecipitator and 1ml of water was added to the syringe and the 
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plunger was inserted to elute into a 1.5ml Eppendorf. This step was 
repeated. Next, the DNA concentration was determined and the plasmid 
was validated by diagnostic restriction enzyme digestion.  
2.2.4.2 Quantification of DNA 
A 2 µl aliquot of DNA was diluted in 198 µl of sterile distilled water and 
its absorbance measured at 260 nm using a NanoDrop ND1000 
Spectrophotometer. The concentration of the DNA was then calculated 
from the A260 value (1 A260 unit = 50 µg of double stranded DNA).  
2.2.4.3           Restriction enzyme digestion of DNA fragments 
Restriction enzymes (New England Biolabs) were used with the 
appropriate buffers, as recommended and supplied by the manufacturers. 
For most digestions, 1 µg of DNA was digested with 1.5 units of the 
required restriction enzyme(s) with the appropriate buffer in 50 µl 
reactions. Bovine serum albumin (BSA) was added if required. The 
reaction was incubated at 37oC for 2 hours. Following digestion, the 
products were then electrophoresed on a 1% agarose gel containing 
ethidium bromide (see below).  
2.2.4.4 Amplification of DNA by Polymerase Chain Reaction (PCR) 
! 95!
Genotyping was performed by polymerase chain reaction (PCR). 
Amplification was performed on an MJ Research PTC-200 Peltier 
Thermal Cycler (check this). Briefly, PCR was performed with 1 µl of 
genomic DNA solution, 12.5 µl of PWO reaction mix (Roche), 
containing Taq polymerase, dNTPs, buffer, blue agarose loading dye and 
stabiliser and 0.2 µl of each oligonucleotide primer (1µg/µl solution) 
specific for the gene-targeted genomic loci (Table 2.1), using the PCR 
cycling parameters described in Table 2.2. Oligonucleotides were 
synthesised to order by Invitrogen. A negative control was prepared for 
each reaction, using 2 µl of sterile water instead of DNA as well as a 
positive control, using 2 µl of control DNA known to give a product of 
correct size. PCR products were electrophoresed through 2% agarose gels 
containing ethidium bromide.  
2.2.4.5            Agarose gel electrophoresis 
The concentration of the agarose gel used was dependent on the size of 
the fragments that were being electrophoresed. In general, 1% agarose 
gels were used to electrophorese diagnostic plasmid digestion products, 
while 2% agarose gels were used to separate PCR products. The agarose 
was weighed and added to the appropriate volume of 1 xTAE buffer. This 
was then heated in the microwave to dissolve the agarose and then cooled 
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to approximately 50oC. Next, 10 mg/ml ethidium bromide was added to a 
final concentration of 0.2 mg/ml. The gel was then poured into a gel tray 
of a suitable size containing a comb. The gel was left to set for 
approximately 30 minutes. The gel was then placed into a tank and 
covered with 1 x TAE. The comb was then removed and the samples 
were added by pipetting. The appropriate DNA ladder (100 bp and 1Kb 
DNA ladders from Invitrogen) were also loaded. Electrophoresis carried 
out at 140V until the fragments had separated sufficiently. The DNA 
fragments in the gel were then visualized by exposure to UV light, which 
allowed ethidium bromide fluorescence detection at 300 nm on a 
GENEgenius Bio Imaging System dark room from Syngene. Gels were 
photographed using the GENESnap software from Syngene and printed 
on a Syngene digital graphic printer UP-D895 using Sony UPP-110HA 
thermal print media. 
2.2.4.6         Site-directed mutagenesis 
Mutant human CENPF plasmids were synthesised using the QuikChange 
Site-Directed Mutagenesis kit ® (Stratagene, Catalogue #200518). Full 
length human CENPF cDNA plasmid was kindly provided by X Zhu, 
Shanghai Institutes for Biological Sciences and N-myc-tagged CENPF 
was kindly provided by David Bader, Vanderbilt University. Control and 
sample reactions were prepared as indicated in Table 2.3. Next, 1 µl of 
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Pfu Turbo DNA polymerase (2.5U/ µl ) was added to each control and 
sample reaction. Each reaction was then overlaid with 30 µl of mineral 
oil. Each reaction was then cycled following the cycling parameters 
outlined in Table 2.4. Next, 1 µl of Dpn I restriction enzyme (10 U/ µl) 
was added below the mineral oil overlay. Each reaction was gently and 
thoroughly mixed and spun down in a microfuge for 1 minute and then 
immediately incubated at 37oC for 1 hour to digest the parental 
supercoiled DNA. 1 µl of the Dpn I-treated DNA from each control and 
sample reaction was transformed into separate 50 µl aliquots of XL1-
Blue supercompetent cells in pre-chilled 14ml Falcon polypropylene 
round bottom tubes. As a control, the transformation efficiency of the 
XL1-Blue supercompetent cells was verified by adding 1 µl of pUC18 
control plasmid (0.1ng/ µl) to a 50 µl aliquots of XL1-Blue 
supercompetent cells. The transformation reactions were swirled gently to 
mix and incubated on ice for 30 minutes. Next, the transformation 
reactions were heat pulsed at 42oC for 45 seconds and then placed on ice 
for a further 2 minutes. Next, 0.5ml of NZY+ broth was pre-heated to 
42oC and the transformation reactions were incubated at 37oC for 1 hour 
while shaking at 220-250 rpm. Following incubation, 250 µl of each 
transformation reaction was plated onto agar plates containing ampicillin. 
For the mutagenesis and transformation controls, cells were spread onto  
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Table 2.1 Oligonucleotide primers used for CENPF sequencing.  
Gene Primer sequences (5’ to 3’) Product size 
CENPF Exon 2 F GAAACTTGATTTTTAGGG 
GTGGT 
324bp 
CENPF Exon 2 R AAATACCAGCACTTCTCT 
GTCAA 
324bp 
CENPF Exon 3 F TGGCTTATTGCAGCTGTA 
TCTC 
417bp 
CENPF Exon 3 R ACGGTACAGAGACCGAA 
TCA 
417bp 
CENPF Exon 4 F CTCTGGGAATGTAAGGC 
ATTG 
387bp 
CENPF Exon 4 R GAATTTCTTTGAAAATAT 
GCCACA 
387bp 
CENPF Exon 5 F TGTGTTTTGATATTTGAG 
TAATTTGA 
358bp 
CENPF Exon 5 R TGAGCCCAAAACCTTTTC 
TC 
358bp 
CENPF Exon 6 F AACTTCTTGGGATTATGG 
CTTT 
457bp 
CENPF Exon 6 R CGATGTGCCTAACAAAAC 
ACA 
457bp 
CENPF Exon 7 F GAAAATCTGTTTCTCCTG 
CTTTC 
546bp 
CENPF Exon 7 R CGGATCTGCCCAACTTAA 
AA 
546bp 
CENPF Exon 8 F TTTTTCATGGCACAAATT 
AGGA 
439bp 
CENPF Exon 8 R GCGCAAAAGTGAAGATG 
TGA 
439bp 
CENPF Exon 9 F ACCTGGATTTGATGCCTG 
AG 
448bp 
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CENPF Exon 9 R GGAAACCTAGAGCCAGA 
ATGG 
448bp 
CENPF Exon 10 F GACGTCGCAAGGTCACA 
TTA 
443bp 
CENPF Exon 10 R GCAATCATATTCTGTCAT 
GGGTTA 
443bp 
CENPF Exon 11 F TTAATAGGCGTATGAACA 
ATGAGAA 
477bp 
CENPF Exon 11 R TTTCTCTAATATGTTAATG 
CCATCC 
477bp 
CENPF Exon 12A F CCAAGTGATCCACTTTCT 
AGGAG 
600bp 
CENPF Exon 12A R AACACGTTGTGAAGGTTT 
CTGA 
600bp 
CENPF Exon 12B F AACTTGTCTGAAGACACA 
GCAAA 
 
549bp 
CENPF Exon 12B R TTCATCTGTTTTTGAGAC 
TCTAATGA 
 
549bp 
CENPF Exon 12C F CTGCCATGCATCATTCCT 
TT 
 
737bp 
CENPF Exon 12C R TCTTTTCCTGTGCTGCTT 
TG 
 
737bp 
CENPF Exon 12D F CAGAGTTATCTGATCAGT 
ACAAGCAA 
 
672bp 
CENPF Exon 12D R TGCAAATTGCTGGTTTCA 
AG 
 
672bp 
CENPF Exon 12E F CGCAGTTGGTGCAATTAG 
AA 
 
413bp 
CENPF Exon 12E R CACCATGGAGAAGACCA 
CTG 
 
413bp 
CENPF Exon 12F F AAGAGGTAGGGAAACTA 
CTAAATGAA 
 
600bp 
CENPF Exon 12F R TCAGATTCTCCTCCTGCA 
GAC 
600bp 
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CENPF Exon 12G F TCTTGTGTGCCTGACAGC 
TC 
 
662bp 
CENPF Exon 12G R TTGGTGTATTTTATTTCCT 
TGAACC 
 
662bp 
CENPF Exon 13A F CCTGAATATTCTTAGCAA 
GGGAAA 
 
592bp 
CENPF Exon 13A R CCCGCAGTTGAAGATTAT 
GG 
 
592bp 
CENPF Exon 13B F GAAACCCACAGGAGAGT 
GCT 
 
456bp 
CENPF Exon 13B R TTCACGTGATGATTTATC 
TGCAT 
 
456bp 
CENPF Exon 13C F CAGGAGGTACAACTAATG 
ACCAAA 
 
422bp 
CENPF Exon 13C R ATCCAGTGCCGTGGTTTT 
T 
 
422bp 
CENPF Exon 13D F TGAGCATGAAGCCCTCTA 
CC 
 
453bp 
CENPF Exon 13D R TGCAGGCTTTCAGATTCC 
TT 
 
453bp 
CENPF Exon 13E F GGCAGAGGTGAAGGAAA 
AGA 
 
389bp 
CENPF Exon 13E R GCTCCTGGTTTTCTTCTG 
ACA 
 
389bp 
CENPF Exon 13F F ACACAGGAGGAAGTGCA 
TCA 
 
446bp 
CENPF Exon 13F R GGGCTCTCAGCTTTTCAA 
TG 
 
446bp 
CENPF Exon 13G F AAAACTGCAGTGGAGAT 
GCTT 
393bp 
CENPF Exon 13G R TTCGCTCTTGCTCTTTTT 
GTAA 
393bp 
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CENPF Exon 13I F AGCCCTGCATAATGACCA 
AG 
 
478bp 
CENPF Exon 13I R TGGTTTCCTGCCTCATGA 
CT 
 
478bp 
CENPF Exon 14 F TGTTGTATCAGAGTGGTC 
GATCT 
262bp 
CENPF Exon 14 R GGAACCAATAAGGAGAG 
TGTGC 
262bp 
CENPF Exon 15 F TGTACAGATTTTATCTTG 
CCCATAA 
413bp 
CENPF Exon 15 R CTGGGGAAAAGATCGTG 
AAG 
413bp 
CENPF Exon 16 F ACTGCGCCCAGCTGTTTT 352bp 
CENPF Exon 16 R TGATGAATGACATCATTT 
TTGACT 
352bp 
CENPF Exon 17 F CGTGAATGGTTTTGTGCA 
TC 
432bp 
CENPF Exon 17 R GCACAAAATTCAGAAATT 
GGAA 
432bp 
CENPF Exon 18 F CCCGAACAAGAGTTGTTT 
GAA 
773bp 
CENPF Exon 18 R GGAAAACATATGCCTCAT 
CCA 
773bp 
CENPF Exon 19 F TGACCACAGTGGCTAGG 
ACA 
352bp 
CENPF Exon 19 R GTCCAATCCTCACCCAG 
GTA 
352bp 
CENPF Exon 20 F GGGACGTCTGATGACTG 
GTT 
454bp 
CENPF Exon 20 R TCCTGTAGGCACAGCCTT 
ATC 
454bp 
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LB-ampicillin agar plates containing 80 µg/ml of X-gal and 20mM IPTG. 
The transformation plates were incubated at 37oC for 16 hours. 
2.2.5 Immunolabelling techniques 
2.2.5.1       Antibodies 
The following antibodies and their dilutions were used. Mouse 
monoclonal anti-CENPF [1: 200; Abcam (catalogue number, ab 90)], 
rabbit polyclonal anti-IFT88 (1:800; Proteintech, catalogue number, 
13967-1-AP), mouse monoclonal anti-NuMA (1:200; BD Transduction 
Laboratories, 610562), rabbit polyclonal anti-KIF3B (1:50; Abcam, 
ab42494), mouse monoclonal anti-acetylated-tubulin (1:800; Sigma-
Aldrich, T6793 - clone 6-11B-1), mouse monoclonal anti-gamma-tubulin 
(1:500; Sigma-Aldrich, T6557), mouse monoclonal anti-GT335 (1:800; 
Novus Biologicals), anti-myc antibody (1:100, Sigma M4439), anti-
Pericentrin (1:200; Abcam, ab4448), rabbit polyclonal anti-Ninein 
(1:200; Abcam, ab 4447), mouse monoclonal p150 Glued Dynactin (1:100; 
BD Transduction laboratories, catalogue number 612709), anti-Phospho-
histone serine 10 (1:250, BD Transduction Laboratories) and anti-
Cytokeratin 8 (1:100; Sigma). Alexa-488, Alexa-594 and Alexa-647 
conjugated secondary antibodies were obtained from Invitrogen.  
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2.2.5.2 Preparation of cells for immunolabelling 
For immuno-staining of NIH 3T3 fibroblasts, cells were seeded onto 
18mm round glass coverslips (VWR International, catalogue number 
631-053) and grown in DMEM +10% Foetal Bovine Serum + 
Penicillin/Streptomycin until they reached 70% confluency after which 
medium was replaced with DMEM without serum overnight. For 
immuno-staining of cilia, basal bodies and centrosomes, coverslips were 
fixed in 4% formaldehyde for 5 minutes. Following washing with 1x 
PBS, coverslips were incubated in 1% foetal bovine serum/PBS and 
washed again in 1xPBS. Coverslips were then incubated in ice cold 
acetone for 1 minute and were then rehydrated in PBS prior to blocking 
in 1% foetal bovine serum/PBS. Primary antibody incubations were 
performed at room temperature for one hour in 1% foetal bovine 
serum/PBS. Secondary antibody and DAPI incubations were performed 
for 1 hour at room temperature in 1% foetal bovine serum/PBS. 
Coverslips were mounted in Vectashield antifade reagent (Invitrogen).  
2.2.5.3 Preparation of tissue sections for immunolabelling 
For immunostaining of mouse and human kidney tissue, kidneys were 
dissected from wild-type mice and were fixed in 4% paraformaldehyde at 
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4oC overnight. Murine kidneys were then dehydrated, embedded in wax 
and sectioned at 12 μm. 
2.2.5.4 Tissue immunolabelling 
Microwave antigen retrieval was carried out in citrate buffer in four 5-
minute cycles at medium-hi setting (Panasonic NN-S758WC, 950W max. 
output) followed by a 20 minute cooling period at room temperature. 
Tissue sections were blocked in Universal Blocking Reagent (DAKO). 
For monoclonal incubations, sections were blocked in 5% goat serum for 
one hour. Primary antibody incubations were carried out at 4°C 
overnight. Biotin-conjugated secondary antibodies were diluted 1:1000 in 
blocking reagent, and incubated at room temperature. Primary antibody 
incubations were carried out simultaneously. AlexaFluor 488-, 
AlexaFluor 594-, or Cy5- conjugated secondary antibodies (1:1000; 
Invitrogen) were used for multi-immunofluorescence labelling. Sections 
were counterstained with DAPI, and imaged by fluorescence microscopy 
using a Zeiss Axioskop microscope with an EXFO X-Cite120 120W 
mercury vapour lamp (Photonics Solutions). Digital photographs were 
obtained as above, and merged images were obtained using Photoshop 
v6.0. 
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Table 2.2: Reaction mixtures for control and sample reactions for 
site-directed mutagenesis. 
Reagents Control Reaction Sample Reaction 
10x Reaction buffer 5µl 5µl 
pWhitescript 4.5Kb 
control template  
(5ng/µl ) 
 
2 µl (10ng)  
dsDNA template  5-50ng 
Oligonucleotide 
control primer #1 
(100ng/ µl) 
 
1.25 µl (125ng)  
Oligonucleotide 
control primer #2 
(100ng/ µl) 
 
1.25 µl (125ng)  
Oligonucleotide 
sample primer #1 
(100ng/ µl) 
 
 1.25 µl (125ng) 
Oligonucleotide 
sample primer #1 
(100ng/ µl) 
 
 1.25 µl (125ng) 
dNTP mix 1 µl 1 µl 
ddH2O 50 µl 50 µl 
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Table 2.3: Cycling parameters for site-directed mutagenesis reaction. 
Segment Cycles Temperature Time 
1 1 95oC 30 seconds 
2 12-18 95oC 
55oC 
68oC 
30 seconds 
1 minute 
1 minute/kb 
length 
 
 
2.2.6. Microscopy 
2.2.6.1 Confocal microscopy 
Confocal imaging was performed using a Zeiss LSM-710 system with an 
upright DM6000 compound microscope. Confocal imaging uses a 
pinhole to restrict further the volume of light detected to create an optical 
slice. The thickness of the optical slice may be changed by modifying the 
pinhole aperture diameter. Fluorescent immunolabelling of tissue was 
imaged with a 63 x objective using 488, 568 and DAPI filters. Images 
were processed with the Zen software suite. Z stacks were acquired at 
0.5-μm intervals and converted to single planes by maximum projection 
with FiJi software. 
2.2.6.2 ApoTome microscopy 
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ApoTome imaging was performed using a Zeiss HBO-100 system with a 
Zeiss Imager Z.1 and images were processed with the Axiovision 
software suite (version 4.8). ApoTome imaging uses a grid and an 
algorithim to create an optical slice. Optical slice thickness is fixed and 
depends on the wavelength and the numerical aperture of the objective. 
Images were taken with 20x, 40x and 63x objective. Fluorescent 
immunolabelling of tissue was imaged using 488, 568 and DAPI filters. 
2.2.6.3 Electron microscopy  
For immunogold labelling of RPE cells, cells were serum starved at 70% 
confluency for 3 days and then fixed in 0.25% glutaraldehyde + 4% 
formaldehyde in 0.1 M cacodylate buffer, pH 7.4, and processed for 
embedment in LR White. Ultrathin sections (70 nm) were labelled with 
primary antibody, followed by secondary antibody conjugated to 12 nm 
gold particles. 
2.2.7 Protein techniques 
2.2.7.1 Cell synchronisation studies  
HEKT293, NIH 3T3 fibroblasts and RPE cells were grown under 
standard media conditions. Cells were serum-starved at 40-70% 
confluency for 72 hours. For mitosis block, cells were treated with 2mM 
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Thymidine at 40% confluency for 24 hours, released into standard media 
for 3 hours and then treated with Nocodazole 100ng/μl for a further 12 
hours. 
2.2.7.2 Protein lysis 
On the day before protein lysis, HEKT293, NIH 3T3 fibroblasts or RPE 
cells were plated onto tissue culture 100mm (Corning Incorporated, 
catalogue number 430166) dishes with 10 mls of DMEM medium 
containing 10% FBS and 1% Penicillin/streptomycin. The following day, 
the medium was removed from the adhered cells, which were then 
washed with 1xPBS. Following removal of 1xPBS, 1ml of RIPA lysis 
buffer supplemented with protease inhibitors as follows: 50μl sodium 
orthovanadate, 200μl protease inhibitor cocktail (Sigma, P8340 AEBSF, 
104mM Aprotinin, 80 μM Bestatin, 4mM E-64, 1.4mM Leupeptin, 2mM 
Pepstatin A, 1.5mM), 100 μl phenylmethanesulfonyl fluoride (PMSF) 
were added to the cells while the tissue culture dishes were placed on ice. 
Using sterile cell scrapers (Greiner BioOne), cells were scraped from the 
bottom of the tissue culture dish, while placed on ice, in the cold lysis 
buffer. 1ml of protein lysate per tissue culture dish was pipetted into a 
fresh 1.5ml Eppendorf tube on ice. Using an 18-guage needle and a 1 ml 
syringe, cells were further lysed in the Eppendorf tube by syringing the 
lysate 10 times. The Eppendorf tubes containing the lysates were then left 
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on ice and gently rocked for 15 minutes. Next, the Eppendorf tubes 
containing the lysates were placed in a microfuge at 4oC and centrifuged 
at 14,000rpm for 15 minutes. The supernatant was then removed and 
placed in a fresh 1.5ml Eppendorf tube. 
2.2.7.3 Quantification of protein 
Protein content of cell lysates was quantified using a Pierec bicinchoninic 
acid (BCA protein assay kit (ThermoScientific, catalogue number 23225). 
Diluted albumin standards were prepared with 2mg/ml albumin standard 
ampoules (Table 2.5). Next the BCA working reagent was prepared by 
mixing 50 parts of BCA Reagent A with 1 part of BCA Reagent B (50:1, 
Reagent A:B). 10μl of each standard and unknown sample replicate was 
pipetted into each well of a 96-well plate. Then 200 μl of the BCA 
working reagent was added to each tube and mixed well. The plate was 
then covered and incubated at 37oC for 30 minutes. The protein samples 
were added to the plate in triplicate. Protein quantification was then 
determined by its absorbance at 562 nm on a plate reader (MultiSKAN 
FC, ThermoScientific). The concentration of the protein was then 
calculated from the A562 value (1A562 Unit= 500 μg/ml protein).  
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Table 2.4: Diluted albumin standards 
 
 Volume of 
Diluent 
Volume and 
Source of BSA 
Final BSA 
Concentration 
(µg/ml) 
Vial µl µl µl 
A 0 300 of stock 2000 
B 125 375 of stock 1500 
C 325 325 of stock 1000 
D 175 175 of vial B 
dilution 
750 
E 325 325 of vial C 
dilution 
500 
F 325 325 of vial E 
dilution 
250 
G 325 325 of vial F 
dilution 
125 
H 400 100 of vial F 
dilution 
25 
I 400 0 0 
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2.2.7.4 Co-Immunoprecipitation studies 
2.2.7.4.1 Antibody coupling with cell lysates 
On the first day, 1 ml (1000mg/ml) of protein lysate was incubated with 
primary antibody (dilution 1:100) in a 1.5ml Eppendorf tube while 
rotating gently on a roller overnight at 4oC. 
2.2.7.4.2 Dynabeads 
Prior to use, host-specific Dynabeads ® (Invitrogen, catalogue numbers 
110.41, 112.03D) were completely resuspended by rotating on a roller for 
5 minutes. Next, the Dynabeads were washed by pipetting 50 µl into a 
1.5ml Eppendorf tube with 1ml of 1xPBS and gently rotating for 5 mins. 
Following each wash, the Eppendorf tubes containing the Dynabeads 
were placed in a magnet (Invitrogen, Dyna-Mag2TM device, catalogue 
number 123-21D) and the supernatant was removed. Following removal 
from the magnet, the Dynabeads were resuspended in 1ml of fresh PBS 
and the wash was repeated as before. Following the third wash, the 
lysates containing the Ag-Ab complexes were removed from their 
Eppendorf tubes and subsequently incubated with 50 µl of the washed 
host-specific Dynabeads, while rotating gently on a roller, overnight at 
4oC. The following day, the Eppendorf tubes containing the Dynabeads-
Ab-Ag complexes were then placed in the magnet the supernatant was 
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removed with a pipette with care to avoid touching the bound Dynabeads 
and placed into a clean 1.5 ml Eppendorf tube on ice. 
2.2.7.4.3 Protein denaturation 
Prior to use, 50 µl of β-mercaptoethanol was added to 950µl of Laemmli 
Sample Buffer (BioRad). Fifty microlitres of protein lysate from both the 
supernatant and immunoprecipitates were placed in an equal volume of 
sample buffer and samples were mixed by gentle pipetting up and down. 
Next, proteins were then denatured by heating the samples containing the 
sample buffer for 5 min at 90oC. 
2.2.7.4.4 SDS-Page gel electrophoresis 
Proteins of the desired molecular weights were separated by 
electrophorectic separation by SDS-polyacrylamide gel electrophoresis 
(SDS-Page). For proteins with a molecular weight within the range of 25-
250kDa, 10% SDS-page gels were prepared as follows: (4mls H2O, 
3.3mls 30% Acrylamide, 2.5mls 1.5M Tris-HCl pH8.8, 100μl 10% SDS, 
50μl 10% APS, 5μl TEMED). Cast gels were allowed to set between a 
short plate and a spacer plate (BioRad, Mini-PROTEAN Tetra 
Electrophoresis system, catalogue number, 165-8004). Once set, 4% 
stacking gel was prepared as follows: 3mls H2O, 0.65mls 30% 
Acrylamide, 1.25mls 0.5M Tris-HCl pH 6.8, 50μl 10% APS, 5μl 
! 113!
TEMED) and poured on top of the set SDS-page gel. A ten prong comb 
(BioRad) was inserted into the stacking gel solution, which was then 
allowed to set. After solidifying, the set gels were then placed in a Mini-
PROTEAN Tetra Electrophoresis system container with 1x Running 
Buffer. The first lane of the stacking gel was loaded with 20 µl of protein 
pre-stained standard (Precision Plus Protein Kaleidoscope Standard, 
BioRad, catalogue number 161-0375; MW 10-250kDa) with 1:1 Laemmli 
Buffer. Thirty microliters of denatured protein lysate were then loaded 
into each well of the stacking gel. The lid of the gel apparatus was then 
placed on top and was connected to the PowerPac TM HC power supply 
(BioRad) under constant voltage at 120V for 90 minutes until proteins 
were electrophoresed to the desired molecular weight as determined by 
the position of the protein ladder relative to the end of the SDS-page gel 
2.2.7.4.5 Membranes 
Immuno-Blot ® Polyvinylidene difluoride (PVDF) membranes (BioRad, 
catalogue # 162-0177) were used for protein electroblotting. Prior to 
electrophorectic transfer, PVDF membranes cut to the dimensions of the 
SDS-page gel (measuring 8cm x 6cm), were thoroughly soaked in 100% 
methanol for one minute and then washed in distilled water for a further 
minute before being thoroughly soaked and equilibrated in transfer buffer 
for 15 minutes. 
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2.2.7.4.6 Transfer  
Proteins from the SDS-page gel were transferred to PVDF membranes by 
semi-dry electrophorectic transfer. Firstly, 6 sheets of Whatman filter 
paper per PVDF membrane, cut to the dimensions of the SDS-page gel 
(measuring 8cm x 6cm), were equilibrated with the SDS-page gel for 15 
minutes in transfer buffer prior to electrophorectic transfer. On 
completion of protein electrophoresis to the desired molecular weight, the 
stacking gel was excised using a sharp scalpel from the SDS-page gel. In 
preparation for a semi-dry transfer, the transfer buffer was spread lightly 
over the surface of the platinum anode plate of the Trans-Blot SD Semi-
Dry cell (BioRad). Next, three pieces of buffer-soaked Whatman filter 
paper were placed onto top of each other, and a plastic 19ml pipette was 
rolled over the surface of the filter paper to push out all air bubbles. Next, 
the pre-soaked membrane was placed on top with the protein standard on 
the left-hand side and air bubbles were further rolled out with the pipette. 
Next, the pre-soaked gel was then placed on top of the membrane so that 
it aligned with the centre of the membrane. Three further pieces of buffer-
soaked Whatman filter paper were placed, one after the other, on top of 
the PVDF membrane. Any trapped air bubbles were further rolled out. 
Care was taken not to move the membrane or gel after it was positioned 
to avoid ghost prints or artifacts. The cathode plate was then carefully 
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placed on top of the stack. Next, the safety cover was placed back onto 
the unit. The cables of the Trans-Blot SD Semi-Dry cell were then 
connected to the PowerPacTM HC power supply (BioRad) under constant 
voltage at 12 V for 45 minutes. Upon completion of the run, the cathode 
assembly was removed and the gel and membrane sandwich was 
removed. The membrane was rinsed briefly in distilled water to ensure 
that no residual gel pieces or sample adhere to the membrane. 
2.2.7.4.7 Blocking of transferred proteins 
Protein transfer was determined by the presence of the clarity of the 
transferred protein ladder. The membrane was immersed in Ponceau stain 
for up to one hour with gentle agitation, after which the membrane was 
washed in distilled water to remove background. PVDF membranes with 
the transferred proteins were then placed in clean containers of 
proportionate size containing 5% nonfat dry milk to block unbound 
membrane sites while gently rocking for 1 hour at room temperature. 
2.2.7.4.8 Primary antibody incubation 
Protein interactions were assessed by immunoblotting onto PVDF 
membranes (Millipore), detected using primary antibodies (dilution 
1:100) incubated overnight at 4oC while gently shaking on a roller. 
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2.2.7.4.9 Secondary antibody incubation 
Following overnight incubation with primary antibody at 4oC, excess 
antibody was removed by washing the PVDF membranes in 1xPBS for 4 
washes with each wash lasting 10 minutes. Next, the membranes were 
incubated with secondary rabbit and mouse- conjugated horseradish 
peroxidase (HRP) antibodies (dilution 1:2000) by gently shaking on a 
roller at room temperature for one hour. 
2.2.7.4.10 Enhanced chemiluminescence detection 
Following secondary antibody incubation, PVDF membranes were then 
washed in 1xPBS for 4 washes with each wash taking 10 minutes. Next, 
identification of specific proteins immunoblotted onto the PVDF 
membranes was detected by enhanced chemiluminescence (ECL System, 
Amersham Pharmacia Biotech; substrate, luminol). Reagent A was mixed 
with Reagent B in a 1:1 ratio and 2 mls were pipetted onto the PVDF 
membrane placed in a fresh clean container of proportionate size. The 
container was gently rocked by hand to ensure the entire PVDF 
membrane contained within was immersed in the developing solution for 
at least 1 minute. Using a forceps the edge of the PVDF membrane was 
gently lifted out of the container pouring off excess solution and was 
placed on a layer of clean dry Saran wrap so that the membrane was 
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positioned with the protein standard on the left hand side and the highest 
MW was superior whilst the lower MW was inferior. Another layer of 
clean dry Saran wrap was then placed on top of the PVDF membrane 
with care to avoid trapping of any bubbles underneath. The PVDF 
membrane covered in Saran wrap was then secured in a developing 
cassette so that the membrane was positioned with the protein ladder on 
the left hand side and the highest MW was superior whilst the lower MW 
was inferior. 
2.2.7.4.10 Developing reagents & developer 
Detection of the activated light signal was captured on X-ray film, which 
was placed on top of the PVDF membrane wrapped in Saran and 
exposure time varied between 30 seconds and 5 minutes depending on the 
antibody. Radiographs were processed using the Compact X4 processor 
(Xograph). 
2.2.8 shRNA experiments 
For CENPF gene knockdown, the ThermoScientific Open Biosystems 
pGIPZ Cenp-F (V3LMM_104294) and non-silencing control vectors 
(RHS4346) were used. RPE cells were cultured in DMEM:F12 1:1 in 
10% FBS. 5 x 104 cells were seeded per well in 24-well dishes (plastic 
bottom) in triplicate, 24 hours prior to being transduced with 1 µg of 
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Cenp-F shRNA and 1 µg non-silencing control vector. One plate was 
harvested to determine knockdown efficiency by quantitative real-time 
PCR four days following transduction, another was harvested to 
determine knockdown efficiency by western blotting for Cenp-F protein 
at 6, 12, 24, 30 and 48 hours following knockdown.  
2.2.9 Rescue experiments 
Following determination of earliest point of Cenp-F depletion, RPE cells 
were transfected with either FLAG-CENPF-WT (kind gift from Xueliang 
Zhu, Shanghai Institutes for Biological Sciences), FLAG-CENPF-
p.E582X or Nm-myc-CENPF aa 1-474 (kind gift from David Bader, 
Vanderbilt University) plasmids by using Effectene ® transfection 
reagent (Qiagen). After 48 hours, cells were processed for quantitative 
real-time PCR and western blotting to confirm restoration of CENPF 
mRNA and protein. Cells were also fixed in 4% paraformaldehyde and 
immunolabelled with anti-acetylated tubulin and % cilia-positive nuclei 
were counted (n=700). 
2.2.10 Analysis of ciliation 
 
Ciliation was induced in NIH 3T3 fibroblasts and RPE cells following 
serum starvation (1% FBS) at 70% confluency for 72 hours. 
Immunolabelling of ciliary axonemes with anti-acetylated tubulin 
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antibody allowed for detection of ciliation. Percentage of ciliated cells 
compared to total cell number as determined by number of DAPI-positive 
nuclei were quantified. Measurement of cilia length was determined using 
the Simple Neurite tracer software programme following Z-stack 
projection of imaged micrographs. 
2.2.11 Zebrafish studies 
 
2.2.11.1 Zebrafish husbandry and embryogenesis 
 
Wild type zebrafish, from AB x Tup LF were staged and housed as 
previously described (Westerfield et al., 1986). Groups of 25-50 stage-
matched embryos were collected at 8 and 18-somite stages, 24 hours post 
fertilisation (hpf), 36hpf, 48hpf, 72hpf and 96hpf. 
 
2.2.11.2 Morpholino injection 
 
For cenpf knockdown, antisense morpholino oligonucleotides (MO) 
(GeneTools, LLC) were designed against the 25 base pairs upstream of 
transcript start codon of cenpf (Table 2.5). 
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Table 2.5: Morpholino sequences for zebrafish studies 
 
Oligos 
 
 
5’-3’ sequence 
 
ATG cenpf MO 
 
 
TCCACTCTTCTACAGCCCAACTCAT 
 
Splice cenpf MO 
 
 
TGGAGTCTGAAAATGCAATATTTGA 
Embryos were injected with MO (2ng/embryo) at the 1- to 2-cell stage 
and allowed to develop at 28.5°C to desired stages.  
2.2.11.3 Whole-mount in situ hybridization 
Groups of 25-50 stage-matched embryos were collected at 18-somite 
stages were fixed in 4% PFA/PBS overnight at 4oC.  
2.2.11.3.1 Probe linearisation 
The vector containing the probe of interest was linearised using a 
restriction enzyme located at the 3’ end of the cDNA insert. 
Electrophoresis of an aliquot of the digest on an agarose gel subsequently 
determined linearisation of the vector. The linearised plasmid was then 
excised from the agarose gel with a scalpel and thereafter was extracted 
using QIAGEN PCR purification kit. The gel slice was weighed and 3 
volumes of Buffer QG to 1 volume of gel was added. During the 10 
minute incubation of the gel at 50oC, the gel was vortexed every 2-3 until 
the gel slice had completely dissolved. One volume of isopropranolol was 
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then added to the sample and mixed. The QIAquick spin column was 
placed in a 2ml collection tube and the sample was added to the 
QIAquick spin column and centrifuged for 1 minute. The flow-through 
was then discarded and the QIAquick column was placed back in the 
same collection tube. Next, 0.5ml of Buffer QG was added to the 
QIAquick column and centrifuged for 1 minute. Then, 0.75mls of Buffer 
PE was added to the QIAquick column and the sample was centrifuged 
for 1 minute. The flow-through was discarded and the QIAquick column 
was centrifuged for an additional 1 minute at 13,000 rpm. Next, the 
QIAquick column was placed into a clean 1.5ml microcentrifuge tube. 
DNA was eluted by adding 50μl of Buffer EB to the centre of the 
QIAquick membrane and the column was centrifuged for 1 minute. The 
concentration of DNA was then measured using the Nanodrop 
spectrophotometer as previously described. 
2.2.11.3.2 Transcription 
 
The linearised plasmid was transcribed with the appropriate enzyme (T3, 
T7 or SP6 polymerase). For a 20 µl reaction, 1 µg of DNA template was 
used as well as 20mM nucleotide mix, including digoxygenin (DIG) 
labeled-UTP, 40 units/ml of RNAse inhibitor, 10mM transcription buffer-
containing dithiothreitol (DTT) and 20 units/ml of the appropriate 
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enzyme. This was incubated at 37oC for 2 hours, upon which the probe 
was precipitated by addition of 100 µl ddH2O, 8 µl of 5M LiCl, 1µl of 
glycogen and 300 µl of absolute alcohol and then incubating at -20oC for 
30 minutes to overnight. The probe was centrifuged at 4oC for 15 minutes 
and washed firstly with 70% ethanol and then absolute alcohol. The pellet 
was dissolved in 15-45 µl of water for a final concentration of 
approximately 1mg/ml. The probe was denatured by heating to 95oC for 3 
minutes and diluted to a final concentration of 500-1000 ng/ml in 
hybridization buffer and stored at -20oC until required. 
2.2.11.3.3 Embryo pre-treatments 
Following removal of 4% PFA/PBS by pipetting, fixed embryos were 
washed 4 times in PBTween 0.5% each wash lasting 5 minutes. After the 
last wash, embryos were then washed into 100% MeOH and incubated at 
-20oC overnight. The following day, the embryos were then washed back 
into PBTween 0.5% for 5 washes, each wash lasting 10 minutes. 
Following the last wash, the embryos were then washed into 
Hybe:PBTween 0.5% at a ratio of 1:1.  
2.2.11.3.4  Hybridization 
The embryos were then incubated for 1 hour at 65oC in 100% Hybe 
containing yeast tRNA and heparin (see below) in an Eppendorf tube 
with gentle rocking in a Hybe oven. Next, the Hybe was removed by 
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pipetting and replaced with the riboprobe of choice at a dilution of 1:200 
to 1:600 and the embryos were incubated with the riboprobe at 65oC 
overnight. The following day, the embryos were washed in Hybe buffer, 
2xSSC followed by 0.2xSSC in the 65oC Hybe oven and then at room 
temperature.  
2.2.11.3.5 Post-hybridization washes 
Following the last wash, the embryos were washed in 1xMAB and 
incubated in blocking solution (Boehringer block 2% w/v) for 1 hour at 
room temperature with gentle shaking. After blocking, the embryos were 
incubated with anti-digoxigenin labelled antibody (Roche Applied 
Science, catalogue number, 11093274910) diluted in blocking buffer 
(dilution 1:2000) in 4oC overnight on a rolling platform.  
2.2.11.3.6  Developing 
The following day, the embryos were washed in 1xMAB for 8 washes, 
each wash lasting 15 minutes. Next, to develop the staining, the embryos 
were incubated in nitro-blue tetrazolium chloride/5-bromo-4-chloro-3’-
indolyphosphate p-toluidine salt (NBT/BCIP) solution in the dark until an 
insoluble black-purple precipitate forms, as a result of NBT/BCIP 
reaction with AP. After the colour had developed, the reaction was 
stopped by washing twice for 10 minutes in 1xTBST. The embryos were 
post-fixed in 4% PFA/PBS for 30 minutes at room temperature.  
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2.2.11.3.7 Solutions for in situ hybridization 
 
1x PBS    137mM NaCl, 3mM KCl, 10mM Na2HPO4,  
1.8mM KH2PO4, pH 7.2 
1x PBT    1x PBS + 0.1% Tween-20 
Hybridization buffer  50% Formamide, 5x SSC pH 4.5,  
50µg/ml tRNA,1% SDS,50µg/ml heparin 
Washing solution 1  50% Formamide, 5x SSC pH 4.5 
Washing solution 2  50% Formamide, 2x SSC pH 4.5 
10x TBST    1.4M NaCl, 27.0mM KCl,250.0mM Tris-HCl 
Blocking buffer   Boehringer block 2% w/v 
NTMT    100mM NaCl, 100mM Tris-HCl pH 9.5,50mM 
MgCl2, 1% Tween-20 
NBT     75mg/ml in 70% DMF 
BCIP     50mg/ml in 100% DMF 
Staining solution   NTMT+ 4.5µl/ml NBT+3.5µl/ml BCIP 
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2.2.12 Statistical analysis 
Statistical analyses were performed in GraphPad Prism version 5 
(GraphPad Prism Software Inc, USA). Numbers were reported as median 
values and comparison was made using the two sample Wilcoxon rank 
sum test where the data was not normally distributed. The empirical 
distribution of normally distributed data (the histogram) should be bell-
shaped. Numbers were reported as mean values and comparison was 
made using the Student’s t-test where the data was normally distributed. p 
< 0.05 was considered statistically significant.  
 !
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CHAPTER 3. MUTATIONS IN HUMAN CENPF CAUSE  
A NEW CILIOPATHY SYNDROME 
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3.I INTRODUCTION 
Historically, the genetic basis of human disease has been classified as 
either monogenic and rare or polygenic and common. Monogenic diseases are a 
group of rare diseases accounted for by a mutation in a single gene (of about 
25,000 genes). Currently, allelic variants have been identified in only about 
3,000 of nearly 5,400 known Mendelian disorders, thereby leaving the 
remaining 2,400 unaccounted for (Bamshad et al., 2011). Several factors have 
historically limited more traditional gene-discovery strategies (Antonarakis and 
Beckmann, 2006) which include a small number of affected individuals or 
kindreds, low penetrance, locus heterogeneity and an inability to reliably 
reproduce results. Therefore, the recent discovery of novel genomic 
technologies that involve deep sequencing of all human genes for discovery of 
pathogenic variants could potentially assist the discovery of new genes 
underlying any rare monogenic disorder. Owing to the fact that about 85% of all 
disease-causing mutations in Mendelian disorders are within coding exons, the 
recent application of massive parallel deep-sequencing with exon capture has 
shown the efficacy of this technique for the rapid identification of mutations in 
single-gene disorders (Choi et al., 2009; Ng et al., 2008). Exome sequencing 
involves the targeted resequencing of all protein-coding sequences, which 
requires 5% as much sequencing as a whole human genome (Ng et al., 2009). 
As the majority of Mendelian disorders are due to mutations that disrupt 
protein-coding sequences, the use of exome capture to identify allelic variants in 
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rare monogenic disorders is well justified. Furthermore, highly functional 
variation can also be accounted for by changes in splice acceptor and donor 
sites, sequences of which, will also be targeted by exome capture. Exome 
sequencing has led to the genetic identification of over 180 Mendelian disorders 
over the past 3 years (Bamshad et al., 2011; Gilissen et al., 2011). Also 
beginning to emerge as a consequence of next generation sequencing strategies 
is the molecular basis of novel and rare developmental phenotypes (Glazov et 
al., 2011).  
According to population-based registries of congenital anomaly in 
Europe, birth defects affect 1 in every 40 pregnancies with 360,000 new cases 
arising every year (Dolk et al., 2010). Foetal malformation syndromes account 
for 20% and investigation thereof, represent a unique opportunity to explore the 
molecular mechanisms of critical processes involved in human embryogenesis. 
Consequences of a greater understanding of how the human embryo develops, 
should provide mechanistic insight into foetal re-programming strategies in 
certain disease contexts. Therefore, in the era of regenerative medicine, it seems 
particularly timely that personalised genomics can greatly facilitate the 
elucidation of novel molecular mechanisms underlying lethal developmental 
phenotypes. 
In the current study, we employed whole exome capture coupled with 
massive parallel, deep sequencing to identify mutations in human CENPF as the 
genetic defect underlying a novel developmental phenotype.  
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3.2 RESULTS 
3.2.1 Exome capture of a single affected case is sufficient to identify the 
genetic aetiology of a novel phenotype 
A nonconsanguineous kindred consisting of six offspring of which four 
foetuses exhibited intrauterine death during the second trimester of pregnancy 
(Figure 3.1). All affected foetuses were dysmorphic with craniofacial features 
that included a high nasal bridge, short columella, micrognathia, wide mouth 
and low-set ears (Figure 3.2). Of note, neither parent nor two unaffected 
siblings exhibited dysmorphic features. Autopsy findings revealed underlying 
systemic malformations that included cerebellar vermis hypoplasia, corpus 
callosum agenesis, cleft palate, duodenal atresia and bilateral renal hypoplasia 
(Table 3.1). A search of several validated dysmorphology databases including 
the Winter-Baraitser Dysmorphology Database (WBDD) failed to show 
phenotypic identity with any known syndrome. While there was some overlap 
with syndromes such as Fryns Syndrome, Miller-Dieker lissencephaly and 
Feingold syndrome (Table 3.2), the craniofacial features were not typical of that 
described with Fryns and neither did the foetuses exhibit any terminal 
phalangeal hypoplasia, congenital diaphragmatic hernia nor pulmonary 
hypoplasia. Cytogenetic studies of the placenta, muscle and cartilage did not 
reveal any abnormalities.  
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Figure 3.1: Pedigree of novel ciliopathy phenotype. A single kindred consisting 
of nonconsanguineous parents with six offspring, of which, four were affected 
and died in utero and two were unaffected and are healthy. 
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Figure 3.2: Gross morphological features of an affected foetus. (A) 
Dysmorphic craniofacial features included a high nasal bridge, short columella, 
micrognathia, wide mouth and low-set ears (B) Gross morphological 
examination of dissected gastrointestinal tract from the same affected foetus 
revealed complete duodenal atresia (Photos courtesy of Dr Charu Deshpande). 
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Table 3.1: Clinical characteristics of genotyped subjects 
 
Affected or unaffected; ** SI= small intestine 
 
 
 
 
Status* 
 
 
Cerebral 
 
Cranio-facial 
 
Gastrointestinal 
 
Genitourinary 
 
 
1.5  
XX 
 
 
Normal 
 
Normal 
 
Normal 
 
Normal 
 
1.8  
XY 
 
 
Normal 
 
Normal 
 
Normal 
 
Normal 
 
1.1  
XY 
TOP  
21wk 
 
Hydrocephalus 
Cerebellar 
hypoplasia 
Agenesis of 
corpus callosum 
 
 
Cleft palate 
Micrognathia 
Rounded head 
Low set ears 
 
Duodenal atresia 
 
Bilateral  
renal 
hypoplasia 
 
1.2  
XX 
IUD  
17wk 
 
Hydrocephalus 
 
Prominent 
nose 
High nasal 
bridge 
Short 
columella 
Wide mouth 
 
 
Duodenal atresia 
 
Bilateral  
renal 
hypoplasia 
 
1.3  
XX  
Twin1 
IUD  
22wk 
 
 
Hydrocephalus 
Agenesis of 
corpus callosum 
 
Cleft palate 
 
Duodenal atresia 
Malrotation 
Accessory spleens 
 
Bilateral  
renal 
hypoplasia 
 
1.4  
XY  
Twin 2 
IUD  
22wk 
 
Hydrocephalus 
Agenesis of 
corpus callosum 
 
Microcrania 
Hypertelorism 
Broad nasal 
root 
Low set ears 
 
 
Duodenal atresia 
Multiple SI** 
atresia 
Malrotation 
 
Bilateral  
renal 
hypoplasia 
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Table 3.2: Differential diagnoses for novel phenotype 
!
Characteristics Subject 
Syndrome 
Fryns 
Syndrome 
OMIM 
229850 
 
Miller-Dieker 
Lissencephaly 
OMIM 
247200 
Feingold 
Syndrome 
OMIM 
164280 
Genetic Findings CENPF 
mutations 
1q41q42 
microdeletion 
LIS1 
mutations 
1. MYCN 
    Mutations 
2.MIR17HG 
 
Microcephaly √ √ √ √ 
Brain 
Abnormalities 
√ √ √  
Growth Retardation √ √ √ √ 
Downslanting 
palpebral fissures 
√    
Microretrognathia √ √ √ √ 
Ear anomalies √ √ √ √ 
Anteverted nostrils  √  √ 
Depressed Nasal 
Bridge 
√ √  √ 
Broad nasal tip  √   
Hypertelorism √ √ √  
Prominent philtrum   √  
Cleft palate √ √   
CDH*  √   
CHD**  √ √ √ 
Limb shortening  √   
Clubfoot     
Short fingers √ √  √ 
Nail/terminal 
phalanges 
hypoplasia 
 √   
Gastrointestinal 
malrotations & 
multiple atresias 
√ √ √ √ 
Renal 
Malformations 
√ √  √ 
Hydrocephalus √ √   
Cerebellar 
Malformations 
√ √   
Coarse facies  √   
Hypoplastic thorax  √   
Urogenital 
anomalies 
 √ √  
 
* CDH= congenital diaphragmatic hernia; ** CHD=congenital heart disease 
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Genome-wide single nucleotide polymorphism (SNP) analysis using high 
density SNP arrays (Affymetrix 500k Marshfield version 2) was undertaken on 
all except one member (CIL 1.1). Linkage analysis using GENEHUNTER 
version 2.1 lr5 (Multipoint) revealed ten regions with a maximum positive 
HLOD of 1.32. Linked intervals were identified on Chromosome 1 (2 intervals), 
2, 6, 7, 8, 13, 19, and 20. One of the intervals on Chromosome 1 and the 
interval on Chromosome 19 were the largest and contained the most 
homozygous markers covering a total 839 genes. Using IBD Finder, significant 
regions of homozygosity were not present, consistent with declared non-
consanguinity. We prioritised candidate genes based on their presence in the 
ciliome (www.ciliaproteome.org Version 3) and excluded mutations in eight 
transcripts including TUBB4, WDR63, DNAJB4, CENPJ, MCPH6 and RFX2.  
Given that the linked regions were large, spanning up to 33Mb on 
chromosome 1 and the recent success of whole exome capture and consecutive 
massive parallel deep sequencing for gene identification (Figure 3.3), I 
undertook exome capture of one affected and one unaffected offspring as a 
strategy to identify the underlying genetic aetiology of this novel phenotype 
(Methods). 
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Figure 3.3: Increasing number of genetically defined Mendelian disorders 
diagnosed by exome sequencing strategies. Twenty five disorders were defined 
genetically in 2010. In 2011, another 112 disorders were identified by exome 
analysis. For the first 3 months of 2012, the genetic aetiology of 48 diseases has 
been uncovered.  
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Figure 3.4: Manhattan plot of multipoint linkage analysis in a kindred with 
novel ciliopathy phenotype. Ten chromosomal regions were identified with a 
positive LOD score. Linked intervals were identified on Chromosome 1 (2 
intervals), 2, 7, 8, 12, 13, 14, 16, 19, and 20. One of the intervals on 
Chromosome 1 and the interval on Chromosome 19 were the largest and 
contained the most homozygous markers covering a total 839 genes. Plot 
derived from GENEHUNTER version 2.1 (Kruglyak et al., 1996). 
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Variants were prioritised for analysis on the basis of novel coding loss of 
function variants (predicted to severely disrupt protein coding genes): nonsense 
variants, splice-site disrupting variants, frameshift insertions or deletions, 
missense variants (Table 3.3). A further variant filtering strategy based on an 
autosomal recessive mode of inheritance, as suggested by the pedigree, 
identified 2 novel homozygous and 40 novel compound heterozygous mutations 
in 20 genes that were unique to the affected offspring (Table 3.3). Only 1 of the 
22 candidate genes, were present in a linked interval which was located on 
chromosome 1.  
 
3.2.2 Compound heterozygous mutations of human CENPF cause a novel 
syndrome 
Two novel pathogenic variants were found in the CENPF gene 
(NM_016343.3), involving a heterozygous splice-site mutation in intron 5 
(IVS5-2A>C) that was predicted to abolish the consensus splice-acceptor site 
from exon 6 (Figure 3.5.1, Figure 3.5.2) and a second heterozygous nonsense 
substitution (c.1744G>T; encoding p.E582X; NP_057427.3) (Figure 3.5.3). The 
truncating mutation in exon 12 was predicted to be “probably damaging” by 
PolyPhen (Figure 3.4.4). 
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Table 3.3: Prioritisation of variant analysis 
 
 Foetus 1.2 (Affected) Foetus 1.5 (Unaffected) 
Total Reads 43, 376, 158 43, 379, 788 
Mappable Reads 39, 220, 720 40, 429, 960 
Mean Coverage (x) 29.95 24.27 
Total variants called 42, 606 48, 254 
Novel variants 10, 432 10, 970 
Exonic + Disruptive  
Splice Site  
(Phred>50) 
4, 112 4, 306 
 
 
Nonsense, Disruptive 
Splice Site, Frameshift 
InDels & Missense 
648 656 
Homozygous 3 4 
 
Compound Heterozygous 
 
24 (48 variants) 
 
17 (34 variants) 
 
Unique to sample 
Homozygous 
 
2 
 
3 
 
Unique to sample 
Compound Heterozygous 
 
20 (40 variants) 
 
12 (24 variants) 
 
Linked regions 
 
1 
 
 
Segregation analysis 
 
 
1 
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Figure 3.4.5 describes the locations of the mutated base pairs in the genomic 
DNA, cDNA and amino acid sequence. Sanger sequencing of both variants 
confirmed segregation with affected offspring and revealed that each parent 
carried a single variant (Figure 3.6). Neither variant was detected in 200 
ethnically matched control alleles, further supporting the concept of 
pathogenicity. Furthermore, neither variant was identified in 200 control in-
house exomes. With RT-PCR, I confirmed altered splicing of CENPF RNA in 
the heterozygous parent compared to an unrelated control individual (Figure 
3.7). Sequencing revealed that the affected allele introduced a frameshift 
resulting in a premature stop codon at amino acid position 202. (p.K191fs202). 
The mutated amino acid sequence is highly conserved amongst vertebrates 
(Figure 3.8). Human CENPF consists of 20 coding exons that generate at least 
two protein-coding transcripts (as determined in Ensembl, Table 3.4).  
 
Table 3.4: Protein coding transcripts for CENPF 
 
Name Transcript ID Length 
(bp) 
Protein ID Length 
(aa) 
 
CENPF-001 
 
 
ENST00000366955 
 
10307 
 
ENSP00000355922 
 
3114 
 
CENPF-201 
 
ENST00000391896 
 
525 
 
ENSP00000375766 
 
175 
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The small transcript (ENST00000391896) is protein coding, as is the long 
transcript (ENST00000366955). The small transcript comes from an alternative 
transcription start within the intron of the long transcript (between exon 13 and 
14). The small transcript is sharing 3 exons with the long transcript (exons 
14/15/16 are similar to exons 3/4/5 in the short transcript). CENPF encodes a 
350kDa protein consisting of 3114 amino acid residues (Figure 3.9). Cenp-F is 
required for kinetochore-microtubule interactions and spindle checkpoint 
function (Yang et al., 2003) (Figure 3.10). Cenp-F was first characterised as a 
kinetochore (KT)-interacting protein, which has since been shown to have a 
dynamic localisation pattern throughout the cell cycle (Liao et al, 1995), (Figure 
3.11). In G2, Cenp-F is predominantly nuclear and binds to the nuclear 
envelope at the transition between G2 and M. In early prophase until anaphase 
onset, it is found at the KT, the attachment point for the microtubule (MT) 
network at the centromere. In early anaphase, it is found at the spindle midzone 
while in late anaphase, it migrates with dynein to the spindle poles. In early G0, 
it undergoes proteasome degradation (Varis et al., 2006). Previous studies have 
revealed many different domains, binding partners and functions of Cenp-F, 
which include microtubule-binding domains, kinetochore-binding domains and 
Nde1-binding domains. In Chapter 4, I will discuss novel functions for Cenp-F 
that helps explain the phenotype observed in the affected foetuses carrying 
CENPF mutations. 
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Figure 3.5.1: Representation of a BAM file demonstrating a heterozygous 
essential splice site nonsynonymous mutation, IVS5-2A>C at the splice 
acceptor site of human CENPF at a depth of 36x coverage. Blue lines represent 
forward reactions while maroon lines represent reverse reactions. 
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Figure 3.5.2: Pathogenicity prediction of IVS5-2A>C CENPF mutation. 
CENPF mutation IVS5-2A>C is likely to disturb normal splicing with loss of 
CENPF acceptor site.  
 
  
 143 
 
Figure 3.5.3: Representation of a BAM file demonstrating a heterozygous 
nonsynonymous mutation, c.1744G>T in exon 12 of human CENPF at a depth 
of 13x coverage. 
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Figure 3.5.4: Pathogenicity prediction of c.1744G>T CENPF mutation.  
CENPF mutation c.1744G>T is predicted to have deleterious consequences and 
results in a premature stop codon at p.E582X.  
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Figure 3.5.5: Mutated amino acids resulting from mutations in CENPF. (a) The 
heterozygous mutation, IVS5-2A>C affects the essential splice acceptor site of 
human CENPF at lysine (K) residue. (b) The heterozygous truncating mutation, 
c.1744G>T results in a premature stop codon at glutamic acid (E) residue, 582 
of human CENPF. Top rows represent position on genomic DNA, middle row 
represents position in cDNA and last row represents position in protein 
sequence.  
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Figure 3.6: Segregation of compound heterozygous mutations in CENPF.   
The heterozygous essential splice site nonsynonymous mutation, IVS5-2A>C 
segregates to the unaffected father while a heterozygous nonsynonymous 
nonsense mutation, c.1744G>T segregates to the unaffected mother and two 
unaffected siblings. Both mutations are present in all four affected foetuses. 
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Figure 3.7: Altered splicing in CENPF variant IVS5-2A>C.   
Effect of the splice-site mutation on the RNA of the heterozygous father shows 
two different products of equal intensity in lane 2 (650 bp and 230 bp for the 
upper and lower band, respectively). Lane 1 shows the product of an unrelated 
control (650 bp). 
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Figure 3.8: Conservation of mutated CENPF amino acid sequence.  
(A) Conservation of lysine residue across species from H. sapiens to M. 
musculus. (B) Conservation of glutamic acid residue across species from H. 
sapiens to R norvegicus. 
 
  
 149 
 
Figure 3.9: Schematic of CENPF gene and protein. The CENPF gene contains 
20 exons. Astersisks (white) denote location of mutations identified. CENPF 
encodes a protein of 350kDa, consisting of 3114 amino acid residues. CENPF 
protein consists of mainly colied coil domains (blue), several leucine heptad 
repeats (purple), microtubule (MT) binding domains at both the N- and C-
termini in addition to Nudel (Nde) binding, Kinetochore (KT) and Nup133-
binding domains. The kinetochore localization domain and a bipartite nuclear 
localization sequence reside in the C-terminal region. Purple arrows show 
location of two CENPF mutations near N-terminus, p.K191fs202 and p.E582X.  
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Figure 3.10: Kinetochore-microtubule interaction network. The kinetochore-
microtubule network consists of a multiprotein complex assembled on 
centromeres in mitosis and meiosis and connects with spindle microtubules. The 
C-terminal domain of Cenp-F interacts with itself, the kinesin-related motor 
protein Cenp-E and the spindle checkpoint component, Bub1 which is 
consistent with roles in chromosome segregation and/or spindle checkpoint 
control. [Adapted from (Przewloka and Glover, 2009)].  
  
 151 
 
Figure 3.11: Cenp-F has a dynamic localisation throughout the cell cycle.  
In G2, Cenp-F is predominantly nuclear and binds to the nuclear envelope (NE) 
at the transition between G2 and M phases. In early prophase until anaphase 
onset, it is found at the kinetochore (KT), the attachment point for the 
microtubule network at the centromere. In early anaphase, it is found at the 
spindle midzone while in late anaphase, it migrates with dynein to the spindle 
poles. In early G0, it undergoes proteasomal degradation. [Adapted from (Holt 
et al., 2005; Nigg and Raff, 2009), Liao et al, 1995]  
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3.3 DISCUSSION 
 
3.3.1 Whole exome sequencing identifies the genetic cause of a novel 
phenotype where conventional approaches had failed 
Whole exome capture coupled with massively parallel DNA sequencing 
has become a powerful new tool for determining nearly all the coding variation 
present in an individual human genome in a cost-effective manner. In the 
current report, I show the success of exome sequencing in circumstances where 
conventional approaches such as linkage analysis had failed. Significant locus 
heterogeneity was observed following linkage analysis with the identification of 
ten linked regions on Chromosome 1 (2 intervals), 2, 6, 7, 8, 13, 19, and 20. 
One of the intervals on Chromosome 1 and the interval on Chromosome 19 
were the largest and contained the most homozygous markers covering a total 
839 genes. Using IBD Finder, significant regions of homozygosity were not 
present, consistent with declared non-consanguinity. CENPF, the causative gene 
identified herein, lies amongst 311 other genes in a large region spanning 33Mb 
on chromosome 1. With traditional candidate gene sequencing approaches, the 
cost of time to undertake DNA sequencing would have been estimated to be 
four-fold higher than exome sequencing (Metzker, 2010). Furthermore, given 
the fact that both parents were nonconsanguineous and the compound 
heterozygous nature of the mutations identified in CENPF, it is not surprising 
that homozygosity mapping had failed. 
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3.3.2 Identification of the causal alleles through analysis of an unfiltered 
approach for depth of coverage 
A key challenge of using exome sequencing in this study was how to 
identify two different disease-related alleles in the same gene. In the current 
study, I utilised a commercial kit (Nimblegen version 1), which targeted 
180,000 exons of 25,000 genes. Newer kits now target over 50 Mb 
encompassing coding exons annotated by the GENCODE project as well as 
CCDS and RefSeq databases and incorporates exonic regions and non-coding 
RNAs (Clark et al., 2011). Limitations remain despite existing targets. First of 
all, data pertaining to the true nature of all protein-coding exons in the genome 
is still incomplete so that current capture probes only target exons that have 
been correctly annotated. Secondly, the efficiency of the capture probes varies 
such that some sequences fail to be targeted by capture probe design altogether. 
Thirdly, not all templates are sequenced with equal efficiency and alignment to 
the reference genome to facilitate base calling cannot be achieved with all 
sequences. Effective coverage (eg 50x) of exons using currently available 
commercial kits varies substantially. Indeed, in the current study, a key step in 
the identification of the second disease-related allele was achieved by not 
filtering the variants for depth of coverage, as the second allele was found at a 
depth of 13x coverage. 
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3.3.3 A single affected case was sufficient following application of a 
successful filtering strategy for finding the disease-causing variants   
Gene identification in over 180 Mendelian disorders has been achieved in 
less than 3 years (Bamshad et al., 2011) (Figure 3.1). The majority of these 
studies have compared exome sequences and variants in a small number of 
unrelated or closely related affected individuals. In the current study, I have 
shown that it is possible to identify the genetic cause in a single affected case 
through the use of a successful filtering strategy that is summarised in Table 
3.2. From a template of over 40,000 polymorphisms, variants could be further 
filtered on the basis of novelty, assuming that disease-causing alleles are likely 
to be novel and not previously described in public databases such as dbSNP and 
1000 Genomes Project in addition to those found in a set of unaffected 
individuals (> 200 in house control exomes). Therefore, all previously described 
single nucleotide polymorphisms (SNPs) are removed by the filter. In the 
current study, this reduced the number of candidate genes to just over 10,000 
variants. This strategy may be disadvantageous as potentially pathogenic 
variants may be filtered on the assumption that dbSNP does not contain any 
pathogenic alleles which is untrue. Secondly, filtering independent of the minor 
allele frequency (MAF) runs the risk of eliminating truly pathogenic alleles that 
segregate in the general population at low frequencies.  
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Further stratification of candidate alleles was determined on the basis of 
their predicted impact with greater emphasis being given to frameshift, stop 
codons and disruptions of canonical splice sites than to missense variants 
(MacArthur et al., 2012). The disadvantage to using this strategy is that certain 
causal alleles may not directly alter protein-coding sequences or canonical 
splice sites. Based on this strategy, further stratification to 650 alleles was 
achieved in the current study.  
An important next step was to consider the autosomal recessive mode of 
inheritance. A search for homozygous mutations led to the stratification of only 
3 candidate genes, none of which were in the linked region. As a result of this 
finding, a search for compound heterozygous mutations in the same gene led to 
the stratification of a further 24 candidate genes, only 1 of which lay within a 
linked interval. Therefore, the mode of inheritance clearly influenced the 
stratification design in the penultimate stages of gene identification of this 
monogenic novel disorder. The strategy of combining discrete filtering of 
exome datasets with mapping data is supported by several other successful 
reports (Bamshad et al., 2011). Depending on the production pipeline, the 
success of exome sequencing in gene identification currently lies at 50% 
(Gilissen et al., 2011). Failure to identify the candidate gene by this strategy 
may occur as a result of the causative gene not being in the target definition 
(either the gene is unknown or is not targeted by the capture probe); there is 
 156 
inadequate coverage that contains the causal variant (attributable to poor capture 
or poor sequencing); the causal variant is covered but not accurately called (eg 
in the context of a small complex indel); true novel variants are called in the 
same gene but only because of the size of the gene; false variants are called 
because of mismapped reads or errors in alignment.  
In addition to these technical failures, failure to identify the candidate 
gene by the aforementioned strategy, may also be accounted for by analytical 
failures. A major limitation of the current study was a failure to identify further 
cases of CENPF mutations in families with phenotypic overlap in the context of 
other known ciliopathy disorders. However, the likelihood that the mutations 
identified were neutral mutations was greatly reduced by the nature of the two 
mutations with one mutation affecting a canonical splice site and the second 
mutation resulting in a premature stop codon (Chen et al., 2010). Furthermore, 
an analysis of the quantitative estimate of the functional impact of both 
mutations based on analysis of high sequence conservation of affected 
nucleotides and amino acid residues for the mutated bases and amino acids was 
also applied to predict the pathogenicity. Both CENPF mutations identified 
were predicted to result in (i) loss of a splice acceptor site and (ii) truncation of 
the mutated protein.  
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3.4 SUMMARY 
In this chapter, I have identified the causative gene for a novel disorder 
through the application of next generation sequencing technologies where 
linkage analysis and homozygosity mapping had previously failed. Following 
exome capture with an early version of Nimblegen’s exome capture kit and 
establishment of a production pipeline at University College London, I 
subsequently optimised a filtering strategy for gene identification. A key step 
was to consider to omit stratification for depth of coverage. Further filtering 
thereafter for novelty and functional impact, facilitated the reduction in the 
number of possible disease-causing variants. Importantly, I have shown that, 
with this filtering strategy, it is possible to utilise the exome of just one affected 
case to identify the causative gene, provided the gene is in the target definition 
and a productive pipeline exists. Following analysis of pathogenicity 
predictions for the mutated alleles, I have shown that indeed, the mutated alleles 
segregate with the other affected foetuses in the kindred and with each parent 
carrying a single mutated allele. Importantly, it will now be possible to screen 
for further affected foetuses in future pregnancies in this kindred. 
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CHAPTER 4. DETERMINING THE ROLE OF CENPF  
IN CILIA FORMATION AND FUNCTION 
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4.1 INTRODUCTION 
 
Mutations in human CENPF have been identified for the first time in a 
novel phenotype, features of which are inconsistent with any known syndrome. 
Considering the embryonic lethality in mid-gestation in all affected foetuses, 
together with the constellation of defects affecting craniofacial development, 
cerebellar morphogenesis, palatogenesis, foregut and renal development, 
malfunction of a critical cellular process seemed most likely to underlie the 
phenotypic features observed in affected foetuses with CENPF mutations. 
Interestingly, Shh plays an important role in early craniofacial development (Hu 
and Helms, 1999), in cerebellar morphogenesis (Kim et al., 2011), in foregut 
development (Mao et al., 2010), and in renal development (Cain et al., 2009). 
Furthermore, the constellation of clinical features such as hydrocephalus, 
cerebellar malformations, cleft palate and renal malformations have been 
described in disorders associated with either abnormal formation and/or 
function of primary cilia (Table 1.2). As discussed in Chapter 1, genetic studies 
have shown that IFT proteins act at the heart of the Shh pathway, downstream 
of the transmembrane Shh receptor, Patched 1 (Ptch1) and its downstream 
effector, Smoothened (Smo) and upstream of the Gli transcription factors that 
implement the pathway (Huangfu et al., 2003). As a result, I hypothesised that 
some of the phenotypic features observed in foetuses carrying CENPF 
mutations could be attributed to defects in cilia function.  
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 Several studies supported this hypothesis. Firstly, a centrosomal 
localisation has recently been shown for murine Cenp-F, where it acts as a 
major regulator of microtubule (MT) nucleation (Moynihan et al., 2009). 
Secondly, Cenp-F has previously been shown to interact with Nde1 (Vergnolle 
and Taylor, 2007), a centrosomal phosphoprotein, recently shown to negatively 
regulate cilia length. Nde1-mediated control of ciliogenesis relies on its 
interaction with the dynein light chain, LC8, which is tethered by Nde1 to the 
basal body (Kim et al, 2011). LC8 is a component of retrograde IFT in C. 
reinhardtii (Pazour et al., 1998) where it is required for the formation of 
flagella, and has been localised to the human ciliary axoneme (Ostrowski et al., 
2002). Intriguingly, IFT88 has been shown to rescue the Nde-1 effect on ciliary 
length, (Kim et al, 2011). Furthermore, recent studies have shown that 
cytoplasmic dynein is required for the transport of IFT88 to the spindle poles 
(Delaval et al, 2011). In late anaphase, the poleward migration of cytoplasmic 
dynein depends on Nde1 (Yan et al., 2003; Zylkiewicz et al., 2011). Cenp-F 
also migrates poleward with cytoplasmic dynein in late anaphase (Yang et al, 
2003) but whether Cenp-F functions in the Nde1-LC8-IFT88  ciliogenic 
pathway is currently unknown. In this chapter, I will explore the hypothesis that 
Cenp-F regulates cilia formation.  
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4.2 RESULTS  
4.2.1. Human CENP-F shares 40% identity with a C. reinhardtii FAP58   
Given the elucidation of the Nde1-LC8-IFT88 pathway in ciliogenesis 
and the role of Chlamydomonas reinhardtii LC8 in retrograde IFT, a 
comparative genomics approach was employed as a strategy to identify 
potential novel functions of CENP-F that could be extrapolated to the loss of 
function phenotype. A BLAST analysis of the C. reinhardtii proteome revealed 
that human CENP-F protein (NP_057427.3) has 33% identity (E-value, 0.010) 
with a flagellar associated protein (FAP58, Accession: XP_001693603.1), 
previously discovered in the flagellar proteome of C. reinhardtii (Pazour et al., 
2005) (Figure 4.1.1). BLAST analysis of the Schmidtea mediterranea proteome 
for sequence similarity to C. reinhardtii FAP58 protein revealed sequence 
similarity to KIF3A-like and KIF3B-like protein sequences in the S. 
mediterranea proteome (28% identity, E-value, 2e-08; 20% identity, E-value, 7e-
05). CLUSTALW alignment with human CENP-F showed sequence similarity 
with human KIF3A (Figure 4.1.2). 
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Figure 4.1.1: Human CENP-F (NP_057427.3) shares 33% identity with a 
flagellar associated protein in the Chlamydomonas reinhardtii proteome 
(XP_001693603). 
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Figure 4.1.2: CLUSTALW alignment with human CENP-F (NP_057427.3) 
showed 36% sequence similarity with human KIF3A (NP_008985.3). 
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4.2.2. CENP-F is localised to the basal bodies and subdistal appendages of 
the mother centriole of ciliated 3T3, IMCD3 and RPE cells  
 
Based on the sequence similarity of CENP-F to C. reinhardtii FAP58 and 
the phenotypic overlap of the developmental malformations observed in 
CENPF-mutated foetuses with diseases affecting cilia function or formation, I 
hypothesised that CENP-F may be localised to primary cilia. Dual 
immunofluorescence microscopy of ciliated NIH 3T3 fibroblasts, with a mouse 
monoclonal CENPF antibody and acetylated tubulin antibody further confirmed 
a basal body localisation for CENP-F (Figure 4.2). CENP-F was not detected 
along the ciliary axonemes but colocalised with Ninein, which marks the 
subdistal appendages of the mother centriole in IMCD3 cells (Figure 4.3). To 
gain further insight into the subcellular localisation of CENP-F at the 
ultrastructural level, immunogold labelling of CENP-F in serum starved RPE 
cells were imaged by transmission electron microscopy which confirmed a 
centriolar localisation for CENP-F, where localisation was observed at the 
subdistal appendages and the distal end of the centriole (Figure 4.4).  
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Figure 4.2: CENP-F is localised at basal bodies of ciliated NIH 3T3 cells 
(A-F). Shown are representative micrographs of cilia following dual 
immunofluorescence labelling of ciliated NIH 3T3 cells with anti-CENPF and 
anti-acetylated tubulin antibodies (A, D) Green channel images showing anti-
CENPF immunodetection with Alexa488-conjugated secondary antibody. (B, 
E) Red channel images showing anti-acetylated tubulin immunodetection with 
Alexa594-conjugated secondary antibody. (C, F) Merged images of 
corresponding micrographs obtained through green and red channel images. 
Sections are counterstained with 4′, 6-diamidino-2-phenylindole DAPI. (C, F) 
White arrows, CENP-F localisation at basal bodies of primary cilia. Scale bar, 
10 µm.
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Figure 4.3: CENP-F is localised at the subdistal appendages of the mother 
centriole of ciliated IMCD3 cells 
(A-D). Shown are representative micrographs of cilia following dual 
immunofluorescence labelling of IMCD3 cells with anti-CENPF and anti-
Ninein antibodies. (A) Green channel images showing anti-CENPF 
immunodetection with Alexa488-conjugated secondary antibody. Scale bar 5µm 
(B) Red channel images showing anti-Ninein immunodetection with Alexa594-
conjugated secondary antibody. (C, D) Merged images of corresponding 
micrographs obtained through green and red channel images. Sections are 
counterstained with DAPI. (A-C) White arrows, CENP-F localisation at the 
subdistal appendages of the mother centriole. 
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Figure 4.4: Ultrastructural localisation of CENP-F (A-C). Immunogold 
localisation of CENP-F at the subdistal appendages of the mother centriole in 
serum starved RPE cells. Scale bar 100nm. (A) Black arrows point to 
immunogold particles along the microtubules of the mother centriole. (B) Black 
arrows point to immunogold particles at the subdistal appendages of the mother 
centriole. (C) Black arrows point to the subdistal appendages of the mother 
centriole of serum starved RPE cells. Scale bar 250nm. (D) Schematic showing 
molecular components of subdistal appendages. 
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4.2.3 Zebrafish cenpf morphants exhibit a high mortality at 24hpf. 
 
To understand the functional relevance of CENP-F in relation to its localisation 
at the basal body of primary cilia, I designed both translation-blocking and 
splice-blocking morpholinos against the intron 3-exon 4 boundary of zebrafish  
cenpf, which shares 60% homology with its human orthologue. Aberrant 
splicing of zebrafish cenpf  mRNA in cenpf splice morphants indicating mis-
splicing of the cenpf transcript (Figure 4.5). Given the embryonic lethality 
observed in the affected foetuses with CENPF mutations, I next analysed the 
percentage of surviving zebrafish embryos injected with standard and cenpf 
morpholino at 24 hours post fertilisation to confirm a role for zebrafish cenpf in 
early embryogenesis. Compared to controls (n=118), a significantly reduced 
number of cenpf morphants (1ng, n=136), [Std-MO mean % survival vs. cenpf-
MO (1ng) mean % survival 85±0.8 vs 46±1.2, p<0.008] survived. There was no 
significant difference in mortality between 1ng and 2ngs of cenpf MO [cenpf-
MO (1ng) mean % survival vs. cenpf-MO (2ng) mean % survival 46±1.2 vs 
35±2.8, p<0.09, ns] survived (Figure 4.6). 
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Figure 4.5: RT-PCR of RNA from cenpf splice zebrafish morphants 
demonstrating specificity of splice morpholinos. Aberrant splicing of cenpf 
mRNA in cenpf splice morphants compared to control embryos at 24 hpf.  
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Figure 4.6: Zebrafish cenpf morphants exhibit high mortality in first 24 hours. 
Quantification (%) of surviving zebrafish embryos injected with MO at 24 
hours post fertilisation. Graphic representation of results showing the mean 
percentage of survival at 24hpf of standard-MO, 1ng cenpf MO and 2ngs cenpf 
MO. Bars represent an average of three experiments. Error bars denote standard 
error of the mean (S.E.M). *p< 0.008, ** p< 0.001, ns, p< 0.09. The number of 
surviving standard-MO injected zebrafish embryos was significantly greater 
compared to the number of cenpf-MO injected embryos at 24hpf.  
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4.2.3 Zebrafish cenpf morphants exhibit a ciliopathy phenotype 
Morphological analysis of surviving zebrafish embryos revealed defects 
in body axis curvature, block-shaped somites and otolith number anomalies at 
30hpf (Figure 4.7). As these features have all been previously described in 
zebrafish injected with morpholinos targeting genes involved in cilia function, I 
next examined the morphological features of cenpf-MO that survived during the 
later stages of embryogenesis (Figure 4.8). At 48 hpf, cenpf morphants carrying 
the cardiac myosin light chain (cmcl2)-gfp transgene exhibited abnormal heart 
looping compared to standard-MO injected embryos. At 72hpf, hydrocephalus 
was also observed in cenpf morphants and at 5dpf, 100% of surviving cenpf 
morphants exhibited pronephric cysts (Figure 4.8). 
 
4.2.4 Zebrafish cenpf morphants exhibit left-right patterning defects at 18 
somites with defective ciliogenesis at Kupffer’s vesicle. 
Owing to the significant early embryonic lethality observed in zebrafish 
embryos within the first 24 hours coupled with the abnormal heart looping 
observed in embryos who survived to 48hpf, I hypothesised that left-right 
patterning (LR) defects would also be evident earlier in cenpf morphant 
zebrafish. Cilia-driven fluid flow within zebrafish Kupffer’s vesicle or across 
the mouse ventral node, has been shown to underlie a conserved symmetry 
breaking event that establishes LR pattern (Hirokawa et al., 2006; Kramer-
Zucker et al., 2005).   
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Figure 4.7: Zebrafish cenpf morphants exhibit ciliopathy features at 30hpf. (A-
F) Representative images of zebrafish embryos at 30hpf from control (A, C, E) 
and cenpf-MO (B, D, F) injected embryos. (A) Normal body axis in wild-type 
embryos. Scale bar 200 µm (B) Increased body axis curvature in cenpf-MO 
injected embryos. (C) Chevron-shaped somites in control embryos compared to 
block-shaped somites in cenpf-MO injected embryos. Scale bar 100 µm (E) 
Two otoliths present in control embryos. (F) Excess otoliths in cenpf-MO 
injected embryos. Scale bar 100 µm (G) Significantly increased number of MO-
injected embryos with increased body axis curvature. (H) Significantly 
increased number of MO-injected embryos with somite defects.  
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Figure 4.8: Surviving cenpf morphants have ciliopathy features during the later 
stages of embryogenesis. (A, B) Representative images of Tg cmlc2-gfp 
zebrafish embryos at 48hpf from control (A) and cenpf-MO (B) injected 
embryos, showing abnormal heart looping in cenpf-MO injected embryos. (C, 
D) Representative images of zebrafish embryos at 72hpf from control (C) and 
cenpf-MO (D) injected embryos, showing hydrocephalus in cenpf-MO injected 
embryos (red arrow). (E, F) Representative images of zebrafish embryos at 5dpf 
from control (E) and cenpf-MO (F) injected embryos, showing pronephric cysts 
in cenpf-MO injected embryos (red arrow). Scale bar 150µm. (G) Quantitative 
graph showing increased occurrence of axis curvature defects, laterality 
malformations, hydrocephalus and pronephric cysts in cenpf morphants (blue 
bars) compared to control embryos (red bars) and compared to cenpf morphants 
injected with human CENPF RNA (black bars). Bars represent an average of 
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three experiments. Error bars denote standard error of the mean (S.E.M). [Std-
MO (n=266) % ventral axis curvature at 24hpf vs. cenpf-MO (n=173) 12.7±1.5 
vs. 88.7±1.4, * p<0.001; cenpf-MO (n=173) vs. cenpf-MO with human CENPF 
RNA (n=256) 88.7±1.4 vs. 38.7±2.0, * p<0.001; WT (n=223) % laterality 
defects at 48hpf vs. cenpf-MO (n=152) 4.0±0.6 vs. 81.7±2.8, *p<0.001; cenpf-
MO (n=152) vs. cenpf-MO with human CENPF RNA (n=229) 81.7±2.8 vs. 
28±2.6, ***p <0.01; Std-MO (n=204) % hydrocephalus at 72hpf vs. cenpf-MO 
(n=93) 1±0.6 vs. 68.3±1.7, *p<0.001; cenpf-MO (n=93) vs. cenpf-MO with 
human CENPF RNA (n=197) 68.3±1.7 vs. 40.3±1.7, *p <0.001; Std-MO 
(n=158) % pronephric cysts at 120hpf vs. cenpf-MO (n=76) 1.2±0.9 vs. 96±0.6, 
****p<0.0001; cenpf-MO (n=76) vs. cenpf-MO with human CENPF RNA 
(n=122) 96±0.6 vs. 37.3±1.9, *p <0.001]. 
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Therefore, I next analysed expression of southpaw, the zebrafish paralogue of 
Nodal, a member of the TGF beta superfamily, which is essential for 
organisation of left-right axial structures during early embryogenesis (Figure 
4.9). At mid-somite stages, normal LR patterning can be defined by southpaw 
expression in the left lateral plate mesoderm (Kramer-Zucker et al, 2005) 
(Figure 4.9). In cenpf morphant embryos, bilateral, right-sided and absent 
expression of southpaw was significantly increased (Figure 4.9).  
To determine whether cenpf morphant laterality defects are caused by 
defects in KV cilia, I next analysed cilia formation in the KV of 8-somite-stage 
control and cenpf-MO injected zebrafish embryos. To do this, ciliary axonemes 
were labelled with an anti-acetylated tubulin antibody following fixation of 
stage-matched embryos at 8-somites. Z-stack projection of ApoTome 
micrographs through the KV floor of control (n=5 embryos) and cenpf-MO 
injected embryos (n=5 embryos) revealed that, the length of cenpf morphant 
cilia were shorter compared to controls [Control mean cilia length (µm ±SD) vs. 
cenpf-MO mean cilia length; 4.8 ±0.8 vs. 2.7±0.6, p<0.0001) (Figure 4.10).  
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Figure 4.9: Zebrafish morphants exhibit left-right patterning defects at 18 
somites. (a-d) Representative images of dorsal views of 18-somite stage 
embryos showing lateral plate mesoderm expression of southpaw mRNA by in 
situ hybridisation. Zebrafish cenpf knockdown results in left-right patterning 
defects in 18-somite stage (ss) embryos such as (b) right (arrow), (c) bilateral 
(arrows), (d) absent (arrow), southpaw mRNA expression in the lateral plate 
mesoderm compared to (a) normal left-sided expression in stage-matched 
control embryos (arrow, top left panel). Scale bar 100 µm. (e) Quantitative 
graph demonstrating number of cenpf morphants exhibiting right-sided, left-
sided, bilateral and absent southpaw expression compared to control embryos. 
Bars represent an average of three experiments. 
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Figure 4.10: Cenpf morphants exhibit defective Kupffer’s vesicle ciliogenesis. 
(A, B) Representative images of Kupffer’s vesicle of 8-somite stage embryos 
with immunofluorescence labelling of ciliary axonemes with anti-acetylated 
tubulin antibodies. (A) Red channel images showing anti- acetylated tubulin 
immunodetection with Alexa594-conjugated secondary antibody in control 
embryos. (B) Red channel images showing anti- acetylated tubulin 
immunodetection with Alexa594-conjugated secondary antibody in cenpf-MO 
injected embryos, white arrow. (C) Mean ciliary length (µm ±SD) is 
significantly reduced in cenpf-MO injected embryos compared to controls,  
** p < 0.0001. Scale bar 15µm 
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4.2.5 CENP-F depletion in vitro inhibits primary cilia formation. 
To test the role of CENP-F in cilia organisation, I next, depleted CENP-F 
protein levels by shRNA in retinal pigment epithelial cells (RPE). I observed a 
3-fold reduction in CENPF mRNA levels and a dramatic reduction in CENP-F 
protein expression in most cells when compared with control nonsilencing 
shRNAs (Figure 4.11). Following primary cilia induction by serum starvation 
for 72 hours, I next determined ciliation by immunolabelling with anti-
acetylated tubulin in RPE cells treated with CENP-F shRNA or nonsilencing 
control shRNA. In the majority of cells treated with shRNA targeting CENP-F 
(n=227), primary cilia failed to assemble (78%), whereas control cells treated 
with nonsilencing shRNAs, (n=207) assembled normal full-length primary cilia 
(22%). Furthermore, transfection of CENP-F depleted cells with full length 
CENPF rescued defective ciliogenesis while transfection of RPE cells with 
FLAG CENPF-p.E582X only partially rescued ciliogenesis (Figure 4.12).  
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Figure 4.11: CENP-F depletion inhibits primary cilia formation. (A-C) 
Representative image of serum-starved RPE cells treated with GFP-tagged 
CENP-F shRNA and immunofluorescence labelling of ciliary axonemes with 
anti-acetylated tubulin antibodies. (D) Schematic of pGIPZ vector with turbo-
GFP to track shRNA expression and Puromycin selectable marker. (E) 
Significant reduction in mean relative fold change in CENPF mRNA expression 
in CENP-F shRNA-treated RPE cells compared to control nonsilencing shRNA-
treated RPE cells. * p < 0.0001, standard test. Bars represent mean of three 
experiments. (F) Western blot showing CENP-F expression in control-shRNA 
and CENP-F shRNA transduced cells. CENP-F protein expression is 
significantly reduced at 48 hours post-transfection. 
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Figure 4.12: Ciliation in RPE cells treated with control and CENP-F shRNA. 
(A-D) Representative images showing ciliation in RPE cells after 72 hours of 
serum starvation as determined by anti-acetylated tubulin immunolabelling 
(secondary antibody conjugated with Alexa-568). (A) Normal ciliation in RPE 
cells transduced with control shRNA. (B) Reduced or absent ciliation in RPE 
cells transduced with CENP-F shRNA. (C) Rescue of ciliation in RPE cells 
transduced with CENP-F shRNA and full length CENPF. Scale bar 10µm (D) 
Transfection of RPE cells with FLAG CENPF-p.E582X only partially rescued 
ciliogenesis in serum-starved RPE cells. (E) Quantitative graph showing 
percentage ciliation of RPE cells transduced as follows: control shRNA, CENP-
F shRNA, CENP-F shRNA with full length CENPF, CENP-F shRNA with 
p.E582X CENPF. Control shRNA (n=207 cells) vs. CENP-F shRNA (n=227 
cells); 74 ±3.5 vs. 25±6.3, *** p-value<0.0001; CENP-F shRNA (n=227 cells) 
vs. CENP-F shRNA with full length CENP-F (n=180 cells); 25±6.3 vs. 62±4.1, 
*** p-value<0.0001; CENP-F shRNA with (n=227 cells) vs. CENP-F shRNA 
with FLAG CENPF-p.E582X (n=213 cells); 25±6.3 vs. 42.1±6.6, non-
significant (ns), p-value<0.09. 
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4.2.8. CENP-F colocalises with Ift88 and Kif3b in vitro and are  
 
mislocalised in renal epithelial cells of mutant foetal kidneys 
 
Owing to the fact that vertebrate primary cilia formation and function 
requires IFT and KIF proteins (Lin et al., 2003; Murcia et al., 2000; Pazour et 
al., 2000), I hypothesised that CENP-F might function with these proteins 
during primary ciliogenesis. To test this, I first determined whether CENP-F 
colocalises with Ift88 and Kif3b in ciliated interphase cells. For Ift88 
immunolabelling, I used a rabbit polyclonal anti-IFT88 antibody (Proteintech, 
13967-1-AP). Consistent with previous reports, Ift88 localised primarily to the 
distal portion of the mother centriole near the base of the primary cilium and to 
the tips and in spots along the length of primary cilia of IMCD3 cells in vitro 
and in renal epithelial cells of wild-type foetal (22 weeks gestation) kidneys in 
vivo. By dual immunofluorescence labelling, I next, showed that Ift88 
colocalised with CENP-F at centrosomes in RPE cells transfected with FLAG-
tagged full length CENPF (Figure 4.13). In addition, Kif3b also colocalised 
with CENP-F at centrosomes of NIH 3T3 fibroblasts (Figure 4.14). Next, I 
sought to determine whether loss of CENP-F function would affect ciliary 
localisation of Ift88. Compared to ciliary and basal body co-localisation in renal 
epithelial cells of wild-type foetal kidneys, Ift88 was mislocalised within the 
cytoplasm of renal epithelial cells of CENPF-mutant foetal kidneys (Figure 
4.15). 
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4.2.9. CENP-F interacts with IFT and KIF proteins involved in mitosis and 
cilia assembly  
Following the recent observation that cytoplasmic dynein 1 is required for the 
microtubule-dependent spindle pole localisation of IFT88 (Delaval et al, 2011), 
and previous reports that cytoplasmic dynein 1 is required for poleward 
movement of CENP-F (Yang et al, 2003), I hypothesised that Cenp-F might 
also be part of a complex with cytoplasmic dynein 1 and IFT88. This hypothesis 
was further supported by previous and recent observations that Nde-1, which 
interacts with the C-terminus of CENP-F is crucial in recruiting cytoplasmic 
dynein 1 to the spindle poles with Lis1 (Yan et al, Mol Cell Biol 2003; 
Vergnolle et al, 2007; Żyłkiewicz et al, 2011). Furthermore, given the previous 
localisation of kinesin II with components of the mitotic apparatus such as 
spindle microtubules and centrosomes (Haraguchi et al., 2006), I hypothesised 
that CENP-F lies in a mitotic multiprotein complex with key regulators of 
ciliogenesis that not only included IFT proteins but also kinesin II motor 
proteins. A combination of gel filtration and co-immunoprecipitation assays of 
unsynchronised, mitotic and serum-starved HeLa, HEKT293, RPE cells and 
NIH 3T3 fibroblasts, were used to test this hypothesis. Asynchronous HeLa cell 
lysates were fractionated over a Superose-6 gel filtration column (Alison Bright, 
Doxsey Lab, University of Massachusetts). Eluted fractions were probed with 
antibodies against CENP-F, IFT complex B members: IFT88, IFT52, and 
IFT20, and motors: cytoplasmic dynein 1 intermediate chain (Dyn IC 74.1) and 
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Kif3a. CENP-F co-eluted with the IFT proteins and motors, suggesting that it 
exists as a complex with these proteins (Figure 4.16).  Pairwise co-
immunoprecipitation assays of unsynchronized, mitotic and serum-starved 
HEKT293, RPE and 3T3 fibroblasts confirmed that IFT88 precipitates with 
endogenous CENP-F (Figure 4.17). I did not observe coimmunoprecipitation of 
IFT88 nor Kif3b when a nonimmune isotype specific IgG control antibody was 
used (Figure 4.17). As colocalisation of IFT88 was evident with FLAG-tagged 
full length CENPF and not with an antibody against C-terminus CENP-F, I 
hypothesised that the N-terminus of CENP-F is important for its interaction 
with IFT88. Therefore, I next, transfected RPE cells with a vector containing 
NT-myc CENPF1-474aa and sought to determine whether endogenous IFT88 
pulled down with NT-myc CENPF1-474aa. Following immunoblotting of 
precipitates of endogenous IFT88 with a MYC antibody, I confirmed that a 
protein of MW 54kDa immunoblotted with endogenous IFT88 in RPE cells 
(Figure 4.18), thereby confirming that the N-terminus of CENP-F is important 
for its interaction with IFT88. 
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Figure 4.13: Perinuclear colocalisation of Ift88 with CENP-F. Representative 
micrographs of asynchronous RPE cells following dual immunofluorescent 
labeling of RPE cells with IFT88 and FLAG antibodies following transfection 
with FLAG-tagged full length CENP-F. Merged red and green channel images 
showing anti-IFT88 immunodetection with Alexa594-conjugated secondary 
antibody and anti-FLAG immunodetection with Alexa488-conjugated 
secondary antibody. CENP-F localizes to the centrosomes with IFT88 (arrows). 
Scale bar 5 µm. Inset, high power view of CENP-F localization between two 
IFT88 foci.  
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Figure 4.14: Colocalisation of CENP-F with Kif3b in interphase NIH 3T3 
fibroblasts. (A-D) Representative image of NIH 3T3 fibroblast with 
immunofluorescence labelling of centrosomes with anti-CENPF and anti-Kif3b 
antibodies. (A) Green channel images showing anti-CENPF immunodetection 
with Alexa488-conjugated secondary antibody. (B) Red channel images 
showing anti-Kif3b immunodetection with Alexa594-conjugated secondary 
antibody. (C, D) Merged images of corresponding micrographs obtained 
through green and red channel images. Sections are counterstained with DAPI. 
Scale bar 10µm 
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Figure 4.15: Mislocalisation of Ift88 in renal epithelial cells of mutant CENPF 
foetal kidneys. (A, B) Representative micrographs of human fetal renal tubules 
following dual immunofluorescent labeling with anti-GT335 and anti-IFT88 
antibodies. (A) IFT88 localizes to long cilia within the lumina of renal 
collecting ducts of 22 week old wild-type human fetuses (arrows, left panel). 
(B) IFT88 does not localize to cilia of CENPF mutant fetal kidneys (arrows, 
right panel). Scale bar 10 µm. Inset shows absent ciliation in cell with 
intranuclear IFT88. Scale bar 10 µm. 
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Figure 4.16: Gel filtration assay demonstrating co-elution of CENP-F, IFT 
complex B members IFT88, IFT52, and IFT20, and motors: cytoplasmic dynein 
1 intermediate chain (Dyn IC 74.1) and Kif3a. Arrows indicate peak elution 
fractions for calibration proteins: Thyroglobulin (669 KDa; fraction 23), β-
amylase (200 KDa, fraction 28) and BSA (67 KDa, fraction 31). V, void 
volume. (Courtesy of Alison Bright, Doxsey Lab, University of Massachusetts). 
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Figure 4.17: Endogenous IFT88 and KIF3B precipitate with endogenous 
CENP-F in HEKT293 cells. (a) Representative images of co-
immunoprecipitation experiments carried out on protein lysates from mitotic 
HEKT293 cells containing endogenous CENP-F (size 367kDa). Immunoblots 
show that IFT88 and KIF3B co-immunoprecipitates with endogenous CENP-F 
while an IgG isotype control does not co-immunoprecipitate with IFT88. IN= 
input; ten per cent of total input is indicated. (b) Representative images of co-
immunoprecipitation experiments carried out on protein lysates from serum-
starved HEKT293 cells containing endogenous IFT88. Immunoblots show that 
IFT88 co-immunoprecipitates with endogenous CENP-F while an IgG isotype 
control does not co-immunoprecipitate with IFT88. IN= input; ten per cent of 
total input is indicated 
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Figure 4.18: Endogenous IFT88 interacts with the N-terminus of CENP-F. 
Representative images of co-immunoprecipitation experiments carried out on 
protein lysates from confluent unsynchronised RPE cells containing 
endogenous IFT88 and transfected with NT-myc CENPF1-474aa. Immunoblots 
show that NT-myc CENPF1-474aa co-immunoprecipitates with endogenous 
IFT88. IN= input; ten per cent of total input is indicated. 
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Immunoprecipitation experiments with endogenous CENP-F, failed to 
identify an interaction with the intermediate chain of cytoplasmic dynein 1, I 
next determined whether CENP-F interacted with other proteins implicated in 
dynein function. As the dynein intermediate chains interact directly with the 
p150 Glued doublet of dynactin (Vaughan and Vallee, 1995), I sought to 
determine whether CENP-F interacts with the p150 Glued doublet of dynactin. As 
a result, I used co-immunoprecipitation assays of unsynchronised RPE cells to 
confirm that endogenous CENP-F interacts with the p150 Glued doublet of 
dynactin (Figure 4.19). I did not observe coimmunoprecipitation of CENP-F 
when a non-immune isotype specific IgG control antibody was used (Figure 
4.19). Together these biochemical data suggest that CENP-F, IFT88, Kif3b and 
p150 Glued doublet of dynactin form a multiprotein complex in mitotic and 
interphase vertebrate cells, which is also likely to involve cytoplasmic dynein 1 
during early ciliogenesis. 
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Figure 4.19: CENP-F interacts with the p150 Glued dynactin subunit. 
Representative images of co-immunoprecipitation experiments carried out on 
protein lysates from unsynchronised confluent RPE cells containing 
endogenous p150 Glued dynactin. Immunoblots show that CENP-F co-
immunoprecipitates with p150 Glued dynactin and vice versa. IN= input; ten per 
cent of total input is indicated. 
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4.2.10 Mutant CENPF human foetal kidneys have short stumpy cilia 
reminiscent of phenotypes of IFT-dynein mutant cilia. 
Following my observations that cenpf morphant zebrafish show defective 
KV ciliogenesis together with a lack of ciliation in CENP-F depleted cells and 
immunoprecipitation experiments suggesting CENP-F interactions with key 
regulators of ciliogenesis, I next sought to determine what were the 
consequences of mutant CENP-F on mammalian ciliogenesis in vivo. This 
analysis was facilitated by immunofluorescence labelling of ciliary axonemes 
with anti-acetylated tubulin antibodies in kidney sections of autopsy tissue from 
a foetus carrying the CENPF mutations identified in Chapter 3 (Figure 4.15, 
4.20). While renal epithelial cilia were noted to be present, morphologically, 
cilia were noted to have a shortened and bulbous distal end appearance, which 
were reminiscent of phenotypes of IFT-dynein mutant cilia (Merrill et al., 2009; 
Ocbina et al., 2011)(Pazour et al, 1999; Porter et al, 1999) (Figure 4.15, 4.20). 
In Chlamydomonas dynein-2 mutant flagella, these morphological appearances 
have been shown to result from accumulation of IFT particles at the flagellar 
tips (Pazour et al, 1999; Porter et al, 1999).  
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Figure 4.20: Mutant CENPF human foetal kidneys have short stumpy cilia 
reminiscent of defective dynein transport. (A-D) Representative images of renal 
epithelial cilia of 22 week old wild-type (WT) foetuses (A, C) and foetuses with 
compound heterozygous CENPF mutations (B, D). (A, B) CENPF 
immunodetection with Alexa488-conjugated secondary antibody. (A) Nuclear 
localisation of Cenp-F in renal epithelial cells of wild-type foetuses (white 
arrow). Scale bar 10 µm (B) Cytoplasmic localisation of Cenp-F in affected 
foetuses (white arrows). (C, D) Red channel images showing anti-acetylated 
tubulin immunodetection with Alexa594-conjugated secondary antibody in WT 
and mutant foetuses. (C) Long cilia are observed in lumina of collecting ducts 
of WT foetuses (white arrow). (D) Short cilia are evident on renal epithelial 
cells of CENPF mutant foetal kidneys (white arrow). Sections are 
counterstained with DAPI. Scale bar 10 µm 
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4.3 DISCUSSION  
 
4.3.1 Identification of a novel role for CENP-F in ciliogenesis 
Several studies have investigated the role of CENP-F during mitosis 
(Serio et al., 2011), (Vergnolle et al, 2007), (Evans et al., 2007; Feng et al., 
2006), (Ma et al., 2006), (Bomont et al., 2005), (Holt et al, 2005), (Yang et al., 
2005), (Chan et al., 1998), (Zhu et al., 1995). CENP-F depletion leads to a 
spindle checkpoint-dependent mitotic delay that has been ascribed to its role in 
recruiting dynein and CENP-E to the kinetochore (Chan et al, 1998, Yang et al, 
2005; Feng et al, 2006). CENP-F has also been found in the cytoplasm and has 
been shown to play a role in vesicular transport and complexes with SNARE 
proteins including syntaxin 4 in the regulation of vesicular transport (Pooley et 
al., 2008). More recently, a centrosomal localisation has been shown for murine 
CENP-F, where it acts as a major regulator of microtubule nucleation 
(Moynihan et al, 2009). Here, I have identified a novel role for CENP-F in the 
regulation of ciliogenesis, initially suggested by a comparative genomics 
approach whereby the Chlamydomonas flagellar assembly protein, FAP58, 
shares 40% sequence similarity with human CENPF. Following this 
preliminary bioinformatics analysis, I subsequently demonstrated that CENP-F 
is localised to the basal bodies of serum starved 3T3 fibroblasts, which further 
supported a role for CENP-F in cilia formation and/or function.  
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In order to explore the temporal role of CENPF in embryogenesis and in 
the absence of a readily available mammalian model of CENPF loss of function, 
I chose to explore the phenotypic consequences of cenpf gene knockdown in the 
zebrafish, given the 60% sequence similarity of D. rerio cenpf to human 
CENPF. Consequently, I observed phenotypic features that were noted in 
human foetuses carrying CENPF mutations at autopsy such as embryonic 
lethality, craniofacial defects, hydrocephalus and pronephric cysts. Additional 
features observed in cenpf morphant zebrafish included abnormal heart looping, 
increased body axis curvature and block-shaped somites, features of which have 
been described with other zebrafish ciliopathy mutants (Kramer-Zucker et al, 
2005; Delaval et al 2011). Owing to the high rate of early embryonic lethality 
and abnormal heart looping, I hypothesised that cenpf may play a role in KV 
function. Analysis for left-right patterning defects in mid-somite staged 
embryos revealed a combination of right-sided, bilateral and absent expression 
of southpaw in the lateral plate mesoderm in contrast to its normal left-sided 
expression in control embryos. Consistent with previous reports (May-Simera et 
al., 2010) randomisation of southpaw expression was also shown here to be a 
consequence of shortened KV cilia. Further corroborating evidence for a role of 
CENP-F in vertebrate ciliogenesis came from the observation that CENP-F 
protein depletion in vitro resulted in a significant reduction in ciliation in cells 
treated with CENPF shRNA compared to control non-silencing shRNA, an 
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effect which has been described with other centrosomal proteins such as 
pericentrin (Jurczyk et al., 2004). 
 
4.3.2 CENP-F exists in a multiprotein complex with key regulators of 
ciliogenesis that also function in mitosis 
In order to understand the mechanisms underlying the ciliogenesis defects 
with CENP-F depletion observed in vitro and in vivo, several clues existed in 
recent literature implicating ciliogenic functions for other mitotic spindle pole 
proteins such as Nde1 and BubR1 (Kim et al, 2011), (Miyamoto et al., 2011). 
Recent elucidation of a previously uncharacterised Nde1-LC8-IFT88 pathway 
in ciliogenesis and an elegant study reporting the cytoplasmic dynein 1-
dependent spindle pole localisation of IFT88 (Delaval et al, 2011; Kim et al 
2011) suggested that other spindle pole proteins might be implicated in 
ciliogenesis. Supporting this hypothesis were previous observations of poleward 
movement of CENP-F with cytoplasmic dynein 1 in late anaphase (Yang et al, 
2003), a process that is dependent on Nde1, (Vergnolle et al, 2007). Given that 
CENP-F interacts with Nde1, I hypothesised that CENP-F likely interacts with 
IFT88. Co-immunoprecipitation assays in protein lysates from mitotic, 
unsynchronised and serum-starved cells confirmed that Ift88 and Kif3b pulled 
down with endogenous CENP-F. The converse was also proven to be true, 
which was highly suggestive that CENP-F exists in a multiprotein complex that 
perhaps has dual roles in mitosis and ciliogenesis.  
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Interestingly, in the context of human disease, impaired cilia formation 
has been recently reported in patients with Mosaic Variegated Aneuploidy 
(MVA) syndrome, a disorder caused by mutations in BUBR1 and CEP57, a 
mitotic spindle checkpoint regulator (Miyamoto et al, 2011), (Snape et al., 
2011). BUBR1, with other proteins (Mad2, CENP-E, 3F3/2) implicated in 
spindle checkpoint inactivation are recruited to spindle poles from kinetochores 
by CENP-F, a process that relies on cytoplasmic dynein-mediated transport. 
Therefore, it is highly likely that other proteins within the spindle checkpoint 
regulatory complex will be implicated in cilia function.  
 
4.3.3. Ciliary morphology in CENPF mutant human kidneys is reminiscent 
of an IFT-Dynein defect 
Interestingly, in CENPF mutant human renal epithelial cells, ciliogenesis 
defects were observed in some but not all cells based on immunolabelling with 
an anti-acetylated tubulin and anti-GT335 antibodies. Where cilia were 
observed, abnormal cilia morphology was noted and was reminiscent of IFT-
dynein phenotypes such as that described in individuals with DYNC2H1 
mutations (Merrill et al, 2009) and more recently, in Dync2h1 mutant mice 
(Ocbina et al, 2011). Previous studies in Chlamydomonas dynein-2 mutant 
flagella showed that these shortened and bulbous cilia were consequences of 
accumulation of IFT particles at the flagellar tips (Pazour et al, 1999; Porter et 
al, 1999). Supporting this has been the recent report that double the amount of 
 201 
IFT88, accumulated in Dync2h1lln/lln ciliary axonemes (Ocbina et al, 2011). 
Given the localization of CENP-F to the subdistal appendages and its putative 
interactions with p150 Glued dynactin, it possible that CENP-F might act as a 
microtubule anchor at the subdistal appendages where ciliary cargo including 
IFT proteins are loaded during ciliogenesis. 
In the absence of the IFT-dynein retrograde motor, Smo, Gli2 and Ptch1 
traffic into cilia and accumulate which disrupts downstream Sonic hedgehog 
signal transduction. Future analysis of CENPF deficient tissue should yield 
important insights into whether certain phenotypic features of this novel 
syndrome are consequences of aberrant SHH signal transduction.  
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4.3.4 SUMMARY 
 
In this chapter, I have elucidated a potential explanation for the 
phenotypic features observed in the affected foetuses carrying mutations in 
CENPF. A novel function for CENP-F in cilia formation and function is 
proposed through modelling cenpf loss of function in D. rerio and is supported 
by the interactions found with IFT88 and Kif3b, key regulators of ciliogenesis 
together with its ultrastructural localization to the subdistal appendages. 
Furthermore, my data supports emerging evidence for the existence of a 
cytoplasmic dynein 1– dependent multiprotein complex that has dual roles in 
mitosis and ciliogenesis. Enticingly, the morphological appearances of CENPF 
mutant cilia are reminiscent of IFT-dynein phenotypes and further elucidation 
of the molecular nature and function of this complex in both mitosis and 
ciliogenesis should yield mechanistic insight into the phenotypic features 
observed in ciliopathy disorders. 
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CHAPTER 5. CENPF INTERACTS WITH PROTEINS INVOLVED IN 
MITOTIC SPINDLE ORIENTATION AND CENPF DEFICIENCY 
CAUSES DEFECTIVE KIDNEY DIFFERENTIATION. 
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5.1 INTRODUCTION 
 
In preceding chapters, I have shown a novel role for CENP-F, a 
component of the spindle checkpoint inactivation complex, in ciliogenesis. 
Interestingly, impaired cilia formation has been reported in patients with Mosaic 
Variegated Aneuploidy (MVA) syndrome, a disorder caused by mutations in 
BUBR1, a mitotic spindle checkpoint regulator (Miyamoto et al, 2011; Snape et 
al, 2011) and which has previously been shown to interact with the C-terminus 
of CENP-F. BUBR1, with other proteins (Mad2, CENP-E, 3F3/2) implicated in 
spindle checkpoint inactivation are recruited to spindle poles from kinetochores 
by CENP-F, a process that relies on cytoplasmic dynein 1 transport. Recent 
work proposes that spindle-pole and chromosome-derived signals that regulate 
cytoplasmic dynein localisation generate an intrinsic code for spindle position 
and orientation (Kiyomitsu and Cheeseman, 2012). Intriguingly, cytoplasmic 
dynein 1 is required for the microtubule-dependent spindle pole localisation of 
IFT88 during mitotic spindle orientation, a mechanism, which may help, 
explain the pathogenesis of ciliopathy-related phenotypes such renal 
cystogenesis (Delaval et al, 2011).  
Given the identification of CENP-F as a novel interacting partner of 
IFT88 in mitotic and interphase cells, I hypothesised that CENP-F may also be 
implicated in mitotic spindle orientation. This hypothesis was supported by 
previous observations of multi-astral and aberrant bipolar spindles in CENPF-
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depleted cells (Holt et al, 2005). Spindle bipolarity is achieved by the action of 
multivalent minus-end directed microtubule motor complexes, including 
NuMA, cytoplasmic dynein and dynactin in frogs (Heald et al., 1996) and the 
kinesin-like motor Ncd in Drosophila (Matthies et al., 1996). These motor 
complexes tether parallel microtubule bundles and stabilize converging 
microtubules into spindle poles on either side of the centrally located chromatin. 
In this chapter, I will explore the role of CENP-F in mitotic spindle orientation 
and determine potential mechanisms of how CENP-F could regulate 
differentiation of the renal parenchyma.  
 
5.2 RESULTS 
5.2.1 Histological analysis of human mutant CENPF kidneys suggests 
defective differentiation of the renal parenchyma 
Given the autopsy reports of renal hypoplasia in CENPF mutant foetuses, a 
systematic analysis of metanephric mesenchymal differentiation was next 
undertaken to further delineate the nature of the renal phenotype observed. 
Histological analysis of haematoxylin and eosin (H&E) stained kidney sections 
from 22-week-old foetuses carrying the CENPF compound heterozygous 
mutations described in Chapter 3 were compared with kidney sections from 22-
week-old control human foetuses. Morphological analysis suggested that mutant 
kidneys exhibited features of abnormal nephrogenesis exhibiting fewer S-
shaped bodies (glomerular precursors), glomeruli and tubules (Figure 5.1). 
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Compared to age-matched wild-type foetal kidney sections, a reduction in 
nephron number was suggested. To investigate this observation further, I next 
quantified the number of mature glomeruli. Kidney volume and glomerular 
number was measured according to published protocols (Bertram et al. 1995). 
Kidneys sectioned at 5 µm thickness were collected at 100 µm intervals and 
stained with Haematoxylin and Eosin. The area of the tissue section was 
measured with a compound microscope (see Materials) and multiplied by the 
section thickness. Total kidney volume is the sum of volumes for each section. 
Glomeruli were identified by the presence of both a podocyte layer and 
Bowman's capsule. A quantitative difference was observed (Figure 5.1) which  
suggested that CENP-F deficiency results in defective nephrogenesis.  
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Figure 5.1: Histological analysis of human mutant CENPF kidneys suggest 
defective differentiation of the renal parenchyma (A, B) Representative images 
of haematoxylin and eosin stained kidney sections from 22 week old wild-type 
kidneys (A) and kidneys from affected foetuses carrying compound 
heterozygous mutations in CENPF. Scale bar, 100µm. (A) Normal cortical 
nephrogenesis is evident with S-shaped bodies (s) and glomeruli (g) evident. 
(B) Abnormal cortical nephrogenesis in CENPF-mutant kidneys demonstrating 
a disorganised cortical area and immature glomeruli. (C). Quantitative graph 
showing a reduction in glomerular number. Wild-type glomerular number vs. 
CENPF mutant glomerular number  483.3± 116.7 vs. 75±14.4, * p < 0.02. 
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5.2.2. Mutant CENPF nephrogenic structures display aberrant NuMA 
expression within differentiating nephrogenic structures  
A key step during metanephric kidney development, is the induction of the 
metanephric mesenchyme by the outgrowing ureteric bud. Reciprocal signalling 
between the metanephric mesenchyme and the ureteric bud triggers the ureteric 
bud to initiate its first T-branch and induces the metanephric mesenchyme to 
condense and proliferate. If these tissues fail to interact properly, renal agenesis 
or severe renal hypoplasia will occur. As renal hypoplasia has been described in 
SALL1-deficient individuals (Towne-Brock Syndrome) and Sall1-deficient 
metanephric mesenchyme (Kiefer et al., 2003), I next determined, the 
expression of Sall1 in wild-type and CENPF-deficient kidneys. Sall1 is a multi-
zinc finger transcriptional regulator that is expressed in the mesenchyme fated 
to become nephrogenic blastema and is essential for ureteric bud invasion of the 
metanephric mesenchyme (Nishinakamura et al., 2001). In control foetuses, 
Sall1 expression was comparable to that of CENPF mutant foetuses, thereby 
suggesting CENP-F does not play a role in the early specification of the 
metanephric mesenchyme (Figure 5.2).  
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Figure 5.2: Sall1 expression is similar in wild-type and CENPF-mutant kidneys 
at 22 weeks gestation. (A, B) Representative images of kidney sections from 22 
week old wild-type kidneys (A) and kidneys from affected foetuses carrying 
compound heterozygous mutations in CENPF. Merged images of micrographs 
obtained through green channel (Sall1, undifferentiated metanephric 
mesenchyme, white arrows) and red channel (cytokeratin-8, ureteric buds) 
images. Sections are counterstained with DAPI. Scale bar 300 µm. 
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Owing to a reduction in the number of mature glomeruli, I next sought to 
determine whether the processes governing glomerular specification were 
present. During mammalian kidney development, the developing nephrogenic 
structures undergo a series of three primitive transformations from the renal 
vesicle (RV), to the comma and S-shaped bodies (Figure 5.3). During the S-
shaped body stage of glomerulogenesis, the proximo-distal fates of the nephron 
are specified by asymmetric expression of segment-specific markers (Cheng et 
al, 2007). Given recent reports that the Gαi-LGN/AG3-NuMA-p150 Glued 
dynactin complex is implicated in asymmetric cell division which govern cell 
fate determination (Williams et al, 2011) and the interactions identified between 
Cenp-F and p150 Glued dynactin in Chapter 4, I next sought to determine the 
expression of NuMA, a component of this pathway, in S-shaped bodies of 
CENPF-mutant kidneys. In control kidneys, NuMA expression was 
predominantly located within the distal limb of S-shaped bodies while in 
CENPF-mutant kidneys, NuMA was appeared to be expanded along the middle 
limb of S-shaped bodies. These data suggest that Cenp-F may regulate the 
localisation of components of the NuMA-p150 Glued dynactin complex during 
differentiation of nephrogenic structures.  
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Figure 5.3: Expansion of NuMA expression in S-shaped bodies of CENPF 
mutant kidneys. (A, B) Representative images of merged micrographs of S-
shaped bodies of wild-type (A) and CENPF mutant (B) kidneys stained with 
anti-NuMA (red channel, red arrows), anti-CENPF (green channel) and 
counterstained with DAPI. (C, D). Representative images of ureteric bud 
derivatives of wild-type (C) and CENPF mutant (D) kidneys stained with anti-
cytokeratin 8 (red channel, white arrows) showing defective planar polarization 
of epithelium lining collecting ducts of CENPF mutant kidneys. 
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5.2.3. CENPF interacts with NuMA and Par3, proteins involved in 
asymmetric cell division 
In order to understand the mechanisms underlying defective renal 
differentiation in CENPF mutant kidneys, I next explored the hypothesis that 
CENP-F is a component of the Gαi-LGN/AGS3-NuMA-p150glued dynactin 
complex recently implicated in asymmetric cell division and mitotic spindle 
orientation processes which govern cell fate determination (Williams et al., 
2011), (Kiyomitsu et al, 2012). This hypothesis was supported by co-
immunoprecipitation experiments in Chapter 4 showing CENP-F and p150 Glued 
dynactin interactions in addition to previous reports of multiastral and  
bipolar spindles in CENP-F depleted cells (Holt et al, 2005). Expression of the 
cortical targeting protein, NuMA, revealed misoriented and multipolar spindles 
were evident in renal tubular epithelia of affected foetuses (Figure 5.4). This 
observation supported the findings of my pairwise co-immunoprecipitation 
assays of unsynchronized HEKT293 cells which confirmed interactions with 
CENP-F, NuMA and Par3 (Figure 5.4). 
 
5.2.4. Renal tubular epithelia of CENPF mutant kidneys exhibit abnormal 
mitotic spindle orientation 
Given the role of the Gαi-LGN/AGS3-NuMA-p150glued complex in 
mitotic spindle orientation and my findings that CENP-F interacts with 
components of this complex in addition to IFT88 which has also recent 
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implicated in mitotic spindle orientation, I next sought to determine the 
orientation of the mitotic spindle in renal epithelia of the collecting ducts of 
CENPF mutant foetuses compared to age-matched wild-type controls. The 
orientation of mitotic angles to the longitudinal axis of the tubule was 
determined by dual immunofluorescent labeling of mitotic DNA with an anti-
phosphohistone H3 rabbit polyclonal antibody (Karner et al., 2009), (Karner et 
al, 2009), and of collecting ducts with an anti-cytokeratin 8 mouse monoclonal 
antibody (Karner et al, 2009). The majority of cell divisions within the 
collecting duct of wild-type foetal kidneys were well oriented with 83% being 
oriented within 30 degrees of the longitudinal axis of the tubule compared to 
65% of CENPF mutant kidneys (Figure 5.5).  
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Figure 5.4 CENP-F interacts with NuMA and Par3, proteins involved in 
spindle assembly. (A, B) Representative images of mitotic renal epithelial cells 
with dual immunofluorescence labelling of spindle poles with anti- NuMA 
antibodies and DAPI. (A) Normal bipolar spindle poles in wild-type human 
kidney cells (white arrows). (B) Tripolar and disrupted spindle poles in CENPF 
mutant kidney cells (white arrows). (C) Quantitation of mitotic cells with more 
than two spindle poles; mean±sem of three independent experiments in which 
30 mitotic cells were counted. (D) Immunoblots show that NuMA and Par 3 co-
immunoprecipitate with CENP-F in unsynchronised RPE cells. IN= input; ten 
per cent of total input is indicated. 
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Figure 5.5: Mitotic spindle misorientation in CENPF mutant renal epithelial 
cells. (A, B) Representative merged images of mitotic renal collecting duct 
epithelial cells with dual immunofluorescence labelling of mitotic DNA with 
anti- phosphohistone H3 (immunodetection with Alexa488-conjugated 
secondary antibody) and cytokeratin 8 (immunodetection with Alexa594-
conjugated secondary antibody). (A) White arrow points to mitotic orientation 
parallel to longitudinal axis of collecting duct in wild-type kidneys (B) White 
arrow points to mitotic orientation perpendicular to longitudinal axis of 
collecting duct in CENPF mutant kidneys. Scale bar 5µm (C) Graph showing 
distribution of percentage of mitotic collecting duct renal epithelial cells for 
mitotic angle orientation in wild type (blue) and CENPF mutant (red) kidneys.  
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5.3. DISCUSSION 
 
5.3.1. Characterisation of the renal phenotype of CENPF mutant foetuses 
suggests a role for CENP-F in metanephric kidney development 
All four affected foetuses who carried compound heterozygous mutations 
in CENPF were reported to have a renal phenotype suggestive of renal 
hypoplasia. Renal hypoplasia, defined as abnormally small kidneys with normal 
morphology and reduced nephron number can be difficult to differentiate form 
renal dysplasia as hypoplastic kidneys will often exhibit evidence of tissue 
maldifferentiation (Cain et al., 2010). In the absence of control tissue for 
comparison at the time of autopsy, I sought to investigate the histopathological 
features of CENPF-mutant foetal kidneys in greater detail by comparing kidney 
sections with those of age-matched control foetuses. This allowed for a 
definitive characterisation of the renal phenotype, which showed that the 
number of mature glomeruli was reduced, thereby suggestive of renal 
hypoplasia.  
As discussed in Chapter 1, a spectrum of renal disease including renal 
dysplasia, cystic dysplasia and renal cystogenesis have been associated with 
several ciliopathy disorders. However, detailed characterisation of the 
histopathological features in the clinical setting is often precluded by the 
absence of renal biopsy tissue for analysis in affected patients. As a 
consequence, disease mechanisms are then further investigated in mammalian 
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systems such as knockout mouse models and may not necessarily take into 
consideration the effects of hypomorphic mutations on phenotype 
manifestation. The availability of autopsy tissue facilitated a careful 
histopathological characterization of the renal phenotype in the current report, 
which allowed further investigation of the mechanisms underlying the renal 
phenotype. 
 
5.3.2. Mutant CENPF nephrogenic structures display aberrant NuMA 
expression within differentiating nephrogenic structures  
During kidney development, reciprocal interactions between the 
outgrowing ureteric bud and the surrounding metanephric mesenchyme are 
critical for induction of nephrogenesis (Saxen and Sariola, 1987). If these 
tissues fail to interact properly, then renal agenesis and hypoplasia will occur. 
While early specification of the metanephric mesenchyme was normal as 
suggested by normal expression of Sall1, a transcription factor implicated in 
metanephric mesencyhmal cell fate induction (Kiefer et al, 2003), I next 
examined later differentiation of intermediate nephrogenic structures such as S-
shaped bodies, in which the proximo-distal axis is specified through the 
asymmetric expression of segment-specific markers  (Cheng et al, 2003). Here, 
I observed aberrant NuMA expression within the middle domain of the S-
shaped body compared to the distal domain of wild-type S-shaped bodies. 
NuMA is a component of the Gαi-LGN/AGS3-NuMA-p150glued complex, 
 218 
which has recently been implicated in asymmetric cell division and cell fate 
induction (Williams et al, 2011). These findings together with co-
immunoprecipitation data from Chapter 4 which suggested that Cenp-F interacts 
with the p150 Glued dynactin subunit, proposed a role for Cenp-F in 
differentiation of nephrogenic structures into proximal fates which include 
glomeruli.  
 
5.3.3. CENP-F exists in a multiprotein complex implicated in mitotic 
spindle positioning 
Stem and progenitor cells use asymmetric cell divisions to regulate the 
balance between proliferation and differentiation. Studies in Drosophila and C 
elegans, show that this process is regulated by proteins asymmetrically 
distributed at the cell cortex during mitosis (Knoblich, 2008). Par3-Par6-aPKC, 
which confer polarity and Gα(i)-LGN/AGS3-NuMA-dynein/dynactin, which 
govern spindle positioning (Siller and Doe, 2009). In Chapter 4, I show that 
CENP-F co-immunoprecipitates with the p150 Glued subunit of dynactin and in 
the current report, I show that endogenous CENP-F also precipitates with 
NuMA and Par3, thereby implicating a role for CENP-F in mitotic spindle 
positioning. These data were further supported by previous reports of 
multiastral and multipolar spindles in CENPF-depleted cells (Holt et al, 2005). 
My findings of multipolar spindles, spindle pole disruption and mitotic spindle 
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orientation in renal epithelial cells of the affected foetuses provide further in 
vivo evidence for a role for CENP-F in spindle assembly and function.  
 
SUMMARY 
 
In the current chapter, I have characterised the renal phenotype of the 
affected foetuses carrying CENPF mutations. A novel role for CENP-F in 
metanephric kidney development is suggested by findings of renal hypoplasia in 
the affected foetuses. Furthermore, my data supports emerging evidence for a 
dual role for proteins implicated in spindle checkpoint inactivation, mitotic 
spindle orientation and ciliogenesis in the pathogenesis of severe ciliopathy-
related phenotypes such as renal dysplasia, hypoplasia and cystogenesis.  
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CHAPTER 6. OVERALL DISCUSSION 
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Almost a decade has passed since multisystemic disorders characterised 
primarily by a combination of retinal degeneration, renal disease and cerebral 
anomalies were first associated with mutations in ciliary genes.  The notion of a 
“ciliopathic” disorder was initially attributed to Bardet–Biedl syndrome (BBS), 
when Ansley and colleagues identified genetic mutations in BBS8 whereby the 
encoded protein was noted to have a pilF domain, suggesting a conserved role 
for BBS8 in prokaryotic pilus formation (Ansley et al., 2003). Intriguingly, the 
phenotypic consequences in one family with a homozygous null mutation in 
BBS8 included situs inversus, a known defect of the embryonic nodal cilium 
(Ansley et al, 2003). Subsequent immunohistochemical analysis confirmed the 
localisation of Bbs8 to centrosomes and basal bodies within human embryonic 
kidney cells (HEK293) in addition to spermatids, the connecting cilium of the 
retina and the ciliated columnar epithelial cells of the lung (Ansley et al, 2003). 
Further supporting evidence for a role in cilia function came from the elegant 
demonstration that other BBS orthologues in Caenorhabditis elegans, bbs1, 
bbs2 and bbs7, all localised to the nematode ciliated sensory neurons where 
osm-5, the orthologue of the mouse polycystic kidney disease gene, polaris, was 
also previously localized (Pazour et al, 2002). Thereafter, the innovative 
utilisation of comparative genomic studies whereby the proteome of the non-
flagellated organism, Arabidopsis, was subtracted from the shared proteome of 
the ciliated/flagellated organisms, Chlamydomonas and human, led to the 
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discovery of mutations in another gene, BBS5, in patients with BBS (Li et al., 
2004). Following development of the original ciliary proteome database, 
subsequent integration of ciliary proteomes from a range of different organisms 
have contributed to the current ciliary proteome database 
(http://www.ciliaproteome.org) (Gherman et al., 2006). The ciliary proteome 
database was employed by Beales and colleagues to identify mutations in 
IFT80, which encodes an intraflagellar transport protein in a subset of patients 
with Jeune asphyxiating thoracic dystrophy (JATD), following the observation 
that patients with JATD exhibited typical ciliopathy features of retinal 
degeneration, renal disease and skeletal dysplasia (Beales et al., 2007). Since 
those early seminal papers, mutations in over 60 genes have been described in 
17 ciliopathy disorders (Logan et al., 2011). Depending on the cell type, it has 
been shown that the ciliary proteome can consist of between 500 and 1800 
polypeptides and consequently, it has been estimated that several more 
ciliopathy disorders exist (Baker et al, 2010). 
 
6.1.        SUMMARY OF ACHIEVEMENTS 
 
 
 Novel genomic technologies that involve deep sequencing of all human 
genes by exon capture has led to the identification of the genetic aetiology of 
over 180 Mendelian disorders over the past 3 years. In Chapter 3, I show the 
success of exome sequencing in circumstances where conventional approaches 
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such as linkage analysis and homozygosity mapping had failed. Furthermore, 
the genetic aetiology of a novel ciliopathy disorder was identified by analysis of 
the exome of just one affected foetus following the application of a filtering 
strategy based on novelty, quality of read and mutation pathogenicity 
prediction. Owing to the compound heterozygous nature of the mutations and 
the fact that one of the mutations was discovered at a depth of coverage of only 
13x, the final success in gene identification was achieved by not prioritising 
variants based on depth of coverage. Furthermore, while significant locus 
heterogeneity was observed following linkage analysis with the identification of 
ten linked regions on Chromosome 1 (2 intervals), 2, 6, 7, 8, 13, 19, and 20, 
linkage analysis proved useful during the final steps of candidate gene selection, 
with only one candidate being present in the linked region following 
prioritisation based on novelty, quality of read and mutation pathogenicity 
prediction. 
 Following a search in several validated dysmorphology databases, the 
phenotype described in the affected foetuses with CENPF mutations, was 
inconsistent with any known disorder. Considering the embryonic lethality in 
mid-gestation in all affected foetuses, together with the constellation of defects 
affecting craniofacial development, cerebellar morphogenesis, palatogenesis, 
foregut and renal development, malfunction of a critical cellular process seemed 
most likely to underlie the phenotypic features observed in affected foetuses 
with CENPF mutations. Interestingly, one of the disorders that overlapped with 
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the phenotype in the context of familial duodenal atresia was Feingold 
syndrome, in which mutations in the SHH target gene, MYCN have been 
described (Van Bokhoven et al, 2005). Shh plays an important role in early 
craniofacial development (Hu and Helms et al 1999), in cerebellar 
morphogenesis (Kim et al, 2011), in foregut development (Mao et al, 2010), and 
in renal development (Cain et al, 2009). Furthermore, the constellation of 
clinical features such as hydrocephalus, cerebellar malformations, cleft palate 
and renal malformations have been described in disorders associated with either 
abnormal formation and/or function of primary cilia (Table 1.2). Previous 
genetic studies have shown that IFT proteins act at the heart of the Shh pathway, 
downstream of the transmembrane Shh receptor, Patched 1 (Ptch1) and its 
downstream effector, Smoothened (Smo) and upstream of the Gli transcription 
factors that implement the pathway (Huangfu et al, 2003). As a result, I 
considered that some of the phenotypic features observed in foetuses carrying 
CENPF mutations could be attributed to defects in cilia function. In Chapter 4, I 
then tested the hypothesis that CENP-F could play a role in cilia formation and 
function. Following the identification of a basal body localisation for CENP-F 
and its subsequent colocalisation with ninein, a marker of the subdistal 
appendages, I then confirmed its ultrastructural localisation at the mother 
centriole in serum-starved RPE cells. In the absence of patient cell availability 
in which to study the consequences of CENPF loss of function, I next 
determined the in vivo consequences of cenpf knockdown in the zebrafish. Even 
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at low doses of morpholino, cenpf morphants exhibited a high mortality at 
24hpf, suggesting a role for cenpf in early embryogenesis. Given the presence of 
hydrocephalus, pronephric cysts and abnormal heart looping, features which 
have been described in other zebrafish ciliopathy mutants (Adams et al., 2012), 
in addition to left-right randomisation during the segmentation stages, I next 
explored the possibility and thereafter confirmed that cenpf function is required 
for KV ciliogenesis. These data were supported by in vitro studies in which 
CENPF shRNA knockdown resulted in a significant reduction in ciliation of 
RPE cells even following serum starvation. Next, I confirmed that the CENPF 
mutation, p.E582X, could not fully rescue the lack of ciliation in transduced 
cells compared with full-length CENPF transduced cells following CENPF 
knockdown. Thereafter, I identified the cilia-related proteins, IFT88 and KIF3B, 
as novel protein interactors of CENP-F following reports that spindle pole 
localisation of IFT88 was dependent on cytoplasmic dynein (Delaval et al, 
2011) in addition to previous reports that spindle pole localisation of Nde1, a 
known interactor of CENP-F is also mediated by dynein. These data were 
supported by recent studies showing a role for Nde1 in the negative regulation 
of cilia length, a phenotype that can be rescued by IFT88 knockdown (Kim et 
al, 2011). Analysis of CENPF-mutant kidneys revealed IFT88 mislocalisation 
compared to wild-type kidneys. Therefore, I hypothesised that CENP-F exists in 
a multiprotein complex at the spindle pole, with proteins that are implicated in 
ciliogenesis as well as mitosis. Even though I failed to show that endogenous 
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CENP-F precipitates with cytoplasmic dynein, I was able to show that the p150 
Glued subunit of dynactin which interacts directly with the dynein intermediate 
chains (Vaughan et al, 1995) interacted with CENP-F which supported my 
hypothesis for a role for a spindle pole complex in early ciliogenesis. 
 Following identification of a novel function for CENP-F in a molecular 
pathway implicated in ciliogenesis, in Chapter 5, I next focussed on the 
phenotypic consequences of CENPF loss of function in vivo. Histological 
analysis of 22-week-old foetal kidney sections from foetuses carrying the 
CENPF compound heterozygous mutations suggested a renal hypoplastic 
phenotype when compared to age-matched wild-type human foetal kidneys. 
Following a quantitative analysis of number of mature glomeruli, which 
confirmed the renal hypoplasia, I next determined that CENPF-mutant kidneys 
exhibited aberrant NuMA expression within S-shaped bodies, which give rise to 
glomerular structures. Given the role of the NuMA/p150 Glued dynactin pathway 
in asymmetric cell division and my previous findings of p150 Glued dynactin 
interactions with CENP-F in Chapter 4, I next tested the hypothesis that CENP-
F plays a role in mitotic spindle orientation. Multipolar spindles were observed 
following immunolabelling with NuMA in CENPF mutant kidneys supporting a 
role for CENP-F in mitotic spindle assembly. Further analysis following dual 
immunofluorescent labelling of mitotic DNA revealed mitotic spindle 
orientation defects in collecting ducts of CENPF-mutant kidneys. These data 
supported the notion that CENP-F, like IFT88, plays a role in mitotic spindle 
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orientation and the renal hypoplastic phenotype could be a consequence of 
failure of mesenchymal differentiation.   
 
6.2.       OVERALL DISCUSSION 
 
6.2.1. Utility of next generation sequencing strategies to identify the genetic 
aetiology of novel Mendelian diseases 
Almost five years has passed since targeted enrichment of an exome by 
hybridisation of shotgun libraries was first described (Hodges et al, 2007). Two 
years later, the targeted capture and massive parallel sequencing of the exomes 
of twelve humans was published (Ng et al, 2009). The following year, the first 
reports emerged on the use of whole exome sequencing in gene identification 
(Choi et al, 2009; Ng et al, 2010). Since then, the genetic aetiology of just under 
200 Mendelian diseases has been discovered in no less than two and a half 
years. The major advantage of whole exome sequencing is that virtually all 
variants within an individual’s genome are uncovered simultaneously which 
allows for direct examination of the list of variants and candidate gene selection 
in the presence or absence of mapping studies. Variant listing is dependent on 
several factors that are dependent on the technology used. For example, the type 
of capture kit, the sequencing platform and sequencing depth can influence the 
variant listing. Additionally, the lists produced will depend on the alignment 
algorithms and the stringency settings of the bioinformatics tools employed for 
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identifying variants. For example, some disease-causing variants can be found 
at a depth of coverage of less than 10 and if the bioinformatic pipeline has a 
stringency cut-off greater than 10, it is possible that the disease-causing variant 
will be missed. Capture kits are continuously improving, initially having 
covered 27Mb and 180,000 coding exons to now up to 62Mb of the human 
genome and over 201,121 coding exons. Each platform uses biotinylated 
oligonucleotide baits complementary to the exome targets to hybridise 
sequencing libraries prepared from fragmented genomic DNA. These bound 
libraries are enriched for targeted regions by pull-down with magnetic 
streptavidin beads and then sequenced. Platforms vary, with some covering 
fewer genomic regions than the other platforms, while others are able to detect a 
greater total number of variants with additional sequencing and others capture 
untranslated regions, which are not targeted by other platforms. 
While whole exome sequencing has facilitated the genetic diagnosis of 
several known Mendelian disorders, the genetic aetiology of rare novel 
phenotypes such as that outlined in Chapter 1 are beginning to unfold. 
Investigation of the genetic aetiology of embryonic lethal phenotypes such as 
that described in the current report, will greatly facilitate the identification of 
molecular mechanisms underlying critical developmental processes. For 
example, my finding that mutations in CENPF, a gene whose role in mitosis 
was previously well characterised, can be associated with a phenotype 
reminiscent of a ciliopathy, provides insight into how mitotic multiprotein 
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complexes have dual roles to play in mitotic spindle orientation and early 
ciliogenesis.  
 
6.2.2. Linking absent cilia to mitotic and planar polarity defects 
As centriole-ciliation is associated with mitotic exit and previous reports 
of absent cilia in several Ift-knockout mice together with the recent finding that 
Ift proteins may play a role in mitotic spindle orientation, I was keen to re-
examine the original literature describing the role of both Ift and kinesin-II 
proteins in ciliogenesis. The observation that Chlamydomonas ift88 insertional 
mutants exhibit absent flagella led to the conclusion that Chlamydomonas ift88 
plays a critical role in flagellar assembly (Pazour et al, 2000). Scanning electron 
microscopy of the collecting ducts of the hypomorphic Tg737-mutant mice 
revealed much shorter cilia in homozygous mutants compared to their wild-type 
littermates when examined at postnatal days 4 and 7 (Pazour et al, 2000). 
Hypomorphic mutations in Tg737 cause kidney disease and death within a few 
weeks of birth (Moyer et al 1994) and closely resemble the cystic kidney 
phenotype observed in ARPKD. Null alleles of Tg737 have a more severe 
phenotype and cause the mice to die during midgestation and exhibit absent 
nodal cilia (Murcia et al. 2000). While characterisation of cell division has been 
not been undertaken in Tg737 mutants in vivo, Chlamydomonas ift88 insertional 
mutants have been reported not to have defects in cell division as suggested by a 
normal growth rate compared to wild-type controls. It is interesting to note that 
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Ift88 has a dynamic subcellular localisation throughout the cell cycle and 
colocalises with γ-tubulin at perinuclear foci in G1 and G2-phases (Robert et al, 
2007). Furthermore, Ift88 depletion in Hela cells results in an increased mitotic 
index and delayed mitotic progression (Delaval et al, 2011). More detailed 
analysis revealed spindle pole disruption, chromosome misalignment and 
spindle misorientation (Delaval et al, 2011). Mitotic functions for other Ift 
proteins have been disclosed recently and include Ift57, Ift52 and Ift20 
(unpublished data, personal communication).  
The phenotype caused by the null Tg737 mutation closely resembles the 
phenotype of kinesin-II knockout mice (Nonaka et al. 1998; Marszalek et al. 
1999, Takeda et al. 1999). Interestingly, similar to Ift proteins, a mitotic role for 
Kif3b has also been described (Haraguchi et al, 2005). Subcellular localisation 
of the Kif3a/3b complex is at the centrosome in interphase and prophase but 
only weak staining at the centrosome after prometaphase when it is mainly 
found at the spindle microtubules. From metaphase through telophase, Kif3a is 
concentrated at the midzone and is mainly at the centrosomes during cytokinesis 
(Haraguchi et al, 2005). Expression of a truncated Kif3b construct lacking the 
C-terminus, also results in mitotic defects such as chromosomal aneuploidy and 
abnormal spindle formation (Haraguchi et al, 2005).  
It is interesting to note that conditional deletion of Ift88 or Kif3a in adult 
mice results in loss of cilia but neither mutant develops kidney cysts or 
hydrocephalus (Davenport et al, 2007). However, deletion of Kif3a during 
 231 
tubule morphogenesis with a collecting duct-specific knockout of Kif3a using a 
Ksp-Cre transgenic mouse which is expressed from embryonic day 15.5 
onwards in the mouse, results in renal cystogenesis which begins at postnatal 
day 5 (Lin et al, 2003). In KspCre; Kif3a flox/flox mice, cyst epithelial cells in 
Kif3a mutant mice exhibited evidence of proliferation and apoptosis. 
Interestingly, apical mislocalisation of the epidermal growth factor receptor 
(EGFR) receptor was evident in mutant mice as has been also reported in other 
cystic phenotypes. To elucidate the roles of primary cilia in the kidney after 
birth, administration of tamoxifen to Ksp-CreERT2;Kif3aflox/−;R26R mice 
(conditional Kif3a mutants) at postnatal day 2 and analysis 4 weeks later 
revealed the presence of multiple cysts in the kidney. Cilia were absent from the 
lacZ-positive cyst epithelial cells in the conditional Kif3a mutant mice. Primary 
cilia were present in adjacent lacZ-negative, non-cystic tubules, indicating that 
the loss of primary cilia and cyst formation was specific to Kif3a mutant cells. 
Interestingly, kidney collecting duct-specific inactivation of Kif3a at postnatal 
day 10 or older ages did not cause cyst formation despite the loss of cilia unless 
kidneys were subjected to injury by ischaemia (Patel et al, 2008). Cysts did not 
develop in the uninjured kidney despite the loss of primary cilia, which 
indicated that ischemic injury associated cell proliferation during epithelial 
regeneration triggered cyst formation (Patel et al, 2008). Interestingly, Kif3a 
mutant kidneys exhibited mitotic spindle orientation defects compared to their 
littermate controls (only 46% of mitotic spindles were oriented within 20° of the 
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axis of the collecting ducts versus in control kidneys, where 91% of mitotic 
spindles were oriented within 20° of the longitudinal axis of the collecting 
ducts)(Patel et al, 2008). Therefore it appears that both loss of Ift88 and Kif3a 
function is associated with defects in mitotic spindle orientation and 
cystogenesis. Loss of cilia per se does not result in cystogenesis in adult 
kidneys. It is plausible to consider that renal cystogenesis in these models is a 
consequence of defective planar polarity and mitotic defects, which could 
ultimately result in defective ciliogenesis. Whether the defective ciliogenesis 
phenotype described in Tg737 epithelia is a consequence of mitotic arrest or 
defective polarity requires further investigation.  
 
6.3 FUTURE WORK 
 
6.3.1 Screening of candidate syndromes for CENPF mutations 
Following identification of CENPF as a new ciliopathy disease gene, it will be 
of great interest to determine what role CENPF loss of function plays, if any, in 
the context of other ciliopathies. Following screening of BBS and MKS cohorts, 
my colleagues did not identify any disease-causing mutations in CENPF in 
these ciliopathy phenotypes. However, given the phenotypic overlap with Fryns 
syndrome, it would be worthwhile screening this cohort of patients for 
mutations in CENPF. Of interest, CENPF lies on chromosome 1q41 and 
recently, Fryns syndrome has been reported to fit the severe end of a syndrome 
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associated with microdeletions of 1q41q42 (Rosenfeld et al., 2011). While 
CENPF does not lie within this critical microdeletion interval, it is possible that 
the genes implicated in more severe Fryns-like phenotypes lie outside this 
interval.  
Given the recent elucidation of the Nde1-LC8-IFT88 pathway, and the 
finding of NDE1 mutations in primary microcephaly phenotypes, it is possible 
that CENPF mutations may be found in other primary microcephaly cohorts 
(Alkuraya et al., 2011; Bakircioglu et al., 2011). Interestingly, mutations in 
several genes encoding centriolar proteins have recently been discovered in 
primary microcephaly and have been associated with defective ciliogenesis (Sir 
et al., 2011), (Guernsey et al., 2010; Nicholas et al., 2010; Rauch et al., 2008), 
(Bond et al., 2005) 
 
6.3.2 Relating CENP-F loss of function to organ-specific phenotypes 
Given the ciliogenesis defects and midgestation lethality observed in the 
affected foetuses features of which is reminiscent of those seen with Kif3b and 
Ift88- null mice in addition to the putative interactions suggested by my co-
immunoprecipitation assays,  it will be necessary to examine the consequences 
of murine Cenpf deletion to investigate whether Cenpf mutant mice exhibit left-
right patterning defects, hydrocephalus, cleft palate, gastrointestinal 
manifestations, cerebral or renal differentiation defects.  
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As defective planar polarity with mitotic spindle misorientation are 
evident in the kidneys of affected foetuses, future work could be directed at 
examining the role of CENP-F in kidney development and renal cystogenesis. 
In order to investigate the role of CENPF in kidney development, it will be 
necessary to delete CENPF in a spatiotemporal manner. Effects of CENPF 
depletion in the early stages of kidney development could be faciliated by 
employing a metanephric mesenchymal specific deletion of CENP-F using the 
retinoic acid receptor β isoform 2 (Rarb2)-Cre transgenic mouse line 
(Kobayashi et al., 2005). From E9.5 of mouse gestation, Rarb2-Cre, reporter 
expression is restricted to the nephric mesenchyme in the anterior region of the 
mesonephros, but not in the nephric duct epithelium. Therefore, crossbreeding 
with a conditional Cenpf flox/flox (first five exons flanked by loxP sites) 
(Moynihan et al, 2009), should facilitate analysis of the effects of CENPF 
depletion on the specification and differentiation of the developing metanephric 
mesenchyme as nephrogenesis proceeds from differentiation of the condensing 
metanephric mesenchyme to the renal vesicle, S-shaped body and specification 
of the proximal and distal fates such as podocyte progenitor, proximal tubule 
precursors and distal tubular epithelia. Metanephric kidney development begins 
with the induction of the metanephric mesenchyme by the outgrowing ureteric 
bud (Saxen et al). Reciprocal signalling between the ureteric bud and the 
metanephric mesenchyme are involved in the further differentiation of the renal 
parenchyma. Effects of Cenpf depletion in the early stages of kidney 
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development will be further facilitated by employing a ureteric bud specific 
deletion of Cenpf using the Hoxb7-Cre transgenic mouse line (Yu et al., 2002). 
From E9.5 of mouse gestation, Hoxb7-Cre, reporter expression is restricted to 
the nephric duct epithelium but not the metanephric mesenchyme. Therefore, 
crossbreeding with a transgenic conditional Cenpf flox/flox (first five exons flanked 
by lox P sites) (Moynihan et al, 2009) should facilitate analysis of the effects of 
CENPF depletion on the specification and differentiation of the developing 
metanephric mesesnchyme.  
 Following identification of a role for misorientated cell division in renal 
cystogenesis and the finding that CENP-F interacts with components of the 
mitotic spindle orientation complex, it would be interesting to determine the 
consequences of Cenpf depletion in the renal collect duct system. Utilising a 
tamoxifen inducible collecting duct-specific model of Cenpf depletion by 
crossbreeding inducible Ksp-CreERT2 (Patel et al, 2008) and Cenpf flox/flox 
transgenic mice (Moynihan et al, 2009), subsequent analysis could be 
undertaken in the early postnatal period and in adult mice to determine whether 
Cenpf is implicated in the pathogenesis of renal cysts. This should provide 
direct evidence for a role for CENP-F in the regulation of planar cell polarity 
signalling in the context of renal tubule morphogenesis, a process which has 
recently been shown to be regulated by Wnt signalling (Karner et al, 2009), of 
which NuMA,  is a downstream target and which has been shown in the present 
work, to interact with CENP-F. 
 236 
6.4 FINAL REMARKS 
I have shown the utility of whole exome sequencing in the genetic identification 
of a novel ciliopathy phenotype which is attributed to mutations in CENPF, a 
protein whose function has been well characterised in mitosis. The underlying 
mechanisms for the phenotypic overlap with other ciliopathies could be 
explained by my findings which suggests a novel role for CENP-F in vertebrate 
ciliogenesis. CENP-F localises to the subdistal appendages of the mother 
centriole and co-immunoprecipitates with proteins implicated in ciliogenesis. 
Analysis of foetal kidney sections suggests that CENP-F may also regular 
planar polarization of renal tubular epithelia. These findings are supported by 
interactions with proteins implicated in mitotic spindle orientation. Future work 
will now focus on the consequences of mammalian Cenpf depletion in the 
developing kidney and should provide support for emerging evidence which 
implicates a role for mitotic spindle orientation proteins in the pathogenesis of 
severe ciliopathy-related phenotypes such as renal dysplasia and renal 
cystogenesis. 
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